data_1w4g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1w4g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.842 0.353 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.04 164.55 9.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.405 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 29.1 mmm -76.49 141.64 69.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.431 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.599 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 72.2 Cg_exo -48.62 -45.53 27.21 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.302 2.001 . . . . 0.0 112.403 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 3.2 p -63.56 -32.67 74.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 65.6 t -66.0 -40.49 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.085 0.469 . . . . 0.0 109.791 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' HG23 ' A' ' 146' ' ' ILE . 2.5 mmm180 -63.45 -44.01 95.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.904 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -65.87 -41.1 92.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.418 ' CZ3' ' HE3' ' A' ' 142' ' ' LYS . 54.9 t-105 -58.07 -50.17 74.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.086 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.78 -52.56 64.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.033 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -54.93 -30.45 58.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.44 -35.23 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.418 ' HE3' ' CZ3' ' A' ' 138' ' ' TRP . 0.8 OUTLIER -91.75 -3.99 55.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.745 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.93 63.07 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.575 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.0 t -101.0 145.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.265 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 24.2 t0 -111.24 133.89 53.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.348 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.416 HG12 ' CB ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -58.1 -33.45 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.43 . . . . 0.0 110.797 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.85 -22.64 15.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.889 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.451 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.98 25.6 11.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.721 0.296 . . . . 0.0 111.405 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.1 t -129.04 112.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 111.247 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -80.56 73.03 7.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.75 150.47 17.67 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.651 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.09 12.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.267 . . . . 0.0 111.202 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -70.09 95.1 0.48 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.711 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.14 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.689 0.28 . . . . 0.0 111.259 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.6 p30 -97.11 5.7 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.099 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.13 26.04 4.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.621 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -77.35 122.43 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 36.5 t -71.11 102.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.843 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 mt -94.14 173.08 7.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -51.34 -30.11 17.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.654 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -69.02 -41.11 78.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.404 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -63.39 -49.39 74.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.392 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 40.9 mm -59.81 -52.28 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.275 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -31.71 61.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.332 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -33.2 49.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.183 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.451 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 18.4 t80 -60.88 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.441 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.93 -40.2 40.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.076 -179.913 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.871 0.367 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.411 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.15 166.05 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.075 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.7 mtp -91.89 149.88 39.72 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.77 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.4 -30.98 28.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.487 2.124 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -66.04 -40.69 91.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 39.3 t -72.3 -44.44 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -58.32 -46.64 85.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 109.775 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -63.09 -39.95 96.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.941 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -63.11 -46.27 88.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.221 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.37 -47.28 79.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.235 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.2 -29.53 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.864 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -80.81 -31.23 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.997 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -5.36 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.576 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.42 -10.11 64.98 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.669 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.74 145.02 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 53.6 t0 -110.65 113.36 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.222 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.411 HG12 ' CB ' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -44.47 -25.61 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -18.03 27.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.542 HD11 ' CZ ' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -115.44 29.16 8.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.621 0.248 . . . . 0.0 111.545 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.1 t -129.04 109.54 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.393 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 82.29 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.428 ' HA2' ' C ' ' A' ' 157' ' ' ARG . . . -53.6 142.57 29.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.787 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -118.25 -21.14 8.28 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.51 153.3 36.64 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.493 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 48.02 -104.8 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -105.46 30.04 6.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.734 0.302 . . . . 0.0 111.435 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.27 20.48 13.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.761 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 159' ' ' LEU . 22.4 ptt180 -85.47 154.15 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.649 0.262 . . . . 0.0 110.399 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.74 133.93 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.488 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -119.34 169.82 9.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -52.17 -30.7 28.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.02 -39.99 78.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.412 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.406 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 87.6 m-20 -64.1 -51.05 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.436 ' O ' HD21 ' A' ' 167' ' ' LEU . 42.2 mm -59.48 -52.06 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -54.38 -33.85 60.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.384 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.73 -31.19 52.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.209 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 148' ' ' LEU . 24.2 t80 -64.24 -37.66 88.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.628 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 163' ' ' ILE . 3.2 mm? -89.06 -26.64 21.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.361 -179.831 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 130' ' ' ILE . 23.8 mm . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.795 0.331 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.11 160.98 8.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.3 mtp -81.92 145.88 54.51 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.68 -32.55 45.6 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.489 2.126 . . . . 0.0 112.283 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -40.41 95.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.697 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.25 -46.26 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.2 OUTLIER -56.31 -45.7 80.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.798 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -61.92 -41.1 97.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.615 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.42 ' CD1' HG22 ' A' ' 163' ' ' ILE . 54.0 t-105 -61.24 -50.48 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.247 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.09 89.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.76 -32.76 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.88 -27.47 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -96.69 -6.07 37.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.606 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.74 -9.01 71.13 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.63 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.1 t -82.06 145.21 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.888 0.375 . . . . 0.0 111.49 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.457 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 62.5 t0 -110.24 122.67 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.425 HG12 ' CB ' ' A' ' 131' ' ' ALA . 1.1 tp -50.7 -27.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.294 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -61.36 -23.22 65.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.933 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 145' ' ' ASP . 1.1 pp -109.44 23.52 14.35 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.409 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.91 114.74 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.9 78.98 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.65 142.16 34.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.718 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p -118.05 23.93 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -75.08 90.09 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.537 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.64 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.618 0.247 . . . . 0.0 111.145 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . 87.4 m-20 -85.69 -0.74 56.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.145 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.03 26.07 4.82 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.587 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.92 122.87 27.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.735 0.302 . . . . 0.0 110.816 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 35.4 t -67.9 111.27 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.939 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 mt -102.44 175.28 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.744 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -32.49 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.33 -35.43 75.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.415 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.424 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 138' ' ' TRP . 43.8 mm -60.95 -45.78 97.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.27 -41.12 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.311 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.62 -34.59 74.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.348 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.448 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 19.2 t80 -59.98 -45.46 92.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.372 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.6 -27.73 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.394 -179.859 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.404 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.18 150.89 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.0 mtm -74.99 161.67 76.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.55 -29.28 84.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.524 2.149 . . . . 0.0 112.125 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 p -67.02 -37.32 83.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.598 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.0 t -74.77 -47.52 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.403 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 109.746 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -61.68 -41.78 98.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.752 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.434 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 49.6 t-105 -60.22 -47.24 86.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.43 -50.34 73.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.069 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -54.21 -33.5 58.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.095 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -29.73 47.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.817 0.341 . . . . 0.0 110.943 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.422 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 2.1 mmtt -92.98 -3.64 54.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.9 12.68 68.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.569 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.416 ' CG2' ' CD2' ' A' ' 167' ' ' LEU . 20.4 t -104.04 145.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.367 . . . . 0.0 111.214 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 22.6 t0 -107.82 121.06 43.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.344 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.404 HG12 ' CB ' ' A' ' 131' ' ' ALA . 2.1 tp -50.74 -26.41 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.449 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -23.37 64.34 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.707 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.473 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -110.15 25.77 11.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.0 111.503 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.405 HG21 HD11 ' A' ' 148' ' ' LEU . 39.7 t -127.09 108.01 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -76.15 79.02 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -53.26 159.34 3.87 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.765 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 p -118.27 8.48 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -63.85 87.07 0.06 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.65 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.623 0.249 . . . . 0.0 111.257 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.8 m-80 -87.7 3.21 48.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.119 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.16 4.78 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 113.3 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 0.0 110.918 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.84 111.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 mt -100.65 176.16 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -30.97 60.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.676 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.73 -33.83 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.73 -47.61 62.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.434 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 36.5 mm -60.99 -47.74 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.31 -40.06 85.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.299 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.41 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.132 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.473 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.0 t80 -60.01 -46.03 90.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.201 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.416 ' CD2' ' CG2' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -76.28 -27.12 56.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.132 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.282 -179.802 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.77 152.41 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.39 153.94 71.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.52 -33.26 67.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.191 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.2 m -64.01 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.17 -48.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.403 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -57.27 -47.0 82.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.829 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -61.56 -42.1 98.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.729 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.441 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 51.5 t-105 -59.32 -48.93 79.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.136 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.05 -49.59 76.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.016 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 tpt85 -54.47 -30.7 53.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.84 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -79.71 -32.21 41.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HD3' ' CH2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -92.18 -2.67 56.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.713 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.77 16.06 64.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.491 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.86 145.11 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.368 . . . . 0.0 111.261 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.1 t0 -108.77 122.11 46.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.408 HD13 HD12 ' A' ' 163' ' ' ILE . 2.9 tp -50.06 -27.15 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 111.292 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 mmt-85 -60.04 -25.17 65.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.469 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -107.41 25.43 11.46 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.344 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.3 t -126.51 111.3 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.975 0.417 . . . . 0.0 111.459 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -79.91 74.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.536 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -53.31 145.59 22.08 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.773 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.7 p -118.05 24.21 11.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.991 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -73.68 101.72 1.22 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.7 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.62 -83.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.651 0.262 . . . . 0.0 111.197 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -97.09 6.28 48.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.463 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.99 26.07 4.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.715 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -83.45 125.26 31.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.95 119.44 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 mt -113.34 171.99 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.815 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -50.6 -28.8 9.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.975 0.417 . . . . 0.0 110.729 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -72.47 -41.0 66.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.507 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.3 -45.74 91.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.6 mm -62.75 -49.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -31.8 63.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.202 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.46 -41.21 40.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.892 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.469 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 16.3 t80 -61.38 -24.85 66.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.202 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 167' ' ' LEU . 4.5 mp -87.95 -39.96 14.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.82 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.409 -179.843 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 157' ' ' ARG . 35.0 mm . . . . . 0 C--O 1.23 0.029 0 CA-C-O 120.853 0.359 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.21 157.96 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.094 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.95 161.89 54.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.75 -28.96 87.35 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.536 2.157 . . . . 0.0 112.119 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.8 p -67.5 -37.1 82.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t -74.6 -47.71 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.403 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -59.51 -43.63 93.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 109.789 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -64.07 -41.17 97.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.533 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 53.5 t-105 -61.01 -50.32 73.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.099 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.35 -47.19 87.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.156 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -57.71 -30.22 65.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.791 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.09 -40.17 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.29 -9.38 67.31 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.676 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.4 ' CG2' ' CD2' ' A' ' 167' ' ' LEU . 19.4 t -80.17 145.25 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' HD13 ' A' ' 148' ' ' LEU . 8.8 t0 -111.27 130.75 55.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.425 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.407 HG12 ' CB ' ' A' ' 131' ' ' ALA . 0.8 OUTLIER -56.7 -28.65 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.127 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.4 mtt85 -59.46 -19.0 44.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.961 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.478 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -114.71 27.23 9.59 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.621 0.248 . . . . 0.0 111.391 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.5 t -128.87 115.98 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.35 73.97 7.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.05 142.74 21.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.715 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.2 p -118.03 26.11 9.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -78.16 100.71 1.66 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.665 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.41 -85.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.58 0.228 . . . . 0.0 111.095 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 10.6 p30 -83.94 -4.76 58.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.05 26.02 4.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 130' ' ' ILE . 23.8 ptt-85 -82.21 134.86 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.969 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.7 t -69.34 119.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.306 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 mt -111.73 176.99 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.619 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.43 -35.16 62.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -69.15 -32.58 72.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.59 -50.0 55.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.623 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.427 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 43.6 mm -60.1 -46.2 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -39.7 84.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.224 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -33.96 70.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.316 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.478 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.5 t80 -58.7 -49.24 78.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.4 ' CD2' ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -73.56 -31.55 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.79 0.329 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.42 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.07 177.35 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.7 mtm -108.79 155.45 40.67 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.94 -30.75 31.6 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.48 2.12 . . . . 0.0 112.284 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.2 m -63.86 -45.95 87.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.31 -44.4 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.835 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 12.8 mmm-85 -58.63 -42.88 89.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 109.869 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.4 -41.65 98.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.413 ' CZ3' ' HE2' ' A' ' 142' ' ' LYS . 58.1 t-105 -61.87 -51.0 69.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.207 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 13.6 ttm105 -60.35 -31.38 70.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -77.52 -34.85 53.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.413 ' HE2' ' CZ3' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -89.98 -5.87 56.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.574 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.6 72.75 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.717 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.93 145.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.875 0.369 . . . . 0.0 111.355 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.438 ' O ' HD13 ' A' ' 148' ' ' LEU . 49.4 t0 -109.52 134.28 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.42 HG12 ' CB ' ' A' ' 131' ' ' ALA . 2.0 tp -60.37 -28.82 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -61.51 -17.09 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.84 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.476 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -115.4 25.02 11.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.539 0.209 . . . . 0.0 111.402 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.59 111.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.93 75.34 5.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.661 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -51.04 159.5 1.88 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.729 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.0 p -118.11 12.14 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.642 0.258 . . . . 0.0 111.356 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.67 92.17 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.697 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt 56.6 -86.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -88.07 5.95 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.294 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.07 4.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.572 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -73.35 115.9 13.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.8 t -67.92 119.65 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.03 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -110.78 177.41 4.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -33.34 61.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.98 0.419 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -70.46 -33.2 71.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.453 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.79 -48.87 65.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.545 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.8 mm -61.49 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.492 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.09 -39.08 81.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.27 64.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.6 t80 -59.47 -52.36 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.09 -38.42 75.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.88 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.271 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.711 0.291 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.415 ' HB1' HG12 ' A' ' 146' ' ' ILE . . . -169.94 160.24 8.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.218 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 mtp -74.56 148.95 85.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.568 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.551 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.4 Cg_endo -53.52 -46.29 34.88 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.492 2.128 . . . . 0.0 112.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.533 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 65.3 p -63.57 -32.03 73.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.69 -41.06 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 110.04 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.433 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.906 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -66.96 -40.53 87.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.381 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -59.89 -47.3 86.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.137 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.09 66.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.076 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -51.99 -37.01 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.904 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.66 -40.74 80.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -85.03 -4.77 59.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.66 10.06 65.69 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.646 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.4 t -99.19 145.04 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.362 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 52.5 t0 -112.06 114.11 26.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.928 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.433 ' CG2' ' HD3' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -45.76 -26.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -57.46 -20.11 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.55 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.6 OUTLIER -113.79 24.15 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.609 0.242 . . . . 0.0 111.327 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.0 t -123.06 111.75 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.96 78.79 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.717 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.57 152.24 12.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.4 p -117.95 19.21 13.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.557 0.218 . . . . 0.0 111.25 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -72.59 88.17 0.53 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.483 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.74 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.647 0.26 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.7 OUTLIER -84.02 -0.34 51.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.211 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.07 26.04 4.82 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.609 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.29 119.75 21.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.32 . . . . 0.0 110.915 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.02 111.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.97 176.4 5.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.755 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.22 -31.96 54.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.55 -35.5 75.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.578 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -68.22 -47.62 67.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 44.8 mm -60.04 -48.42 88.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -58.87 -39.68 82.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.178 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.28 72.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.422 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.55 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 18.5 t80 -59.18 -50.26 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -35.35 74.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.232 -179.938 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.881 0.372 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.08 153.09 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.6 mtp -81.33 150.43 67.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.81 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.56 -31.24 39.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.1 m -63.91 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.34 -49.66 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -56.56 -47.07 80.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -45.97 90.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.596 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.423 ' CG ' ' HE2' ' A' ' 160' ' ' LYS . 52.4 t-105 -57.04 -49.17 76.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.402 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . . . -63.11 -38.85 92.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.456 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.39 -30.9 71.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -82.8 -30.51 28.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -88.76 -15.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.506 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.77 45.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.667 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 38.8 t -85.5 145.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 111.264 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' HD13 ' A' ' 148' ' ' LEU . 43.1 t0 -108.98 119.86 40.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.384 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.41 HG12 ' CB ' ' A' ' 131' ' ' ALA . 1.0 OUTLIER -49.17 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.888 0.375 . . . . 0.0 111.498 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -59.47 -27.41 66.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.76 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.472 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -104.64 26.49 9.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.227 . . . . 0.0 111.33 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -128.79 109.7 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 111.429 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -79.11 75.78 5.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.38 145.86 30.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.736 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.9 p -118.1 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.844 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -74.88 100.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.639 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? 59.26 -82.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.535 0.207 . . . . 0.0 111.055 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.1 p30 -97.5 7.16 47.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.655 0.264 . . . . 0.0 111.297 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.94 26.13 4.82 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.526 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.83 123.83 29.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 111.116 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.95 111.1 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 mt -102.11 175.1 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.423 ' HE2' ' CG ' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -53.83 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.39 -36.76 68.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.432 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -66.0 -46.7 77.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.419 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 34.9 mm -63.01 -50.79 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.332 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -57.45 -31.91 66.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 110.392 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.983 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.472 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.3 t80 -61.83 -28.66 69.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.117 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 167' ' ' LEU . 3.7 mp -81.17 -47.99 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.784 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.4 mt . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.8 0.333 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.441 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.22 174.77 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 33.1 mmm -91.07 147.13 35.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.394 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.54 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 72.0 Cg_exo -48.5 -50.56 12.03 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.444 2.096 . . . . 0.0 112.81 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.516 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -63.44 -26.6 68.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.837 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.59 -38.78 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.907 0.384 . . . . 0.0 110.223 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.6 OUTLIER -67.51 -41.55 84.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.714 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.37 -39.46 81.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.423 ' CD1' HG22 ' A' ' 163' ' ' ILE . 53.3 t-105 -59.93 -50.25 74.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.201 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.61 73.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.99 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.87 -35.73 57.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.84 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -4.24 56.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.541 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.18 -10.56 65.59 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.628 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.97 145.27 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.007 0.432 . . . . 0.0 111.417 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 35.0 t0 -108.24 133.57 52.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.441 HG12 ' CB ' ' A' ' 131' ' ' ALA . 3.4 tp -59.39 -35.28 57.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.116 0.484 . . . . 0.0 110.928 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -55.1 -21.2 12.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.226 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.498 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.08 25.35 11.89 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.13 111.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 111.245 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.15 77.67 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.14 144.81 35.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.646 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.2 p -118.02 26.1 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.739 0.304 . . . . 0.0 111.068 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.5 102.37 1.97 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.718 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? 57.84 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.625 0.25 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.4 p30 -90.7 -0.54 57.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.252 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.02 26.07 4.82 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.679 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -82.33 133.35 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.748 0.309 . . . . 0.0 110.979 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.0 123.89 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.6 mt -114.71 170.17 8.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -32.0 11.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.57 -40.95 73.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.633 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -61.91 -50.91 70.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.572 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.423 HG22 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -58.34 -52.24 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.413 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.65 -34.07 57.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.401 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.45 -32.39 60.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.498 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 19.4 t80 -64.14 -37.68 88.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.496 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.16 -27.56 24.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.043 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.417 -179.861 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.837 0.351 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.434 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -169.97 162.56 9.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.3 mtp -75.12 144.31 78.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.554 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.628 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 73.5 Cg_exo -49.06 -47.56 21.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.386 2.057 . . . . 0.0 112.397 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 1.3 m -63.46 -30.47 71.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.677 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.93 -40.69 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 109.93 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.428 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -64.41 -43.84 93.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.778 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -65.2 -41.36 94.59 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 53.6 t-105 -58.18 -50.83 72.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.236 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.96 -49.22 75.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.853 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -56.4 -29.94 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.781 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.7 -43.53 59.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -84.5 -4.63 59.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.496 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.4 66.28 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.617 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.6 t -78.96 145.09 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 111.311 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 7.6 t0 -108.29 134.6 50.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.418 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.434 HG12 ' CB ' ' A' ' 131' ' ' ALA . 3.4 tp -59.7 -35.17 58.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.021 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -55.59 -21.05 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.14 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.476 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.42 26.8 10.29 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.634 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.95 113.76 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -77.76 76.96 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.721 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.95 142.68 34.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.604 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.7 p -117.46 25.37 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.7 0.286 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -77.51 98.48 1.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.12 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.634 0.254 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 11.7 p-10 -79.32 -6.48 56.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.182 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.09 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -83.83 133.81 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.342 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.4 t -70.44 118.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.136 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -108.16 171.81 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.684 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -32.24 18.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -70.72 -39.26 73.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.621 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.01 -47.28 83.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.427 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.0 mm -60.8 -51.44 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.291 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -33.87 61.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.201 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.29 -34.11 61.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.123 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.8 t80 -60.91 -39.66 90.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.157 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.16 -31.46 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.956 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.87 0.367 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 156.54 6.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -82.91 152.13 65.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.41 -36.26 68.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.505 2.137 . . . . 0.0 112.232 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.4 p -63.92 -34.04 77.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.831 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.1 t -75.18 -47.97 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -47.75 84.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.115 0.483 . . . . 0.0 109.802 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -62.48 -39.54 93.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.767 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -61.39 -49.16 78.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.05 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.167 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -56.75 -30.24 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.824 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.96 -40.95 62.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.9 -4.24 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.616 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.19 66.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.59 145.21 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.365 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 18.3 t0 -111.47 122.98 49.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.507 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.7 tp -50.84 -25.8 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.42 -22.88 63.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.834 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.459 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -110.3 25.65 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.614 0.245 . . . . 0.0 111.394 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.5 t -127.65 106.48 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.88 0.371 . . . . 0.0 111.213 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -75.84 78.91 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.403 ' HA2' ' N ' ' A' ' 158' ' ' VAL . . . -52.26 140.15 28.62 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.784 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.1 p -118.17 26.06 9.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -89.79 128.89 9.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.809 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -87.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.555 0.217 . . . . 0.0 111.524 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 25.0 m-80 -108.99 17.82 21.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.633 0.254 . . . . 0.0 111.376 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 22.55 7.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.009 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -84.45 133.93 34.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.62 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.403 ' N ' ' HA2' ' A' ' 151' ' ' GLY . 33.5 t -69.66 127.21 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.271 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.22 172.54 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -53.46 -30.79 42.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.682 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.12 -35.95 69.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.0 -47.76 73.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.5 mm -61.57 -51.92 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.224 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -55.74 -33.18 64.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.415 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.44 -32.77 54.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.235 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.459 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 22.2 t80 -61.29 -43.08 99.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.4 -42.33 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.21 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.814 0.34 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.05 146.34 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.8 mmm -74.12 151.01 88.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.05 -28.1 39.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.613 2.208 . . . . 0.0 112.073 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 p -63.87 -44.86 91.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.05 -46.63 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -56.17 -47.55 78.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 109.808 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -60.67 -39.91 90.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.889 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.413 ' CH2' ' HE3' ' A' ' 142' ' ' LYS . 60.9 t-105 -62.5 -50.21 72.32 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.199 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . . . -63.74 -38.35 90.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.469 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -30.19 70.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.029 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -82.1 -31.26 30.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.351 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.413 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.6 mmtm -88.39 -24.03 23.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.397 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.83 -5.96 24.07 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.628 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 43.5 t -85.32 145.18 8.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 58.0 t0 -111.52 114.88 28.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.01 -24.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.4 mtp85 -58.25 -19.86 37.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.522 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -111.28 -5.76 14.63 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.04 113.8 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 0.0 111.332 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -79.08 75.92 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.79 142.08 38.45 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.815 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.08 25.87 10.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.0 111.016 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.62 112.32 3.43 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.886 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.53 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.67 0.271 . . . . 0.0 111.399 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 18.4 m-80 -106.07 16.34 25.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.32 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.84 26.04 6.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.686 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -84.29 126.05 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.0 124.08 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.12 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 mt -113.88 169.07 9.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.738 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -50.91 -31.31 17.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.67 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -70.19 -40.16 74.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.456 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.54 -45.7 91.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.404 ' O ' HD21 ' A' ' 167' ' ' LEU . 40.0 mm -60.85 -53.12 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.266 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -53.28 -34.45 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.349 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.93 -31.47 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.522 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 19.7 t80 -63.48 -44.53 94.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 163' ' ' ILE . 3.1 mm? -79.34 -30.05 42.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.318 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.836 0.35 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.14 158.1 6.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 55.8 mtp -77.86 157.34 79.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.626 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.86 -35.54 77.74 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.464 2.109 . . . . 0.0 112.183 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -66.51 -29.6 69.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.08 -49.16 23.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.962 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -59.41 -46.35 88.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.36 94.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -56.78 -51.55 68.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.057 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.22 77.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.211 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -37.53 56.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.17 -49.65 59.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.257 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -72.26 -19.61 61.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.09 13.68 28.42 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.266 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 41.5 t -100.74 145.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.896 0.379 . . . . 0.0 111.233 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.502 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.2 t0 -107.46 115.38 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.417 HG12 ' CB ' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -46.71 -26.23 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -56.86 -22.37 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.008 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 145' ' ' ASP . 0.9 OUTLIER -111.94 28.67 8.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.57 0.224 . . . . 0.0 111.319 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.04 108.53 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.938 0.399 . . . . 0.0 111.302 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.19 77.58 3.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.23 143.69 33.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.689 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 p -118.1 26.16 9.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.801 0.334 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.42 102.4 1.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.1 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.602 0.239 . . . . 0.0 111.272 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.92 -5.07 58.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 0.0 111.317 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.04 26.05 4.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.603 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -85.99 137.74 32.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.95 126.49 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 mt -116.2 169.29 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.568 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -50.33 -30.41 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 110.7 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.88 -40.98 71.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.483 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -62.7 -46.91 85.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.566 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 40.7 mm -62.67 -48.64 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.453 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -57.68 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.355 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.78 -40.87 31.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.471 ' CZ ' ' CD1' ' A' ' 148' ' ' LEU . 21.2 t80 -61.66 -25.9 67.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.256 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 167' ' ' LEU . 3.3 mp -86.04 -45.5 11.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.148 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mt . . . . . 0 N--CA 1.458 -0.032 0 CA-C-O 120.848 0.356 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.12 162.23 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 31.2 mtp -79.53 155.38 76.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.659 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.82 -32.99 93.39 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.525 2.15 . . . . 0.0 112.072 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -33.62 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.464 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.93 -47.32 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.881 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.423 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -58.13 -49.62 76.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.54 -41.31 94.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.762 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CD1' HG22 ' A' ' 163' ' ' ILE . 48.5 t-105 -59.89 -48.28 82.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.123 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.47 73.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.181 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.91 -28.84 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -81.03 -28.59 35.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.033 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -96.53 -4.03 42.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.62 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.19 8.95 64.05 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.784 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.92 145.19 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.852 0.358 . . . . 0.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 23.5 t0 -108.4 121.13 44.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.504 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.423 ' CG2' ' HD3' ' A' ' 136' ' ' ARG . 1.2 tp -50.02 -27.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.943 0.401 . . . . 0.0 111.38 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -59.56 -21.83 60.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.063 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.477 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -111.39 26.78 10.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.559 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -129.04 107.15 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.84 81.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.04 139.38 43.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.689 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.19 26.07 9.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.55 128.91 9.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.873 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.62 -88.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 80.5 m-20 -105.55 26.27 9.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.4 24.08 27.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.801 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.97 136.73 33.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.0 t -69.23 130.52 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.301 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.6 mt -117.51 169.47 9.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.584 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -33.3 23.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 110.673 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.76 -38.68 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.53 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.91 -49.37 75.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.427 HG22 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -59.2 -52.19 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.414 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -54.97 -33.56 62.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.335 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.224 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.477 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 38.6 t80 -60.27 -43.25 96.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.434 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.91 -39.13 43.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 -179.838 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.831 0.348 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.01 165.28 9.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 30.9 mtp -80.34 149.93 69.84 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.612 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.554 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.9 Cg_endo -53.15 -47.68 26.21 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.588 2.192 . . . . 0.0 112.201 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.542 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 28.7 t -63.58 -30.6 71.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.605 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.24 -40.86 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 109.986 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.454 ' HD3' HG23 ' A' ' 146' ' ' ILE . 4.1 mmm180 -65.35 -41.4 93.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.935 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 1.5 mttt -68.43 -38.19 80.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.468 ' CZ2' ' HD3' ' A' ' 142' ' ' LYS . 64.0 t-105 -61.39 -50.01 74.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.72 -45.27 93.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.933 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -60.18 -31.38 70.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.918 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.25 -31.38 54.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.468 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -92.37 -6.79 49.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.422 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.28 -10.42 67.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.348 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.0 t -80.58 145.17 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.528 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 32.0 t0 -107.36 132.84 52.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.219 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.454 HG23 ' HD3' ' A' ' 136' ' ' ARG . 3.7 tp -59.34 -35.2 57.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 110.996 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -55.59 -21.23 16.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.084 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.493 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -109.6 26.25 10.87 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.56 0.219 . . . . 0.0 111.548 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 30.4 t -127.28 112.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.261 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.33 73.09 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -57.74 153.42 24.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.62 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.2 p -118.18 25.63 10.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.677 0.275 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -76.99 105.17 2.0 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.941 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.612 0.244 . . . . 0.0 111.399 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -108.56 13.42 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.721 0.296 . . . . 0.0 111.068 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 110.58 26.08 4.94 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.436 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 122.83 26.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.11 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' A' ' 151' ' ' GLY . 11.5 t -67.97 113.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.062 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.9 mt -105.52 170.48 7.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.614 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -30.65 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.924 0.392 . . . . 0.0 110.723 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -71.26 -40.74 70.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.602 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -61.98 -46.62 88.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.43 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.7 mm -61.11 -52.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.278 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -32.93 56.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.16 -33.1 61.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.238 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.493 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 18.3 t80 -63.97 -39.2 93.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.404 ' N ' HD23 ' A' ' 167' ' ' LEU . 3.2 mm? -85.89 -24.97 26.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.424 -179.746 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.6 mm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.772 0.32 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.441 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -167.57 162.49 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.243 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.42 149.12 81.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.465 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.508 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.2 Cg_endo -53.6 -45.99 37.0 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.527 2.152 . . . . 0.0 112.147 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.537 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 12.2 p -63.58 -31.71 72.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.92 -41.93 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.169 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.29 -44.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.834 179.118 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.537 ' HG3' ' HA ' ' A' ' 134' ' ' SER . 1.2 mtmt -65.08 -40.79 95.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.439 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 50.9 t-105 -58.46 -51.97 67.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.157 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.53 94.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.027 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -29.99 69.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.984 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.72 -30.63 51.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -95.21 -5.57 43.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.575 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.79 -9.52 68.47 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.492 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.5 t -80.56 145.18 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.902 0.382 . . . . 0.0 111.638 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.455 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.3 t0 -106.65 133.17 51.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.441 HG12 ' CB ' ' A' ' 131' ' ' ALA . 5.8 tp -58.45 -38.27 68.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -54.3 -20.72 7.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.379 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.461 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.21 27.79 9.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.607 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.54 117.18 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -79.23 75.57 5.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.588 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.2 154.4 5.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.861 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.5 p -118.19 21.7 12.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.649 0.261 . . . . 0.0 111.124 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.83 94.86 1.34 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.696 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.02 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.586 0.232 . . . . 0.0 111.203 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -88.27 5.07 43.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.26 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.88 26.05 4.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.612 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -74.18 120.6 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.309 . . . . 0.0 110.963 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.7 t -67.93 115.13 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.3 mt -105.03 170.35 7.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.504 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -31.36 13.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.86 -40.32 72.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.608 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.12 -46.08 90.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.482 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.439 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 36.9 mm -61.27 -51.72 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -53.98 -33.88 58.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.69 -33.65 62.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.461 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 17.5 t80 -60.43 -44.79 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.361 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.76 -34.07 58.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.853 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 -179.95 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.888 0.375 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.4 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.07 152.51 4.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 44.3 mtp -80.33 151.46 72.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.48 -35.98 57.46 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.573 2.182 . . . . 0.0 112.218 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -64.01 -33.22 75.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.44 -48.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -47.7 84.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.09 0.472 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.26 -40.5 96.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.599 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.429 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 53.5 t-105 -60.27 -49.43 77.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . . . -60.82 -50.32 73.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -54.35 -30.51 51.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.82 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.54 -34.94 53.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.422 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.5 mmpt? -90.42 -2.94 57.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.7 65.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 23.1 t -103.72 145.18 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.794 0.331 . . . . 0.0 111.269 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.3 t70 -104.89 132.23 51.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.4 HG12 ' CB ' ' A' ' 131' ' ' ALA . 2.0 tp -61.23 -28.85 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.401 . . . . 0.0 111.148 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.09 -17.92 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.983 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.501 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -112.47 25.86 11.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.8 t -128.2 110.76 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.97 0.414 . . . . 0.0 111.266 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -69.63 82.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -57.57 129.65 49.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.565 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.14 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.719 0.295 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -81.76 102.72 2.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.722 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 56.51 -84.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.617 0.246 . . . . 0.0 111.405 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -86.98 -0.17 56.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.82 26.03 5.71 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.661 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 133.2 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 44.2 t -67.92 119.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.149 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 mt -108.41 171.92 7.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.796 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -51.65 -30.1 20.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.742 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.48 -39.34 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -63.3 -50.39 70.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.429 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.1 mm -59.91 -51.72 69.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.209 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.56 -31.94 57.55 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.67 -32.82 47.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.501 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 21.8 t80 -60.74 -40.33 91.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.64 -37.28 25.14 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.964 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.6 mt . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.906 0.384 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.98 141.61 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.1 mmm -67.65 158.29 83.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.84 -28.64 87.68 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.537 2.158 . . . . 0.0 112.062 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -64.96 -42.57 94.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.625 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.42 -46.95 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 1.1 mmm180 -56.1 -51.0 69.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.689 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -59.15 -39.37 82.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.785 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.425 ' CD1' HG22 ' A' ' 163' ' ' ILE . 48.9 t-105 -60.54 -50.65 72.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . . . -59.49 -48.54 81.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.195 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -54.97 -33.94 62.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -79.92 -27.34 39.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -4.01 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.31 13.45 65.77 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.532 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 21.4 t -106.58 145.26 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 12.9 t0 -107.56 128.81 54.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.413 ' CG2' ' HD3' ' A' ' 136' ' ' ARG . 2.4 tp -57.09 -28.61 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.91 0.386 . . . . 0.0 111.046 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -61.18 -19.24 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.889 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.474 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -112.53 25.72 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.386 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.48 112.28 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.333 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.68 77.13 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -53.64 145.47 23.87 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.76 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.5 p -117.94 18.8 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.622 0.248 . . . . 0.0 111.315 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -69.81 97.21 0.55 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.478 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.58 -87.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.499 0.19 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 153' ' ' GLY . 82.3 m-20 -78.03 -6.79 55.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.666 0.269 . . . . 0.0 111.256 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.11 4.81 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.603 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -84.37 131.41 34.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.2 t -67.9 123.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.257 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.95 172.72 6.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.472 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -32.72 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.933 0.397 . . . . 0.0 110.762 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.12 -39.36 75.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.12 -47.76 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.598 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.425 HG22 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -60.07 -51.66 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.4 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.52 -34.91 62.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.295 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.79 -33.52 62.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.277 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.474 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 22.5 t80 -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.55 -32.75 36.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.861 0.362 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.408 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.09 148.82 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.75 154.79 73.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.81 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.17 -30.17 31.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.508 2.139 . . . . 0.0 112.362 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -64.18 -41.31 97.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.03 -47.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.403 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -56.62 -48.97 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.252 0.548 . . . . 0.0 109.686 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -59.82 -41.96 92.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.832 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.412 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 55.6 t-105 -60.33 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.296 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.52 -48.0 83.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.21 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -56.2 -31.62 63.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -81.49 -28.08 34.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.73 -3.52 49.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.723 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.17 14.67 66.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.611 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.0 t -105.54 145.13 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.201 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 9.7 t0 -106.71 120.77 42.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 131' ' ' ALA . 1.4 tp -50.34 -28.27 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.965 0.412 . . . . 0.0 111.378 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -60.73 -21.53 63.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.076 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 145' ' ' ASP . 0.8 OUTLIER -109.75 25.86 11.31 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.292 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.0 t -129.01 108.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -75.99 79.0 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.831 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.28 149.93 26.19 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.704 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.78 12.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.68 0.276 . . . . 0.0 111.3 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.57 105.43 2.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.663 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.084 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -93.38 13.0 22.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.09 26.08 7.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.389 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.0 ttm105 -77.54 125.28 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.319 . . . . 0.0 110.999 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.02 121.08 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.22 172.22 6.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -51.86 -29.82 21.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.77 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -71.66 -38.98 70.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.588 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -64.46 -49.56 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.529 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.2 mm -59.27 -52.47 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -34.84 62.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.363 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 -31.92 60.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.293 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.466 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 21.0 t80 -63.15 -40.83 98.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.455 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.58 -34.0 35.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.912 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.297 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.777 0.322 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.49 -47.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.98 127.51 47.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.926 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.5 t -64.0 159.4 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.8 mt -113.43 119.64 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.317 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.04 164.55 9.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.405 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 29.1 mmm -76.49 141.64 69.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.431 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.599 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 72.2 Cg_exo -48.62 -45.53 27.21 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.302 2.001 . . . . 0.0 112.403 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 3.2 p -63.56 -32.67 74.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 65.6 t -66.0 -40.49 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.085 0.469 . . . . 0.0 109.791 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' HG23 ' A' ' 146' ' ' ILE . 2.5 mmm180 -63.45 -44.01 95.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.904 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -65.87 -41.1 92.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.418 ' CZ3' ' HE3' ' A' ' 142' ' ' LYS . 54.9 t-105 -58.07 -50.17 74.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.086 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.78 -52.56 64.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.033 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -54.93 -30.45 58.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.44 -35.23 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.418 ' HE3' ' CZ3' ' A' ' 138' ' ' TRP . 0.8 OUTLIER -91.75 -3.99 55.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.745 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.93 63.07 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.575 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.0 t -101.0 145.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.265 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 24.2 t0 -111.24 133.89 53.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.348 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.416 HG12 ' CB ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -58.1 -33.45 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.43 . . . . 0.0 110.797 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.85 -22.64 15.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.889 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.451 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.98 25.6 11.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.721 0.296 . . . . 0.0 111.405 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.1 t -129.04 112.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 111.247 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -80.56 73.03 7.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.75 150.47 17.67 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.651 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.09 12.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.267 . . . . 0.0 111.202 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -70.09 95.1 0.48 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.711 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.14 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.689 0.28 . . . . 0.0 111.259 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.6 p30 -97.11 5.7 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.099 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.13 26.04 4.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.621 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -77.35 122.43 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 36.5 t -71.11 102.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.843 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 mt -94.14 173.08 7.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -51.34 -30.11 17.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.654 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -69.02 -41.11 78.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.404 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -63.39 -49.39 74.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.392 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 40.9 mm -59.81 -52.28 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.275 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -31.71 61.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.332 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -33.2 49.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.183 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.451 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 18.4 t80 -60.88 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.441 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.93 -40.2 40.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.4 30.82 3.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -139.78 27.87 2.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.494 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.1 p30 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.752 0.31 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.31 77.72 0.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -94.84 -179.94 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.2 t -91.2 141.03 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mt -126.15 120.8 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.3 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.411 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.15 166.05 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.075 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.7 mtp -91.89 149.88 39.72 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.77 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.4 -30.98 28.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.487 2.124 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -66.04 -40.69 91.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 39.3 t -72.3 -44.44 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -58.32 -46.64 85.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 109.775 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -63.09 -39.95 96.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.941 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -63.11 -46.27 88.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.221 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.37 -47.28 79.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.235 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.2 -29.53 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.864 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -80.81 -31.23 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.997 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -5.36 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.576 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.42 -10.11 64.98 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.669 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.74 145.02 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 53.6 t0 -110.65 113.36 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.222 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.411 HG12 ' CB ' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -44.47 -25.61 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -18.03 27.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.542 HD11 ' CZ ' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -115.44 29.16 8.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.621 0.248 . . . . 0.0 111.545 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.1 t -129.04 109.54 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.393 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 82.29 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.428 ' HA2' ' C ' ' A' ' 157' ' ' ARG . . . -53.6 142.57 29.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.787 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -118.25 -21.14 8.28 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.51 153.3 36.64 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.493 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 48.02 -104.8 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -105.46 30.04 6.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.734 0.302 . . . . 0.0 111.435 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.27 20.48 13.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.761 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 159' ' ' LEU . 22.4 ptt180 -85.47 154.15 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.649 0.262 . . . . 0.0 110.399 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.74 133.93 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.488 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -119.34 169.82 9.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -52.17 -30.7 28.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.02 -39.99 78.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.412 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.406 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 87.6 m-20 -64.1 -51.05 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.436 ' O ' HD21 ' A' ' 167' ' ' LEU . 42.2 mm -59.48 -52.06 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -54.38 -33.85 60.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.384 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.73 -31.19 52.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.209 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 148' ' ' LEU . 24.2 t80 -64.24 -37.66 88.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.628 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 163' ' ' ILE . 3.2 mm? -89.06 -26.64 21.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.73 31.06 1.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.361 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -137.49 27.0 2.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.523 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.525 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.846 0.355 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -83.61 -24.18 31.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -56.08 172.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.1 t -103.86 158.13 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.005 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 130' ' ' ILE . 23.8 mm -127.05 121.98 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.245 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.11 160.98 8.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.3 mtp -81.92 145.88 54.51 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.68 -32.55 45.6 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.489 2.126 . . . . 0.0 112.283 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -40.41 95.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.697 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.25 -46.26 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.2 OUTLIER -56.31 -45.7 80.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.798 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -61.92 -41.1 97.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.615 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.42 ' CD1' HG22 ' A' ' 163' ' ' ILE . 54.0 t-105 -61.24 -50.48 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.247 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.09 89.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.76 -32.76 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.88 -27.47 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -96.69 -6.07 37.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.606 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.74 -9.01 71.13 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.63 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.1 t -82.06 145.21 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.888 0.375 . . . . 0.0 111.49 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.457 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 62.5 t0 -110.24 122.67 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.425 HG12 ' CB ' ' A' ' 131' ' ' ALA . 1.1 tp -50.7 -27.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.294 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -61.36 -23.22 65.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.933 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 145' ' ' ASP . 1.1 pp -109.44 23.52 14.35 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.409 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.91 114.74 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.9 78.98 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.65 142.16 34.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.718 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p -118.05 23.93 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -75.08 90.09 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.537 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.64 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.618 0.247 . . . . 0.0 111.145 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . 87.4 m-20 -85.69 -0.74 56.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.145 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.03 26.07 4.82 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.587 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.92 122.87 27.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.735 0.302 . . . . 0.0 110.816 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 35.4 t -67.9 111.27 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.939 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 mt -102.44 175.28 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.744 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -32.49 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.33 -35.43 75.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.415 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.424 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 138' ' ' TRP . 43.8 mm -60.95 -45.78 97.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.27 -41.12 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.311 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.62 -34.59 74.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.348 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.448 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 19.2 t80 -59.98 -45.46 92.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.372 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.6 -27.73 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.59 30.97 1.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.394 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -102.6 -27.25 6.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.41 -1.217 . . . . 0.0 112.509 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 t30 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.839 0.352 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -124.55 68.91 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.688 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.03 139.81 43.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.29 126.32 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.011 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.7 mt -117.85 128.3 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.037 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.404 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.18 150.89 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.0 mtm -74.99 161.67 76.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.55 -29.28 84.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.524 2.149 . . . . 0.0 112.125 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 p -67.02 -37.32 83.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.598 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.0 t -74.77 -47.52 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.403 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 109.746 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -61.68 -41.78 98.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.752 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.434 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 49.6 t-105 -60.22 -47.24 86.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.43 -50.34 73.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.069 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -54.21 -33.5 58.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.095 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -29.73 47.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.817 0.341 . . . . 0.0 110.943 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.422 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 2.1 mmtt -92.98 -3.64 54.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.9 12.68 68.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.569 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.416 ' CG2' ' CD2' ' A' ' 167' ' ' LEU . 20.4 t -104.04 145.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.367 . . . . 0.0 111.214 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 22.6 t0 -107.82 121.06 43.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.344 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.404 HG12 ' CB ' ' A' ' 131' ' ' ALA . 2.1 tp -50.74 -26.41 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.449 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -23.37 64.34 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.707 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.473 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -110.15 25.77 11.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.0 111.503 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.405 HG21 HD11 ' A' ' 148' ' ' LEU . 39.7 t -127.09 108.01 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -76.15 79.02 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -53.26 159.34 3.87 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.765 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 p -118.27 8.48 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -63.85 87.07 0.06 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.65 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.623 0.249 . . . . 0.0 111.257 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.8 m-80 -87.7 3.21 48.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.119 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.16 4.78 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 113.3 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 0.0 110.918 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.84 111.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 mt -100.65 176.16 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -30.97 60.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.676 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.73 -33.83 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.73 -47.61 62.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.434 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 36.5 mm -60.99 -47.74 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.31 -40.06 85.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.299 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.41 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.132 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.473 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.0 t80 -60.01 -46.03 90.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.201 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.416 ' CD2' ' CG2' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -76.28 -27.12 56.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.132 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.22 31.14 1.75 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.282 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -112.23 -27.38 3.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.487 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.534 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.778 0.323 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 85.96 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.44 162.94 12.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.2 t -60.01 159.24 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.61 114.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.218 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.77 152.41 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.39 153.94 71.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.52 -33.26 67.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.191 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.2 m -64.01 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.17 -48.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.403 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -57.27 -47.0 82.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.829 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -61.56 -42.1 98.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.729 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.441 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 51.5 t-105 -59.32 -48.93 79.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.136 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.05 -49.59 76.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.016 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 tpt85 -54.47 -30.7 53.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.84 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -79.71 -32.21 41.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HD3' ' CH2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -92.18 -2.67 56.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.713 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.77 16.06 64.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.491 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.86 145.11 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.368 . . . . 0.0 111.261 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.1 t0 -108.77 122.11 46.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.408 HD13 HD12 ' A' ' 163' ' ' ILE . 2.9 tp -50.06 -27.15 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 111.292 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 mmt-85 -60.04 -25.17 65.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.469 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -107.41 25.43 11.46 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.344 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.3 t -126.51 111.3 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.975 0.417 . . . . 0.0 111.459 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -79.91 74.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.536 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -53.31 145.59 22.08 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.773 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.7 p -118.05 24.21 11.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.991 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -73.68 101.72 1.22 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.7 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.62 -83.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.651 0.262 . . . . 0.0 111.197 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -97.09 6.28 48.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.463 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.99 26.07 4.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.715 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -83.45 125.26 31.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.95 119.44 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 mt -113.34 171.99 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.815 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -50.6 -28.8 9.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.975 0.417 . . . . 0.0 110.729 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -72.47 -41.0 66.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.507 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.3 -45.74 91.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.6 mm -62.75 -49.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -31.8 63.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.202 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.46 -41.21 40.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.892 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.469 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 16.3 t80 -61.38 -24.85 66.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.202 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 167' ' ' LEU . 4.5 mp -87.95 -39.96 14.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.82 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.89 31.02 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.409 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -120.57 27.39 6.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.029 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.468 -179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.799 0.333 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -61.29 -174.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -73.05 157.11 37.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 24.9 t -132.14 158.56 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.158 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 157' ' ' ARG . 35.0 mm -95.58 123.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.21 157.96 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.094 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.95 161.89 54.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.75 -28.96 87.35 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.536 2.157 . . . . 0.0 112.119 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.8 p -67.5 -37.1 82.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t -74.6 -47.71 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.403 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -59.51 -43.63 93.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 109.789 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -64.07 -41.17 97.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.533 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 53.5 t-105 -61.01 -50.32 73.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.099 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.35 -47.19 87.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.156 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -57.71 -30.22 65.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.791 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.09 -40.17 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.29 -9.38 67.31 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.676 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.4 ' CG2' ' CD2' ' A' ' 167' ' ' LEU . 19.4 t -80.17 145.25 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' HD13 ' A' ' 148' ' ' LEU . 8.8 t0 -111.27 130.75 55.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.425 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.407 HG12 ' CB ' ' A' ' 131' ' ' ALA . 0.8 OUTLIER -56.7 -28.65 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.127 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.4 mtt85 -59.46 -19.0 44.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.961 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.478 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -114.71 27.23 9.59 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.621 0.248 . . . . 0.0 111.391 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.5 t -128.87 115.98 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.35 73.97 7.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.05 142.74 21.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.715 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.2 p -118.03 26.11 9.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -78.16 100.71 1.66 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.665 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.41 -85.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.58 0.228 . . . . 0.0 111.095 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 10.6 p30 -83.94 -4.76 58.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.05 26.02 4.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 130' ' ' ILE . 23.8 ptt-85 -82.21 134.86 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.969 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.7 t -69.34 119.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.306 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 mt -111.73 176.99 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.619 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.43 -35.16 62.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -69.15 -32.58 72.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.59 -50.0 55.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.623 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.427 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 43.6 mm -60.1 -46.2 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -39.7 84.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.224 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -33.96 70.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.316 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.478 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.5 t80 -58.7 -49.24 78.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.4 ' CD2' ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -73.56 -31.55 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.38 31.04 2.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -139.87 27.83 2.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.512 -179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.757 0.313 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.4 132.41 35.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -116.89 119.65 36.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.94 141.77 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 mt -98.74 136.16 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.241 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.42 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.07 177.35 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.7 mtm -108.79 155.45 40.67 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.94 -30.75 31.6 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.48 2.12 . . . . 0.0 112.284 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.2 m -63.86 -45.95 87.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.31 -44.4 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.835 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 12.8 mmm-85 -58.63 -42.88 89.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 109.869 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.4 -41.65 98.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.413 ' CZ3' ' HE2' ' A' ' 142' ' ' LYS . 58.1 t-105 -61.87 -51.0 69.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.207 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 13.6 ttm105 -60.35 -31.38 70.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -77.52 -34.85 53.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.413 ' HE2' ' CZ3' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -89.98 -5.87 56.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.574 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.6 72.75 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.717 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.93 145.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.875 0.369 . . . . 0.0 111.355 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' O ' HD13 ' A' ' 148' ' ' LEU . 49.4 t0 -109.52 134.28 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.42 HG12 ' CB ' ' A' ' 131' ' ' ALA . 2.0 tp -60.37 -28.82 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -61.51 -17.09 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.84 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.476 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -115.4 25.02 11.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.539 0.209 . . . . 0.0 111.402 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.59 111.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.93 75.34 5.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.661 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -51.04 159.5 1.88 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.729 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.0 p -118.11 12.14 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.642 0.258 . . . . 0.0 111.356 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.67 92.17 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.697 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt 56.6 -86.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -88.07 5.95 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.294 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.07 4.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.572 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -73.35 115.9 13.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.8 t -67.92 119.65 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.03 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -110.78 177.41 4.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -33.34 61.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.98 0.419 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -70.46 -33.2 71.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.453 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.79 -48.87 65.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.545 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.8 mm -61.49 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.492 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.09 -39.08 81.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.27 64.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.6 t80 -59.47 -52.36 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.09 -38.42 75.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.88 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.9 64.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.271 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -84.76 -29.64 28.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.573 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.518 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.838 0.352 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -116.05 117.89 31.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.963 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.39 120.79 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.771 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.424 ' CG1' HG22 ' A' ' 146' ' ' ILE . 33.6 t -116.46 118.33 58.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.225 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp -127.07 130.45 71.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.415 ' HB1' HG12 ' A' ' 146' ' ' ILE . . . -169.94 160.24 8.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.218 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 mtp -74.56 148.95 85.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.568 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.551 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.4 Cg_endo -53.52 -46.29 34.88 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.492 2.128 . . . . 0.0 112.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.533 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 65.3 p -63.57 -32.03 73.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.69 -41.06 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 110.04 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.433 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.906 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -66.96 -40.53 87.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.381 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -59.89 -47.3 86.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.137 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.09 66.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.076 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -51.99 -37.01 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.904 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.66 -40.74 80.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -85.03 -4.77 59.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.66 10.06 65.69 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.646 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.4 t -99.19 145.04 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.362 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 52.5 t0 -112.06 114.11 26.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.928 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.433 ' CG2' ' HD3' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -45.76 -26.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -57.46 -20.11 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.55 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.6 OUTLIER -113.79 24.15 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.609 0.242 . . . . 0.0 111.327 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.0 t -123.06 111.75 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.96 78.79 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.717 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.57 152.24 12.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.4 p -117.95 19.21 13.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.557 0.218 . . . . 0.0 111.25 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -72.59 88.17 0.53 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.483 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.74 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.647 0.26 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.7 OUTLIER -84.02 -0.34 51.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.211 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.07 26.04 4.82 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.609 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.29 119.75 21.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.32 . . . . 0.0 110.915 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.02 111.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.97 176.4 5.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.755 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.22 -31.96 54.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.55 -35.5 75.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.578 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -68.22 -47.62 67.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 44.8 mm -60.04 -48.42 88.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -58.87 -39.68 82.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.178 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.28 72.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.422 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.55 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 18.5 t80 -59.18 -50.26 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -35.35 74.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.09 67.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.232 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.73 28.84 14.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.324 -1.265 . . . . 0.0 112.479 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -137.3 156.89 47.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.93 160.72 20.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.58 159.18 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.23 118.94 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.08 153.09 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.6 mtp -81.33 150.43 67.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.81 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.56 -31.24 39.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.1 m -63.91 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.34 -49.66 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -56.56 -47.07 80.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -45.97 90.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.596 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.423 ' CG ' ' HE2' ' A' ' 160' ' ' LYS . 52.4 t-105 -57.04 -49.17 76.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.402 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . . . -63.11 -38.85 92.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.456 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.39 -30.9 71.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -82.8 -30.51 28.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -88.76 -15.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.506 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.77 45.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.667 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 38.8 t -85.5 145.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 111.264 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' HD13 ' A' ' 148' ' ' LEU . 43.1 t0 -108.98 119.86 40.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.384 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.41 HG12 ' CB ' ' A' ' 131' ' ' ALA . 1.0 OUTLIER -49.17 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.888 0.375 . . . . 0.0 111.498 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -59.47 -27.41 66.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.76 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.472 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -104.64 26.49 9.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.227 . . . . 0.0 111.33 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -128.79 109.7 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 111.429 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -79.11 75.78 5.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.38 145.86 30.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.736 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.9 p -118.1 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.844 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -74.88 100.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.639 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? 59.26 -82.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.535 0.207 . . . . 0.0 111.055 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.1 p30 -97.5 7.16 47.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.655 0.264 . . . . 0.0 111.297 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.94 26.13 4.82 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.526 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.83 123.83 29.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 111.116 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.95 111.1 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 mt -102.11 175.1 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.423 ' HE2' ' CG ' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -53.83 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.39 -36.76 68.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.432 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -66.0 -46.7 77.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.419 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 34.9 mm -63.01 -50.79 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.332 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -57.45 -31.91 66.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 110.392 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.983 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.472 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.3 t80 -61.83 -28.66 69.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.117 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 167' ' ' LEU . 3.7 mp -81.17 -47.99 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.784 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.03 67.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -84.37 -28.93 31.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.557 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.562 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.808 0.337 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -97.11 25.93 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.15 149.36 52.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.4 t -107.13 156.74 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.039 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.4 mt -127.06 124.84 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.176 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.441 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.22 174.77 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 33.1 mmm -91.07 147.13 35.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.394 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.54 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 72.0 Cg_exo -48.5 -50.56 12.03 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.444 2.096 . . . . 0.0 112.81 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.516 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -63.44 -26.6 68.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.837 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.59 -38.78 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.907 0.384 . . . . 0.0 110.223 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.6 OUTLIER -67.51 -41.55 84.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.714 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.37 -39.46 81.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.423 ' CD1' HG22 ' A' ' 163' ' ' ILE . 53.3 t-105 -59.93 -50.25 74.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.201 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.61 73.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.99 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.87 -35.73 57.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.84 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -4.24 56.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.541 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.18 -10.56 65.59 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.628 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.97 145.27 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.007 0.432 . . . . 0.0 111.417 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 35.0 t0 -108.24 133.57 52.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.441 HG12 ' CB ' ' A' ' 131' ' ' ALA . 3.4 tp -59.39 -35.28 57.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.116 0.484 . . . . 0.0 110.928 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -55.1 -21.2 12.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.226 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.498 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.08 25.35 11.89 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.13 111.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 111.245 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.15 77.67 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.14 144.81 35.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.646 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.2 p -118.02 26.1 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.739 0.304 . . . . 0.0 111.068 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.5 102.37 1.97 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.718 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? 57.84 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.625 0.25 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.4 p30 -90.7 -0.54 57.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.252 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.02 26.07 4.82 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.679 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -82.33 133.35 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.748 0.309 . . . . 0.0 110.979 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.0 123.89 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.6 mt -114.71 170.17 8.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -32.0 11.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.57 -40.95 73.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.633 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -61.91 -50.91 70.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.572 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.423 HG22 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -58.34 -52.24 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.413 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.65 -34.07 57.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.401 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.45 -32.39 60.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.498 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 19.4 t80 -64.14 -37.68 88.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.496 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.16 -27.56 24.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.043 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.32 31.07 1.55 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.417 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 96.7 56.03 1.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.467 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.419 -1.212 . . . . 0.0 112.503 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.96 142.77 58.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -115.3 157.66 23.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.95 159.76 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.83 118.45 55.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.434 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -169.97 162.56 9.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.3 mtp -75.12 144.31 78.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.554 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.628 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 73.5 Cg_exo -49.06 -47.56 21.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.386 2.057 . . . . 0.0 112.397 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 1.3 m -63.46 -30.47 71.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.677 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.93 -40.69 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 109.93 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.428 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -64.41 -43.84 93.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.778 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -65.2 -41.36 94.59 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 53.6 t-105 -58.18 -50.83 72.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.236 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.96 -49.22 75.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.853 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -56.4 -29.94 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.781 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.7 -43.53 59.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -84.5 -4.63 59.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.496 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.4 66.28 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.617 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.6 t -78.96 145.09 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 111.311 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 7.6 t0 -108.29 134.6 50.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.418 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.434 HG12 ' CB ' ' A' ' 131' ' ' ALA . 3.4 tp -59.7 -35.17 58.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.021 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -55.59 -21.05 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.14 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.476 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.42 26.8 10.29 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.634 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.95 113.76 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -77.76 76.96 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.721 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.95 142.68 34.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.604 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.7 p -117.46 25.37 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.7 0.286 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -77.51 98.48 1.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.12 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.634 0.254 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 11.7 p-10 -79.32 -6.48 56.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.182 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.09 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -83.83 133.81 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.342 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.4 t -70.44 118.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.136 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -108.16 171.81 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.684 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -32.24 18.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -70.72 -39.26 73.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.621 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.01 -47.28 83.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.427 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.0 mm -60.8 -51.44 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.291 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -33.87 61.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.201 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.29 -34.11 61.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.123 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 20.8 t80 -60.91 -39.66 90.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.157 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.16 -31.46 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.956 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.65 31.03 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.55 66.43 0.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.367 -1.241 . . . . 0.0 112.524 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.845 0.355 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.93 -46.57 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.964 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -77.21 -177.59 4.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.3 143.46 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.086 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp -84.92 118.39 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 156.54 6.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -82.91 152.13 65.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.41 -36.26 68.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.505 2.137 . . . . 0.0 112.232 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.4 p -63.92 -34.04 77.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.831 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.1 t -75.18 -47.97 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -47.75 84.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.115 0.483 . . . . 0.0 109.802 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -62.48 -39.54 93.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.767 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -61.39 -49.16 78.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.05 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.167 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -56.75 -30.24 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.824 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.96 -40.95 62.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.9 -4.24 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.616 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.19 66.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.59 145.21 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.365 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 18.3 t0 -111.47 122.98 49.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.507 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.7 tp -50.84 -25.8 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.42 -22.88 63.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.834 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.459 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -110.3 25.65 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.614 0.245 . . . . 0.0 111.394 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.5 t -127.65 106.48 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.88 0.371 . . . . 0.0 111.213 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -75.84 78.91 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.403 ' HA2' ' N ' ' A' ' 158' ' ' VAL . . . -52.26 140.15 28.62 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.784 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.1 p -118.17 26.06 9.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -89.79 128.89 9.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.809 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -87.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.555 0.217 . . . . 0.0 111.524 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 25.0 m-80 -108.99 17.82 21.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.633 0.254 . . . . 0.0 111.376 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 22.55 7.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.009 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -84.45 133.93 34.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.62 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.403 ' N ' ' HA2' ' A' ' 151' ' ' GLY . 33.5 t -69.66 127.21 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.271 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.22 172.54 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -53.46 -30.79 42.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.682 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.12 -35.95 69.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.0 -47.76 73.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.5 mm -61.57 -51.92 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.224 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -55.74 -33.18 64.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.415 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.44 -32.77 54.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.235 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.459 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 22.2 t80 -61.29 -43.08 99.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.4 -42.33 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.76 -24.98 64.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.21 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -122.39 28.23 5.83 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.487 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.467 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.0 m120 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.868 0.366 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -107.99 -38.1 5.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 173.01 6.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.47 145.64 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.097 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.69 114.27 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.05 146.34 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.8 mmm -74.12 151.01 88.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.05 -28.1 39.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.613 2.208 . . . . 0.0 112.073 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 p -63.87 -44.86 91.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.05 -46.63 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -56.17 -47.55 78.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 109.808 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -60.67 -39.91 90.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.889 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.413 ' CH2' ' HE3' ' A' ' 142' ' ' LYS . 60.9 t-105 -62.5 -50.21 72.32 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.199 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . . . -63.74 -38.35 90.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.469 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -30.19 70.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.029 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -82.1 -31.26 30.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.351 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.413 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.6 mmtm -88.39 -24.03 23.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.397 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.83 -5.96 24.07 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.628 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 43.5 t -85.32 145.18 8.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 58.0 t0 -111.52 114.88 28.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.01 -24.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.4 mtp85 -58.25 -19.86 37.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.522 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -111.28 -5.76 14.63 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.04 113.8 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 0.0 111.332 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -79.08 75.92 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.79 142.08 38.45 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.815 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.08 25.87 10.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.0 111.016 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.62 112.32 3.43 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.886 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.53 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.67 0.271 . . . . 0.0 111.399 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 18.4 m-80 -106.07 16.34 25.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.32 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.84 26.04 6.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.686 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -84.29 126.05 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.0 124.08 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.12 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 mt -113.88 169.07 9.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.738 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -50.91 -31.31 17.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.67 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -70.19 -40.16 74.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.456 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.54 -45.7 91.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.404 ' O ' HD21 ' A' ' 167' ' ' LEU . 40.0 mm -60.85 -53.12 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.266 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -53.28 -34.45 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.349 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.93 -31.47 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.522 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 19.7 t80 -63.48 -44.53 94.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 163' ' ' ILE . 3.1 mm? -79.34 -30.05 42.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.75 30.98 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.318 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -158.82 -50.03 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.527 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.775 0.321 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -87.54 150.35 23.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.03 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 128.41 33.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.9 t -86.89 146.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.036 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.05 116.97 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.364 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.14 158.1 6.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 55.8 mtp -77.86 157.34 79.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.626 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.86 -35.54 77.74 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.464 2.109 . . . . 0.0 112.183 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -66.51 -29.6 69.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.08 -49.16 23.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.962 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -59.41 -46.35 88.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.36 94.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -56.78 -51.55 68.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.057 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.22 77.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.211 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -37.53 56.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.17 -49.65 59.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.257 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -72.26 -19.61 61.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.09 13.68 28.42 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.266 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 41.5 t -100.74 145.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.896 0.379 . . . . 0.0 111.233 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.502 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.2 t0 -107.46 115.38 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.417 HG12 ' CB ' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -46.71 -26.23 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -56.86 -22.37 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.008 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 145' ' ' ASP . 0.9 OUTLIER -111.94 28.67 8.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.57 0.224 . . . . 0.0 111.319 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.04 108.53 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.938 0.399 . . . . 0.0 111.302 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.19 77.58 3.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.23 143.69 33.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.689 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 p -118.1 26.16 9.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.801 0.334 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.42 102.4 1.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.1 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.602 0.239 . . . . 0.0 111.272 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.92 -5.07 58.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 0.0 111.317 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.04 26.05 4.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.603 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -85.99 137.74 32.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.95 126.49 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 mt -116.2 169.29 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.568 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -50.33 -30.41 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 110.7 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.88 -40.98 71.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.483 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -62.7 -46.91 85.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.566 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 40.7 mm -62.67 -48.64 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.453 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -57.68 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.355 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.78 -40.87 31.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.471 ' CZ ' ' CD1' ' A' ' 148' ' ' LEU . 21.2 t80 -61.66 -25.9 67.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.256 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 167' ' ' LEU . 3.3 mp -86.04 -45.5 11.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.77 31.11 2.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.29 28.04 1.37 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.395 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.449 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 mmt-85 -81.21 74.44 8.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 165.15 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 t -76.95 159.39 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.976 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mt -116.15 113.07 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.208 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.12 162.23 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 31.2 mtp -79.53 155.38 76.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.659 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.82 -32.99 93.39 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.525 2.15 . . . . 0.0 112.072 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -33.62 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.464 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.93 -47.32 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.881 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.423 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -58.13 -49.62 76.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.54 -41.31 94.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.762 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CD1' HG22 ' A' ' 163' ' ' ILE . 48.5 t-105 -59.89 -48.28 82.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.123 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.47 73.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.181 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.91 -28.84 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -81.03 -28.59 35.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.033 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -96.53 -4.03 42.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.62 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.19 8.95 64.05 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.784 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.92 145.19 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.852 0.358 . . . . 0.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 23.5 t0 -108.4 121.13 44.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.504 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.423 ' CG2' ' HD3' ' A' ' 136' ' ' ARG . 1.2 tp -50.02 -27.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.943 0.401 . . . . 0.0 111.38 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -59.56 -21.83 60.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.063 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.477 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -111.39 26.78 10.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.559 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -129.04 107.15 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.84 81.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.04 139.38 43.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.689 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.19 26.07 9.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.55 128.91 9.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.873 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.62 -88.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 80.5 m-20 -105.55 26.27 9.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.4 24.08 27.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.801 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.97 136.73 33.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.0 t -69.23 130.52 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.301 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.6 mt -117.51 169.47 9.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.584 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -33.3 23.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 110.673 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.76 -38.68 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.53 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.91 -49.37 75.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.427 HG22 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -59.2 -52.19 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.414 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -54.97 -33.56 62.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.335 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.224 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.477 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 38.6 t80 -60.27 -43.25 96.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.434 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.91 -39.13 43.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.08 65.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.22 -30.11 76.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.599 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.57 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.857 0.36 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.24 99.39 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -60.0 147.94 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.0 t -72.91 153.83 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.071 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mm -113.87 122.7 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.222 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.01 165.28 9.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 30.9 mtp -80.34 149.93 69.84 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.612 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.554 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.9 Cg_endo -53.15 -47.68 26.21 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.588 2.192 . . . . 0.0 112.201 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.542 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 28.7 t -63.58 -30.6 71.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.605 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.24 -40.86 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 109.986 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.454 ' HD3' HG23 ' A' ' 146' ' ' ILE . 4.1 mmm180 -65.35 -41.4 93.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.935 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 1.5 mttt -68.43 -38.19 80.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.468 ' CZ2' ' HD3' ' A' ' 142' ' ' LYS . 64.0 t-105 -61.39 -50.01 74.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.72 -45.27 93.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.933 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -60.18 -31.38 70.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.918 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.25 -31.38 54.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.468 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -92.37 -6.79 49.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.422 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.28 -10.42 67.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.348 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.0 t -80.58 145.17 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.528 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 32.0 t0 -107.36 132.84 52.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.219 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.454 HG23 ' HD3' ' A' ' 136' ' ' ARG . 3.7 tp -59.34 -35.2 57.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 110.996 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -55.59 -21.23 16.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.084 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.493 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -109.6 26.25 10.87 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.56 0.219 . . . . 0.0 111.548 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 30.4 t -127.28 112.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.261 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.33 73.09 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -57.74 153.42 24.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.62 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.2 p -118.18 25.63 10.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.677 0.275 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -76.99 105.17 2.0 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.941 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.612 0.244 . . . . 0.0 111.399 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -108.56 13.42 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.721 0.296 . . . . 0.0 111.068 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 110.58 26.08 4.94 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.436 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 122.83 26.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.11 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' A' ' 151' ' ' GLY . 11.5 t -67.97 113.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.062 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.9 mt -105.52 170.48 7.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.614 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -30.65 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.924 0.392 . . . . 0.0 110.723 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -71.26 -40.74 70.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.602 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -61.98 -46.62 88.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.43 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.7 mm -61.11 -52.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.278 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -32.93 56.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.16 -33.1 61.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.238 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.493 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 18.3 t80 -63.97 -39.2 93.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.404 ' N ' HD23 ' A' ' 167' ' ' LEU . 3.2 mm? -85.89 -24.97 26.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.7 31.06 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.424 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -110.63 27.61 11.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.479 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.445 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.751 0.31 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -147.41 123.32 10.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.96 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -76.29 158.36 31.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.26 147.03 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.208 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.6 mm -127.01 122.71 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.278 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.441 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -167.57 162.49 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.243 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.42 149.12 81.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.465 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.508 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.2 Cg_endo -53.6 -45.99 37.0 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.527 2.152 . . . . 0.0 112.147 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.537 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 12.2 p -63.58 -31.71 72.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.92 -41.93 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.169 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.29 -44.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.834 179.118 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.537 ' HG3' ' HA ' ' A' ' 134' ' ' SER . 1.2 mtmt -65.08 -40.79 95.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.439 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 50.9 t-105 -58.46 -51.97 67.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.157 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.53 94.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.027 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -29.99 69.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.984 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.72 -30.63 51.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -95.21 -5.57 43.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.575 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.79 -9.52 68.47 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.492 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.5 t -80.56 145.18 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.902 0.382 . . . . 0.0 111.638 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.455 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.3 t0 -106.65 133.17 51.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.441 HG12 ' CB ' ' A' ' 131' ' ' ALA . 5.8 tp -58.45 -38.27 68.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -54.3 -20.72 7.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.379 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.461 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.21 27.79 9.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.607 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.54 117.18 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -79.23 75.57 5.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.588 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.2 154.4 5.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.861 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.5 p -118.19 21.7 12.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.649 0.261 . . . . 0.0 111.124 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.83 94.86 1.34 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.696 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.02 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.586 0.232 . . . . 0.0 111.203 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -88.27 5.07 43.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.26 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.88 26.05 4.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.612 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -74.18 120.6 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.309 . . . . 0.0 110.963 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.7 t -67.93 115.13 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.3 mt -105.03 170.35 7.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.504 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -31.36 13.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.86 -40.32 72.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.608 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.12 -46.08 90.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.482 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.439 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 36.9 mm -61.27 -51.72 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -53.98 -33.88 58.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.69 -33.65 62.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.461 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 17.5 t80 -60.43 -44.79 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.361 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.76 -34.07 58.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.853 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.97 -24.85 67.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -56.54 -26.78 53.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.596 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.591 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.914 0.388 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -31.46 14.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.5 140.94 44.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.05 123.95 49.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.029 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.99 123.78 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.332 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.4 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.07 152.51 4.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 44.3 mtp -80.33 151.46 72.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.48 -35.98 57.46 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.573 2.182 . . . . 0.0 112.218 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -64.01 -33.22 75.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.44 -48.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -47.7 84.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.09 0.472 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.26 -40.5 96.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.599 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.429 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 53.5 t-105 -60.27 -49.43 77.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . . . -60.82 -50.32 73.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -54.35 -30.51 51.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.82 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.54 -34.94 53.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.422 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.5 mmpt? -90.42 -2.94 57.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.7 65.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 23.1 t -103.72 145.18 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.794 0.331 . . . . 0.0 111.269 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.3 t70 -104.89 132.23 51.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.4 HG12 ' CB ' ' A' ' 131' ' ' ALA . 2.0 tp -61.23 -28.85 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.401 . . . . 0.0 111.148 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.09 -17.92 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.983 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.501 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -112.47 25.86 11.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.8 t -128.2 110.76 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.97 0.414 . . . . 0.0 111.266 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -69.63 82.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -57.57 129.65 49.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.565 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.14 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.719 0.295 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -81.76 102.72 2.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.722 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 56.51 -84.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.617 0.246 . . . . 0.0 111.405 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -86.98 -0.17 56.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.82 26.03 5.71 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.661 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 133.2 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 44.2 t -67.92 119.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.149 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 mt -108.41 171.92 7.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.796 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -51.65 -30.1 20.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.742 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.48 -39.34 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -63.3 -50.39 70.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.429 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.1 mm -59.91 -51.72 69.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.209 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.56 -31.94 57.55 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.67 -32.82 47.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.501 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 21.8 t80 -60.74 -40.33 91.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.64 -37.28 25.14 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.964 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.75 30.98 2.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.55 -35.38 6.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.513 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.493 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.838 0.352 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.4 ptt85 -86.02 -175.45 5.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -114.32 144.82 42.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.4 t -101.1 152.64 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.6 mt -126.85 115.43 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.235 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.98 141.61 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.1 mmm -67.65 158.29 83.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.84 -28.64 87.68 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.537 2.158 . . . . 0.0 112.062 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -64.96 -42.57 94.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.625 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.42 -46.95 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 1.1 mmm180 -56.1 -51.0 69.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.689 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -59.15 -39.37 82.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.785 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.425 ' CD1' HG22 ' A' ' 163' ' ' ILE . 48.9 t-105 -60.54 -50.65 72.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . . . -59.49 -48.54 81.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.195 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -54.97 -33.94 62.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -79.92 -27.34 39.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -4.01 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.31 13.45 65.77 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.532 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 21.4 t -106.58 145.26 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 12.9 t0 -107.56 128.81 54.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.413 ' CG2' ' HD3' ' A' ' 136' ' ' ARG . 2.4 tp -57.09 -28.61 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.91 0.386 . . . . 0.0 111.046 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -61.18 -19.24 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.889 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.474 HD12 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -112.53 25.72 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.386 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.48 112.28 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.333 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.68 77.13 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -53.64 145.47 23.87 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.76 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.5 p -117.94 18.8 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.622 0.248 . . . . 0.0 111.315 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -69.81 97.21 0.55 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.478 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.58 -87.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.499 0.19 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 153' ' ' GLY . 82.3 m-20 -78.03 -6.79 55.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.666 0.269 . . . . 0.0 111.256 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.11 4.81 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.603 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -84.37 131.41 34.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.2 t -67.9 123.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.257 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.95 172.72 6.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.472 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -32.72 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.933 0.397 . . . . 0.0 110.762 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.12 -39.36 75.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.12 -47.76 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.598 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.425 HG22 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -60.07 -51.66 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.4 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.52 -34.91 62.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.295 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.79 -33.52 62.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.277 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.474 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 22.5 t80 -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.55 -32.75 36.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.06 27.61 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.63 29.3 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.518 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.493 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.847 0.356 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -91.24 124.53 35.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.99 149.28 24.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.9 t -73.47 138.75 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.046 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.75 123.51 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.408 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.09 148.82 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.75 154.79 73.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.81 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.17 -30.17 31.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.508 2.139 . . . . 0.0 112.362 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -64.18 -41.31 97.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.03 -47.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.403 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -56.62 -48.97 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.252 0.548 . . . . 0.0 109.686 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -59.82 -41.96 92.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.832 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.412 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 55.6 t-105 -60.33 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.296 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.52 -48.0 83.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.21 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -56.2 -31.62 63.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -81.49 -28.08 34.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.73 -3.52 49.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.723 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.17 14.67 66.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.611 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.0 t -105.54 145.13 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.201 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 9.7 t0 -106.71 120.77 42.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 131' ' ' ALA . 1.4 tp -50.34 -28.27 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.965 0.412 . . . . 0.0 111.378 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -60.73 -21.53 63.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.076 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 145' ' ' ASP . 0.8 OUTLIER -109.75 25.86 11.31 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.292 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.0 t -129.01 108.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -75.99 79.0 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.831 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.28 149.93 26.19 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.704 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.78 12.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.68 0.276 . . . . 0.0 111.3 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.57 105.43 2.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.663 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.084 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -93.38 13.0 22.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.09 26.08 7.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.389 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.0 ttm105 -77.54 125.28 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.319 . . . . 0.0 110.999 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.02 121.08 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.22 172.22 6.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -51.86 -29.82 21.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.77 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -71.66 -38.98 70.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.588 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -64.46 -49.56 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.529 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 138' ' ' TRP . 38.2 mm -59.27 -52.47 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -34.84 62.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.363 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 -31.92 60.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.293 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.466 ' CZ ' HD12 ' A' ' 148' ' ' LEU . 21.0 t80 -63.15 -40.83 98.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.455 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.58 -34.0 35.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.912 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.73 30.95 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.297 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -112.99 -28.54 3.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.594 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.402 -1.221 . . . . 0.0 112.553 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.76 HG22 ' HG2' ' A' ' 157' ' ' ARG . 14.8 mt . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.842 0.353 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.04 164.55 9.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.769 ' HB2' HG23 ' A' ' 135' ' ' VAL . 29.1 mmm -76.49 141.64 69.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.431 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.605 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 72.2 Cg_exo -48.62 -45.53 27.21 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.302 2.001 . . . . 0.0 112.403 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.473 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 3.2 p -63.56 -32.67 74.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.822 HG11 ' O ' ' A' ' 158' ' ' VAL . 65.6 t -66.0 -40.49 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.085 0.469 . . . . 0.0 109.791 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 2.5 mmm180 -63.45 -44.01 95.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.904 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -65.87 -41.1 92.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.669 ' CD1' HG21 ' A' ' 163' ' ' ILE . 54.9 t-105 -58.07 -50.17 74.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.086 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.658 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.78 -52.56 64.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.033 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -54.93 -30.45 58.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.44 -35.23 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.415 ' HE3' ' CZ3' ' A' ' 138' ' ' TRP . 0.8 OUTLIER -91.75 -3.99 55.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.745 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.93 63.07 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.575 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.938 HG21 HD21 ' A' ' 167' ' ' LEU . 19.0 t -101.0 145.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.265 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 24.2 t0 -111.24 133.89 53.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.348 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.587 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -58.1 -33.45 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.43 . . . . 0.0 110.797 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.85 -22.64 15.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.889 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.98 25.6 11.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.721 0.296 . . . . 0.0 111.405 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.458 HG11 ' CG1' ' A' ' 158' ' ' VAL . 29.1 t -129.04 112.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 111.247 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -80.56 73.03 7.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.611 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -54.75 150.47 17.67 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.651 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.09 12.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.267 . . . . 0.0 111.202 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -70.09 95.1 0.48 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.711 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.14 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.689 0.28 . . . . 0.0 111.259 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.6 p30 -97.11 5.7 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.099 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.13 26.04 4.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.621 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.76 ' HG2' HG22 ' A' ' 130' ' ' ILE . 12.4 mtt180 -77.35 122.43 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.822 ' O ' HG11 ' A' ' 135' ' ' VAL . 36.5 t -71.11 102.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.843 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.8 mt -94.14 173.08 7.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -51.34 -30.11 17.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.654 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -69.02 -41.11 78.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.404 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -63.39 -49.39 74.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.392 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.9 mm -59.81 -52.28 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.275 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -31.71 61.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.332 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -33.2 49.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.183 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 18.4 t80 -60.88 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.441 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.938 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.93 -40.2 40.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.076 -179.913 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 157' ' ' ARG . 1.9 mt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.871 0.367 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.15 166.05 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.075 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.7 mtp -91.89 149.88 39.72 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.77 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.4 -30.98 28.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.487 2.124 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -66.04 -40.69 91.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.622 HG21 ' O ' ' A' ' 158' ' ' VAL . 39.3 t -72.3 -44.44 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.457 ' HD3' HG21 ' A' ' 146' ' ' ILE . 2.6 mmm180 -58.32 -46.64 85.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 109.775 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -63.09 -39.95 96.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.941 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 163' ' ' ILE . 56.1 t-105 -63.11 -46.27 88.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.221 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.632 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -64.37 -47.28 79.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.235 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.2 -29.53 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.864 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -80.81 -31.23 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.997 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -5.36 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.576 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.42 -10.11 64.98 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.669 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.959 HG21 HD21 ' A' ' 167' ' ' LEU . 40.0 t -82.74 145.02 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 53.6 t0 -110.65 113.36 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.222 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.6 OUTLIER -44.47 -25.61 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -18.03 27.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 149' ' ' VAL . 0.5 OUTLIER -115.44 29.16 8.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.621 0.248 . . . . 0.0 111.545 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 148' ' ' LEU . 43.1 t -129.04 109.54 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.393 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 82.29 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -53.6 142.57 29.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.787 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -118.25 -21.14 8.28 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.859 ' H ' HD21 ' A' ' 159' ' ' LEU . . . -60.51 153.3 36.64 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.493 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 48.02 -104.8 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -105.46 30.04 6.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.734 0.302 . . . . 0.0 111.435 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.27 20.48 13.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.761 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.578 ' HB3' HG22 ' A' ' 130' ' ' ILE . 22.4 ptt180 -85.47 154.15 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.649 0.262 . . . . 0.0 110.399 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.742 ' C ' HD13 ' A' ' 159' ' ' LEU . 22.2 t -80.74 133.93 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.488 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.859 HD21 ' H ' ' A' ' 153' ' ' GLY . 0.0 OUTLIER -119.34 169.82 9.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -52.17 -30.7 28.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.02 -39.99 78.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.412 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.705 ' OD2' HD22 ' A' ' 159' ' ' LEU . 87.6 m-20 -64.1 -51.05 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.652 HG21 ' CD1' ' A' ' 138' ' ' TRP . 42.2 mm -59.48 -52.06 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -54.38 -33.85 60.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.384 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.73 -31.19 52.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.209 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 24.2 t80 -64.24 -37.66 88.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.628 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.959 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -89.06 -26.64 21.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.361 -179.831 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.782 HG22 ' CG ' ' A' ' 157' ' ' ARG . 23.8 mm . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.795 0.331 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.11 160.98 8.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.3 mtp -81.92 145.88 54.51 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.68 -32.55 45.6 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.489 2.126 . . . . 0.0 112.283 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -40.41 95.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.697 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.772 HG21 ' HA ' ' A' ' 159' ' ' LEU . 46.3 t -70.25 -46.26 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.2 OUTLIER -56.31 -45.7 80.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.798 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -61.92 -41.1 97.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.615 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.633 ' CD1' HG21 ' A' ' 163' ' ' ILE . 54.0 t-105 -61.24 -50.48 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.247 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -58.6 -44.09 89.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.76 -32.76 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -77.88 -27.47 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -96.69 -6.07 37.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.606 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.74 -9.01 71.13 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.63 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.743 HG21 HD21 ' A' ' 167' ' ' LEU . 18.1 t -82.06 145.21 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.888 0.375 . . . . 0.0 111.49 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 62.5 t0 -110.24 122.67 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.1 tp -50.7 -27.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.294 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -61.36 -23.22 65.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.933 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.679 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -109.44 23.52 14.35 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.409 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.443 HG23 HD12 ' A' ' 148' ' ' LEU . 44.2 t -123.91 114.74 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.9 78.98 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.66 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.65 142.16 34.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.718 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p -118.05 23.93 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -75.08 90.09 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.537 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.64 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.618 0.247 . . . . 0.0 111.145 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . 87.4 m-20 -85.69 -0.74 56.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.145 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.03 26.07 4.82 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.587 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.782 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -80.92 122.87 27.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.735 0.302 . . . . 0.0 110.816 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.674 ' HB ' HD11 ' A' ' 146' ' ' ILE . 35.4 t -67.9 111.27 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.939 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.772 ' HA ' HG21 ' A' ' 135' ' ' VAL . 3.1 mt -102.44 175.28 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.744 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -32.49 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.33 -35.43 75.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.415 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.424 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.633 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.8 mm -60.95 -45.78 97.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HA ' HD12 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -58.27 -41.12 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.311 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.62 -34.59 74.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.348 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.679 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 19.2 t80 -59.98 -45.46 92.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.372 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.743 HD21 HG21 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -76.6 -27.73 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.099 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.394 -179.859 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.559 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.18 150.89 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.0 mtm -74.99 161.67 76.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.55 -29.28 84.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.524 2.149 . . . . 0.0 112.125 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 p -67.02 -37.32 83.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.598 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 158' ' ' VAL . 45.0 t -74.77 -47.52 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 109.746 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -61.68 -41.78 98.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.752 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.69 ' CD1' HG21 ' A' ' 163' ' ' ILE . 49.6 t-105 -60.22 -47.24 86.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.43 -50.34 73.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.069 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -54.21 -33.5 58.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.095 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -78.42 -29.73 47.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.817 0.341 . . . . 0.0 110.943 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.408 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 2.1 mmtt -92.98 -3.64 54.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.9 12.68 68.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.569 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.805 ' CG2' HD21 ' A' ' 167' ' ' LEU . 20.4 t -104.04 145.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.367 . . . . 0.0 111.214 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 22.6 t0 -107.82 121.06 43.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.344 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.762 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.1 tp -50.74 -26.41 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.449 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -23.37 64.34 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.707 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -110.15 25.77 11.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.0 111.503 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.455 HG23 HD12 ' A' ' 148' ' ' LEU . 39.7 t -127.09 108.01 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -76.15 79.02 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.645 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -53.26 159.34 3.87 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.765 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 p -118.27 8.48 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -63.85 87.07 0.06 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.65 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.623 0.249 . . . . 0.0 111.257 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.8 m-80 -87.7 3.21 48.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.119 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.16 4.78 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.559 ' HG3' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -73.02 113.3 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 0.0 110.918 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.762 ' HB ' HD11 ' A' ' 146' ' ' ILE . 40.1 t -67.84 111.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.518 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -100.65 176.16 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -30.97 60.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.676 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.73 -33.83 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.73 -47.61 62.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.69 HG21 ' CD1' ' A' ' 138' ' ' TRP . 36.5 mm -60.99 -47.74 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.31 -40.06 85.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.299 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.41 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.132 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.686 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.0 t80 -60.01 -46.03 90.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.201 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.805 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -76.28 -27.12 56.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.132 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.282 -179.802 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.7 HG22 ' HG3' ' A' ' 157' ' ' ARG . 2.8 mp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.77 152.41 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.39 153.94 71.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.52 -33.26 67.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.191 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.2 m -64.01 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 159' ' ' LEU . 61.4 t -74.17 -48.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -47.0 82.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.829 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -61.56 -42.1 98.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.729 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 163' ' ' ILE . 51.5 t-105 -59.32 -48.93 79.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.136 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.698 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.05 -49.59 76.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.016 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 tpt85 -54.47 -30.7 53.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.84 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -79.71 -32.21 41.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.412 ' HD3' ' CH2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -92.18 -2.67 56.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.713 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.77 16.06 64.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.491 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 1.083 HG21 HD11 ' A' ' 167' ' ' LEU . 34.4 t -105.86 145.11 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.368 . . . . 0.0 111.261 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.1 t0 -108.77 122.11 46.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.74 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.9 tp -50.06 -27.15 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 111.292 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 mmt-85 -60.04 -25.17 65.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.739 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -107.41 25.43 11.46 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.344 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.426 HG23 HD12 ' A' ' 148' ' ' LEU . 31.3 t -126.51 111.3 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.975 0.417 . . . . 0.0 111.459 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -79.91 74.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.536 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -53.31 145.59 22.08 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.773 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.7 p -118.05 24.21 11.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.991 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -73.68 101.72 1.22 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.7 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.62 -83.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.651 0.262 . . . . 0.0 111.197 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -97.09 6.28 48.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.463 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.99 26.07 4.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.715 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.7 ' HG3' HG22 ' A' ' 130' ' ' ILE . 26.6 ttm180 -83.45 125.26 31.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.74 ' HB ' HD11 ' A' ' 146' ' ' ILE . 21.5 t -67.95 119.44 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.603 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.7 mt -113.34 171.99 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.815 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -50.6 -28.8 9.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.975 0.417 . . . . 0.0 110.729 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -72.47 -41.0 66.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.507 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.3 -45.74 91.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.6 mm -62.75 -49.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -31.8 63.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.202 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.46 -41.21 40.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.892 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.739 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 16.3 t80 -61.38 -24.85 66.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.202 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.083 HD11 HG21 ' A' ' 144' ' ' VAL . 4.5 mp -87.95 -39.96 14.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.82 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.409 -179.843 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 157' ' ' ARG . 35.0 mm . . . . . 0 C--O 1.23 0.029 0 CA-C-O 120.853 0.359 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.21 157.96 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.094 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.95 161.89 54.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.75 -28.96 87.35 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.536 2.157 . . . . 0.0 112.119 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.8 p -67.5 -37.1 82.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' A' ' 159' ' ' LEU . 60.2 t -74.6 -47.71 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -43.63 93.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 109.789 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -64.07 -41.17 97.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.533 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.659 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.5 t-105 -61.01 -50.32 73.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.099 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.35 -47.19 87.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.156 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -57.71 -30.22 65.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.791 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.09 -40.17 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.29 -9.38 67.31 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.676 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.771 ' CG2' HD21 ' A' ' 167' ' ' LEU . 19.4 t -80.17 145.25 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.8 t0 -111.27 130.75 55.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.425 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.686 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.8 OUTLIER -56.7 -28.65 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.127 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.4 mtt85 -59.46 -19.0 44.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.961 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.651 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -114.71 27.23 9.59 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.621 0.248 . . . . 0.0 111.391 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.5 t -128.87 115.98 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.35 73.97 7.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.531 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -52.05 142.74 21.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.715 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.2 p -118.03 26.11 9.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -78.16 100.71 1.66 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.665 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.41 -85.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.58 0.228 . . . . 0.0 111.095 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 10.6 p30 -83.94 -4.76 58.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.05 26.02 4.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.476 ' NE ' HD21 ' A' ' 159' ' ' LEU . 23.8 ptt-85 -82.21 134.86 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.969 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HD11 ' A' ' 146' ' ' ILE . 18.7 t -69.34 119.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.306 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.1 mt -111.73 176.99 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.619 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.43 -35.16 62.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -69.15 -32.58 72.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.59 -50.0 55.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.623 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.659 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.6 mm -60.1 -46.2 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -39.7 84.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.224 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -33.96 70.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.316 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.651 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.5 t80 -58.7 -49.24 78.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -73.56 -31.55 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 157' ' ' ARG . 5.4 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.79 0.329 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.444 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.07 177.35 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.602 ' HE1' HD23 ' A' ' 159' ' ' LEU . 2.7 mtm -108.79 155.45 40.67 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.94 -30.75 31.6 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.48 2.12 . . . . 0.0 112.284 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.2 m -63.86 -45.95 87.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 159' ' ' LEU . 60.3 t -70.31 -44.4 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.835 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 12.8 mmm-85 -58.63 -42.88 89.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 109.869 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.4 -41.65 98.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.643 ' CD1' HG21 ' A' ' 163' ' ' ILE . 58.1 t-105 -61.87 -51.0 69.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.207 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.84 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 13.6 ttm105 -60.35 -31.38 70.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -77.52 -34.85 53.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.428 ' HE2' ' CZ3' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -89.98 -5.87 56.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.574 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.6 72.75 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.717 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.751 ' CG2' HD21 ' A' ' 167' ' ' LEU . 19.2 t -80.93 145.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.875 0.369 . . . . 0.0 111.355 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.4 t0 -109.52 134.28 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 131' ' ' ALA . 2.0 tp -60.37 -28.82 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -61.51 -17.09 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.84 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -115.4 25.02 11.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.539 0.209 . . . . 0.0 111.402 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.59 111.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.93 75.34 5.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.661 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.58 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -51.04 159.5 1.88 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.729 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.0 p -118.11 12.14 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.642 0.258 . . . . 0.0 111.356 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.67 92.17 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.697 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt 56.6 -86.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -88.07 5.95 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.294 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.07 4.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.572 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.65 ' HG3' HG22 ' A' ' 130' ' ' ILE . 25.2 ttm180 -73.35 115.9 13.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 151' ' ' GLY . 41.8 t -67.92 119.65 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.03 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.642 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.3 mt -110.78 177.41 4.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -33.34 61.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.98 0.419 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -70.46 -33.2 71.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.453 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.79 -48.87 65.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.545 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.643 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.8 mm -61.49 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.492 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.09 -39.08 81.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.27 64.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.658 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.6 t80 -59.47 -52.36 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.751 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -70.09 -38.42 75.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.88 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.271 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.76 HG22 ' CG ' ' A' ' 157' ' ' ARG . 1.7 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.711 0.291 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.94 160.24 8.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.218 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.798 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.9 mtp -74.56 148.95 85.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.568 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.588 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.4 Cg_endo -53.52 -46.29 34.88 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.492 2.128 . . . . 0.0 112.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.535 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 65.3 p -63.57 -32.03 73.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 132' ' ' MET . 48.1 t -66.69 -41.06 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 110.04 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.906 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -66.96 -40.53 87.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.381 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.67 ' CD1' HG21 ' A' ' 163' ' ' ILE . 56.5 t-105 -59.89 -47.3 86.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.137 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.07 -52.09 66.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.076 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -51.99 -37.01 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.904 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.66 -40.74 80.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -85.03 -4.77 59.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.66 10.06 65.69 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.646 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.739 HG21 HD21 ' A' ' 167' ' ' LEU . 20.4 t -99.19 145.04 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.362 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 52.5 t0 -112.06 114.11 26.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.928 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.591 ' CD1' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -45.76 -26.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -57.46 -20.11 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -113.79 24.15 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.609 0.242 . . . . 0.0 111.327 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.556 HG23 HD12 ' A' ' 148' ' ' LEU . 40.0 t -123.06 111.75 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.96 78.79 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.717 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.669 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.57 152.24 12.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.4 p -117.95 19.21 13.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.557 0.218 . . . . 0.0 111.25 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -72.59 88.17 0.53 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.483 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.74 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.647 0.26 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.0 p30 -84.02 -0.34 51.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.211 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.07 26.04 4.82 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.609 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.76 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.29 119.75 21.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.32 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.669 HG22 ' N ' ' A' ' 151' ' ' GLY . 41.6 t -68.02 111.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.97 176.4 5.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.755 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.22 -31.96 54.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.55 -35.5 75.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.578 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -68.22 -47.62 67.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.67 HG21 ' CD1' ' A' ' 138' ' ' TRP . 44.8 mm -60.04 -48.42 88.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -58.87 -39.68 82.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.178 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.28 72.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.422 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.539 ' CE2' HD13 ' A' ' 148' ' ' LEU . 18.5 t80 -59.18 -50.26 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -69.73 -35.35 74.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.232 -179.938 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.735 HG22 ' CG ' ' A' ' 157' ' ' ARG . 3.2 mp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.881 0.372 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.08 153.09 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.6 mtp -81.33 150.43 67.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.81 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.56 -31.24 39.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.1 m -63.91 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.744 HG21 ' O ' ' A' ' 158' ' ' VAL . 43.6 t -75.34 -49.66 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.56 -47.07 80.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -45.97 90.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.596 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.636 ' CD1' HG21 ' A' ' 163' ' ' ILE . 52.4 t-105 -57.04 -49.17 76.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.402 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.69 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.11 -38.85 92.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.456 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.39 -30.9 71.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -82.8 -30.51 28.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.497 ' HG2' HD21 ' A' ' 167' ' ' LEU . 2.3 tptt -88.76 -15.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.506 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.77 45.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.667 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 1.074 HG21 HD11 ' A' ' 167' ' ' LEU . 38.8 t -85.5 145.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 111.264 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 43.1 t0 -108.98 119.86 40.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.384 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.671 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.0 OUTLIER -49.17 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.888 0.375 . . . . 0.0 111.498 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -59.47 -27.41 66.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.76 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.762 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -104.64 26.49 9.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.227 . . . . 0.0 111.33 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.445 HG23 HD12 ' A' ' 148' ' ' LEU . 24.8 t -128.79 109.7 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 111.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -79.11 75.78 5.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.621 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -55.38 145.86 30.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.736 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.9 p -118.1 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.844 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -74.88 100.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.639 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? 59.26 -82.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.535 0.207 . . . . 0.0 111.055 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.1 p30 -97.5 7.16 47.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.655 0.264 . . . . 0.0 111.297 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.94 26.13 4.82 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.526 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.735 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -81.83 123.83 29.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 111.116 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.744 ' O ' HG21 ' A' ' 135' ' ' VAL . 24.3 t -67.95 111.1 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.481 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -102.11 175.1 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -53.83 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.39 -36.76 68.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.432 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -66.0 -46.7 77.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.419 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.636 HG21 ' CD1' ' A' ' 138' ' ' TRP . 34.9 mm -63.01 -50.79 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.332 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -57.45 -31.91 66.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 110.392 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.983 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.762 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.3 t80 -61.83 -28.66 69.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.117 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.074 HD11 HG21 ' A' ' 144' ' ' VAL . 3.7 mp -81.17 -47.99 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.784 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.483 HG21 ' OD1' ' A' ' 155' ' ' ASN . 29.4 mt . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.8 0.333 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.444 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.22 174.77 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 135' ' ' VAL . 33.1 mmm -91.07 147.13 35.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.394 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.576 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 72.0 Cg_exo -48.5 -50.56 12.03 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.444 2.096 . . . . 0.0 112.81 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.517 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -63.44 -26.6 68.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.837 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 159' ' ' LEU . 80.5 t -71.59 -38.78 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.907 0.384 . . . . 0.0 110.223 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.6 OUTLIER -67.51 -41.55 84.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.714 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.37 -39.46 81.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.654 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.3 t-105 -59.93 -50.25 74.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.201 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.1 -49.61 73.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.87 -35.73 57.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.84 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -4.24 56.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.541 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.18 -10.56 65.59 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.628 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.967 HG21 HD21 ' A' ' 167' ' ' LEU . 18.8 t -80.97 145.27 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.007 0.432 . . . . 0.0 111.417 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 35.0 t0 -108.24 133.57 52.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.841 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.4 tp -59.39 -35.28 57.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.116 0.484 . . . . 0.0 110.928 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -55.1 -21.2 12.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.226 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.08 25.35 11.89 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.428 HG11 HD13 ' A' ' 163' ' ' ILE . 21.9 t -129.13 111.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 111.245 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.15 77.67 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.407 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -56.14 144.81 35.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.646 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.2 p -118.02 26.1 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.739 0.304 . . . . 0.0 111.068 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.5 102.37 1.97 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.718 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? 57.84 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.625 0.25 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.483 ' OD1' HG21 ' A' ' 130' ' ' ILE . 8.4 p30 -90.7 -0.54 57.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.252 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.02 26.07 4.82 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.679 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.471 ' CB ' HG22 ' A' ' 130' ' ' ILE . 8.6 ptp180 -82.33 133.35 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.748 0.309 . . . . 0.0 110.979 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.841 ' HB ' HD11 ' A' ' 146' ' ' ILE . 5.0 t -68.0 123.89 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.527 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.6 mt -114.71 170.17 8.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -32.0 11.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.57 -40.95 73.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.633 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -61.91 -50.91 70.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.572 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.654 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -58.34 -52.24 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.413 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.65 -34.07 57.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.401 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.45 -32.39 60.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.66 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 19.4 t80 -64.14 -37.68 88.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.496 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.967 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -86.16 -27.56 24.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.043 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.417 -179.861 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.837 0.351 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -169.97 162.56 9.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.799 ' HB2' HG23 ' A' ' 135' ' ' VAL . 15.3 mtp -75.12 144.31 78.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.554 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 73.5 Cg_exo -49.06 -47.56 21.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.386 2.057 . . . . 0.0 112.397 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 1.3 m -63.46 -30.47 71.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.677 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.799 HG23 ' HB2' ' A' ' 132' ' ' MET . 63.6 t -66.93 -40.69 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 109.93 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -64.41 -43.84 93.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.778 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -65.2 -41.36 94.59 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.6 t-105 -58.18 -50.83 72.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.236 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -62.96 -49.22 75.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.853 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -56.4 -29.94 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.781 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.7 -43.53 59.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -84.5 -4.63 59.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.496 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.4 66.28 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.617 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.938 HG21 HD21 ' A' ' 167' ' ' LEU . 18.6 t -78.96 145.09 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 111.311 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 7.6 t0 -108.29 134.6 50.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.418 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.695 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.4 tp -59.7 -35.17 58.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.021 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -55.59 -21.05 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.14 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.644 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.42 26.8 10.29 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.634 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 163' ' ' ILE . 21.8 t -128.95 113.76 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -77.76 76.96 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.721 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.623 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.95 142.68 34.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.604 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.7 p -117.46 25.37 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.7 0.286 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -77.51 98.48 1.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.12 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.634 0.254 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 11.7 p-10 -79.32 -6.48 56.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.182 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.09 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -83.83 133.81 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.342 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.695 ' HB ' HD11 ' A' ' 146' ' ' ILE . 31.4 t -70.44 118.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.568 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.3 mt -108.16 171.81 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.684 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -32.24 18.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -70.72 -39.26 73.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.621 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.01 -47.28 83.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.0 mm -60.8 -51.44 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.291 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -33.87 61.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.201 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.29 -34.11 61.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.123 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.8 t80 -60.91 -39.66 90.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.157 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.938 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -82.16 -31.46 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.956 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.866 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.87 0.367 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 156.54 6.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -82.91 152.13 65.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.41 -36.26 68.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.505 2.137 . . . . 0.0 112.232 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.4 p -63.92 -34.04 77.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.831 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.496 HG12 ' CD1' ' A' ' 146' ' ' ILE . 48.1 t -75.18 -47.97 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -47.75 84.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.115 0.483 . . . . 0.0 109.802 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -62.48 -39.54 93.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.767 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.647 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.2 t-105 -61.39 -49.16 78.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.5 -49.05 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.167 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -56.75 -30.24 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.824 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.96 -40.95 62.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.9 -4.24 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.616 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.19 66.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 167' ' ' LEU . 22.0 t -79.59 145.21 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.365 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 18.3 t0 -111.47 122.98 49.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.507 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.686 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.7 tp -50.84 -25.8 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.42 -22.88 63.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.834 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.697 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -110.3 25.65 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.614 0.245 . . . . 0.0 111.394 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.429 HG23 HD12 ' A' ' 148' ' ' LEU . 28.5 t -127.65 106.48 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.88 0.371 . . . . 0.0 111.213 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -75.84 78.91 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -52.26 140.15 28.62 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.784 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.1 p -118.17 26.06 9.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 157' ' ' ARG . . . -89.79 128.89 9.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.809 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -87.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.555 0.217 . . . . 0.0 111.524 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 25.0 m-80 -108.99 17.82 21.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.633 0.254 . . . . 0.0 111.376 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 22.55 7.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.009 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.461 ' HG3' HD21 ' A' ' 159' ' ' LEU . 7.3 ptp180 -84.45 133.93 34.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.62 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HD11 ' A' ' 146' ' ' ILE . 33.5 t -69.66 127.21 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.271 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.461 HD21 ' HG3' ' A' ' 157' ' ' ARG . 2.8 mt -116.22 172.54 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -53.46 -30.79 42.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.682 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.12 -35.95 69.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.0 -47.76 73.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.647 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.5 mm -61.57 -51.92 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.224 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -55.74 -33.18 64.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.415 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.44 -32.77 54.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.235 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.697 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 22.2 t80 -61.29 -43.08 99.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.4 -42.33 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.832 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.21 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.4 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.814 0.34 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.05 146.34 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.8 mmm -74.12 151.01 88.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.05 -28.1 39.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.613 2.208 . . . . 0.0 112.073 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 p -63.87 -44.86 91.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 159' ' ' LEU . 48.4 t -70.05 -46.63 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.404 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 3.4 mmm180 -56.17 -47.55 78.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 109.808 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -60.67 -39.91 90.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.889 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 163' ' ' ILE . 60.9 t-105 -62.5 -50.21 72.32 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.199 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.74 -38.35 90.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.469 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -30.19 70.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.029 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -82.1 -31.26 30.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.351 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.43 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.6 mmtm -88.39 -24.03 23.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.397 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.83 -5.96 24.07 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.628 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 167' ' ' LEU . 43.5 t -85.32 145.18 8.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 58.0 t0 -111.52 114.88 28.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -47.01 -24.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.4 mtp85 -58.25 -19.86 37.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -111.28 -5.76 14.63 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.518 HG23 HD12 ' A' ' 148' ' ' LEU . 41.4 t -91.04 113.8 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 0.0 111.332 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -79.08 75.92 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.631 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -55.79 142.08 38.45 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.815 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.08 25.87 10.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.0 111.016 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.62 112.32 3.43 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.886 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.53 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.67 0.271 . . . . 0.0 111.399 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 18.4 m-80 -106.07 16.34 25.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.32 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.84 26.04 6.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.686 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.65 ' HG3' HG22 ' A' ' 130' ' ' ILE . 54.0 ttm-85 -84.29 126.05 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 146' ' ' ILE . 20.7 t -68.0 124.08 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.588 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.8 mt -113.88 169.07 9.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.738 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -50.91 -31.31 17.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.67 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -70.19 -40.16 74.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.456 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.54 -45.7 91.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.0 mm -60.85 -53.12 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.266 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -53.28 -34.45 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.349 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.93 -31.47 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 148' ' ' LEU . 19.7 t80 -63.48 -44.53 94.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 144' ' ' VAL . 3.1 mm? -79.34 -30.05 42.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.318 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.836 0.35 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.14 158.1 6.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 55.8 mtp -77.86 157.34 79.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.626 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.86 -35.54 77.74 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.464 2.109 . . . . 0.0 112.183 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -66.51 -29.6 69.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 158' ' ' VAL . 48.7 t -77.08 -49.16 23.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.962 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -46.35 88.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.36 94.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.633 ' CD1' HG21 ' A' ' 163' ' ' ILE . 59.7 t-105 -56.78 -51.55 68.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.057 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -56.51 -48.22 77.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.211 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -37.53 56.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.17 -49.65 59.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.257 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -72.26 -19.61 61.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.09 13.68 28.42 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.266 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 1.066 HG21 HD11 ' A' ' 167' ' ' LEU . 41.5 t -100.74 145.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.896 0.379 . . . . 0.0 111.233 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.2 t0 -107.46 115.38 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.79 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.7 OUTLIER -46.71 -26.23 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -56.86 -22.37 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.008 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -111.94 28.67 8.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.57 0.224 . . . . 0.0 111.319 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 148' ' ' LEU . 21.9 t -129.04 108.53 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.938 0.399 . . . . 0.0 111.302 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.19 77.58 3.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.435 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -55.23 143.69 33.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.689 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 p -118.1 26.16 9.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.801 0.334 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.42 102.4 1.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.1 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.602 0.239 . . . . 0.0 111.272 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.92 -5.07 58.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 0.0 111.317 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.04 26.05 4.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.603 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -85.99 137.74 32.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.79 ' HB ' HD11 ' A' ' 146' ' ' ILE . 5.2 t -67.95 126.49 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.507 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.2 mt -116.2 169.29 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.568 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -50.33 -30.41 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 110.7 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.88 -40.98 71.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.483 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -62.7 -46.91 85.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.566 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.633 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.7 mm -62.67 -48.64 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.453 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -57.68 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.355 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.78 -40.87 31.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.2 t80 -61.66 -25.9 67.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.256 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.066 HD11 HG21 ' A' ' 144' ' ' VAL . 3.3 mp -86.04 -45.5 11.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.148 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 157' ' ' ARG . 1.9 mt . . . . . 0 N--CA 1.458 -0.032 0 CA-C-O 120.848 0.356 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.409 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.12 162.23 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 31.2 mtp -79.53 155.38 76.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.659 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.82 -32.99 93.39 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.525 2.15 . . . . 0.0 112.072 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -33.62 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.464 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 159' ' ' LEU . 41.2 t -74.93 -47.32 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.881 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -58.13 -49.62 76.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.54 -41.31 94.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.762 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.653 ' CD1' HG21 ' A' ' 163' ' ' ILE . 48.5 t-105 -59.89 -48.28 82.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.123 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.19 -50.47 73.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.91 -28.84 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -81.03 -28.59 35.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.033 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -96.53 -4.03 42.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.62 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.19 8.95 64.05 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.784 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 167' ' ' LEU . 22.3 t -100.92 145.19 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.852 0.358 . . . . 0.0 111.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 23.5 t0 -108.4 121.13 44.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.504 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.788 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.2 tp -50.02 -27.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.943 0.401 . . . . 0.0 111.38 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -59.56 -21.83 60.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.063 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.714 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -111.39 26.78 10.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.559 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.438 HG23 HD12 ' A' ' 148' ' ' LEU . 22.4 t -129.04 107.15 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.463 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.84 81.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -56.04 139.38 43.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.689 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.19 26.07 9.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.55 128.91 9.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.873 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.62 -88.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 80.5 m-20 -105.55 26.27 9.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.4 24.08 27.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.801 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.469 ' HB3' HG22 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -83.97 136.73 33.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.788 ' HB ' HD11 ' A' ' 146' ' ' ILE . 24.0 t -69.23 130.52 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.301 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.612 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.6 mt -117.51 169.47 9.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -33.3 23.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 110.673 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.76 -38.68 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.53 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.91 -49.37 75.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.653 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -59.2 -52.19 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.414 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -54.97 -33.56 62.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.335 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.224 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.714 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 38.6 t80 -60.27 -43.25 96.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.434 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.91 -39.13 43.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 -179.838 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.831 0.348 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.01 165.28 9.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.779 ' HB2' HG23 ' A' ' 135' ' ' VAL . 30.9 mtp -80.34 149.93 69.84 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.612 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.9 Cg_endo -53.15 -47.68 26.21 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.588 2.192 . . . . 0.0 112.201 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.539 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 28.7 t -63.58 -30.6 71.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.605 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.779 HG23 ' HB2' ' A' ' 132' ' ' MET . 58.0 t -67.24 -40.86 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 109.986 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 146' ' ' ILE . 4.1 mmm180 -65.35 -41.4 93.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.935 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 1.5 mttt -68.43 -38.19 80.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.693 ' CD1' HG21 ' A' ' 163' ' ' ILE . 64.0 t-105 -61.39 -50.01 74.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -62.72 -45.27 93.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.933 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -60.18 -31.38 70.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.918 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.25 -31.38 54.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.464 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -92.37 -6.79 49.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.422 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.28 -10.42 67.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.348 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.961 HG21 HD21 ' A' ' 167' ' ' LEU . 18.0 t -80.58 145.17 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.528 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 32.0 t0 -107.36 132.84 52.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.219 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.685 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.7 tp -59.34 -35.2 57.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 110.996 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -55.59 -21.23 16.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.084 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.644 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -109.6 26.25 10.87 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.56 0.219 . . . . 0.0 111.548 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.433 HG11 ' CG1' ' A' ' 158' ' ' VAL . 30.4 t -127.28 112.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.261 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.33 73.09 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.495 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -57.74 153.42 24.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.62 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.2 p -118.18 25.63 10.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.677 0.275 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -76.99 105.17 2.0 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.941 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.612 0.244 . . . . 0.0 111.399 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -108.56 13.42 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.721 0.296 . . . . 0.0 111.068 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 110.58 26.08 4.94 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.436 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -78.28 122.83 26.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.11 -179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.685 ' HB ' HD11 ' A' ' 146' ' ' ILE . 11.5 t -67.97 113.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.062 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.9 mt -105.52 170.48 7.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.614 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -30.65 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.924 0.392 . . . . 0.0 110.723 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -71.26 -40.74 70.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.602 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -61.98 -46.62 88.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.43 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.693 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -61.11 -52.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.278 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -32.93 56.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.16 -33.1 61.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.238 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 18.3 t80 -63.97 -39.2 93.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.961 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -85.89 -24.97 26.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.424 -179.746 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.55 HG22 ' HG3' ' A' ' 157' ' ' ARG . 18.6 mm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.772 0.32 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.503 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -167.57 162.49 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.243 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.798 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -76.42 149.12 81.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.465 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.543 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.2 Cg_endo -53.6 -45.99 37.0 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.527 2.152 . . . . 0.0 112.147 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.544 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 12.2 p -63.58 -31.71 72.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 132' ' ' MET . 49.1 t -66.92 -41.93 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.169 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.29 -44.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.834 179.118 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.544 ' HG3' ' HA ' ' A' ' 134' ' ' SER . 1.2 mtmt -65.08 -40.79 95.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.655 ' CD1' HG21 ' A' ' 163' ' ' ILE . 50.9 t-105 -58.46 -51.97 67.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.157 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.14 -45.53 94.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.027 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -29.99 69.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.984 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.72 -30.63 51.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -95.21 -5.57 43.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.575 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.79 -9.52 68.47 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.492 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.978 HG21 HD21 ' A' ' 167' ' ' LEU . 17.5 t -80.56 145.18 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.902 0.382 . . . . 0.0 111.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.3 t0 -106.65 133.17 51.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.785 HD11 ' HB ' ' A' ' 158' ' ' VAL . 5.8 tp -58.45 -38.27 68.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -54.3 -20.72 7.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.379 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.608 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.21 27.79 9.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.607 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 163' ' ' ILE . 22.4 t -128.54 117.18 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -79.23 75.57 5.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.588 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.623 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -52.2 154.4 5.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.861 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.5 p -118.19 21.7 12.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.649 0.261 . . . . 0.0 111.124 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.83 94.86 1.34 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.696 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.02 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.586 0.232 . . . . 0.0 111.203 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -88.27 5.07 43.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.26 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.88 26.05 4.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.612 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.55 ' HG3' HG22 ' A' ' 130' ' ' ILE . 6.5 ttt180 -74.18 120.6 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.309 . . . . 0.0 110.963 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.785 ' HB ' HD11 ' A' ' 146' ' ' ILE . 34.7 t -67.93 115.13 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.579 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.3 mt -105.03 170.35 7.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.504 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -31.36 13.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.86 -40.32 72.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.608 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.12 -46.08 90.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.482 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.655 HG21 ' CD1' ' A' ' 138' ' ' TRP . 36.9 mm -61.27 -51.72 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -53.98 -33.88 58.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.69 -33.65 62.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.608 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 17.5 t80 -60.43 -44.79 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.361 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.978 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -76.76 -34.07 58.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.853 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 -179.95 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 157' ' ' ARG . 4.0 mp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.888 0.375 . . . . 0.0 111.332 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 152.51 4.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 44.3 mtp -80.33 151.46 72.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.48 -35.98 57.46 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.573 2.182 . . . . 0.0 112.218 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -64.01 -33.22 75.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 158' ' ' VAL . 45.2 t -75.44 -48.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -47.7 84.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.09 0.472 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.26 -40.5 96.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.599 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.648 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.5 t-105 -60.27 -49.43 77.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.82 -50.32 73.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -54.35 -30.51 51.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.82 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.54 -34.94 53.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.5 mmpt? -90.42 -2.94 57.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.7 65.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.949 HG21 HD21 ' A' ' 167' ' ' LEU . 23.1 t -103.72 145.18 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.794 0.331 . . . . 0.0 111.269 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.3 t70 -104.89 132.23 51.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.662 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.0 tp -61.23 -28.85 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.401 . . . . 0.0 111.148 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.09 -17.92 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.983 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.647 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -112.47 25.86 11.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 163' ' ' ILE . 23.8 t -128.2 110.76 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.97 0.414 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -69.63 82.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.609 ' CA ' HG22 ' A' ' 158' ' ' VAL . . . -57.57 129.65 49.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.565 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.14 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.719 0.295 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -81.76 102.72 2.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.722 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 56.51 -84.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.617 0.246 . . . . 0.0 111.405 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -86.98 -0.17 56.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.82 26.03 5.71 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.661 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.595 ' HD2' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -90.05 133.2 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.903 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.713 ' O ' HG21 ' A' ' 135' ' ' VAL . 44.2 t -67.92 119.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.149 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.595 HD21 ' HD2' ' A' ' 157' ' ' ARG . 2.6 mt -108.41 171.92 7.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.796 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -51.65 -30.1 20.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.742 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.48 -39.34 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -63.3 -50.39 70.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.1 mm -59.91 -51.72 69.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.209 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.56 -31.94 57.55 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.67 -32.82 47.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.647 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.8 t80 -60.74 -40.33 91.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.949 HD21 HG21 ' A' ' 144' ' ' VAL . 3.3 mm? -82.64 -37.28 25.14 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.6 mt . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.906 0.384 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -169.98 141.61 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.1 mmm -67.65 158.29 83.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.84 -28.64 87.68 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.537 2.158 . . . . 0.0 112.062 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -64.96 -42.57 94.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.625 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' A' ' 159' ' ' LEU . 47.6 t -71.42 -46.95 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 1.1 mmm180 -56.1 -51.0 69.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.689 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -59.15 -39.37 82.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.785 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.638 ' CD1' HG21 ' A' ' 163' ' ' ILE . 48.9 t-105 -60.54 -50.65 72.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -59.49 -48.54 81.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.195 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -54.97 -33.94 62.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -79.92 -27.34 39.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -4.01 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.31 13.45 65.77 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.532 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.89 HG21 HD21 ' A' ' 167' ' ' LEU . 21.4 t -106.58 145.26 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 12.9 t0 -107.56 128.81 54.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.698 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.4 tp -57.09 -28.61 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.91 0.386 . . . . 0.0 111.046 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -61.18 -19.24 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.889 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.665 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -112.53 25.72 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.386 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 163' ' ' ILE . 22.0 t -127.48 112.28 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.68 77.13 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -53.64 145.47 23.87 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.76 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.5 p -117.94 18.8 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.622 0.248 . . . . 0.0 111.315 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -69.81 97.21 0.55 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.478 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.58 -87.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.499 0.19 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 153' ' ' GLY . 82.3 m-20 -78.03 -6.79 55.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.666 0.269 . . . . 0.0 111.256 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.11 4.81 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.603 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -84.37 131.41 34.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.698 ' HB ' HD11 ' A' ' 146' ' ' ILE . 32.2 t -67.9 123.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.257 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.728 ' HA ' HG21 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -114.95 172.72 6.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.472 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -32.72 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.933 0.397 . . . . 0.0 110.762 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.12 -39.36 75.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.12 -47.76 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.598 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.638 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -60.07 -51.66 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.4 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.52 -34.91 62.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.295 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.79 -33.52 62.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.277 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.665 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 22.5 t80 -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.89 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -80.55 -32.75 36.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.61 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.3 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.861 0.362 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.09 148.82 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.75 154.79 73.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.81 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.17 -30.17 31.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.508 2.139 . . . . 0.0 112.362 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -64.18 -41.31 97.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.7 HG21 ' O ' ' A' ' 158' ' ' VAL . 40.9 t -73.03 -47.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -48.97 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.252 0.548 . . . . 0.0 109.686 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -59.82 -41.96 92.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.832 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 163' ' ' ILE . 55.6 t-105 -60.33 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.296 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.52 -48.0 83.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.21 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -56.2 -31.62 63.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -81.49 -28.08 34.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.73 -3.52 49.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.723 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.17 14.67 66.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.611 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.943 HG21 HD21 ' A' ' 167' ' ' LEU . 26.0 t -105.54 145.13 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.201 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.483 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 9.7 t0 -106.71 120.77 42.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.4 tp -50.34 -28.27 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.965 0.412 . . . . 0.0 111.378 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -60.73 -21.53 63.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.076 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.671 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -109.75 25.86 11.31 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.292 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.515 HG11 HD13 ' A' ' 163' ' ' ILE . 29.0 t -129.01 108.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -75.99 79.0 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.831 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.641 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -56.28 149.93 26.19 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.78 12.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.68 0.276 . . . . 0.0 111.3 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.57 105.43 2.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.663 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.084 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -93.38 13.0 22.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.09 26.08 7.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.389 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.61 ' HG3' HG22 ' A' ' 130' ' ' ILE . 16.0 ttm105 -77.54 125.28 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.319 . . . . 0.0 110.999 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.7 ' O ' HG21 ' A' ' 135' ' ' VAL . 40.0 t -68.02 121.08 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.48 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -110.22 172.22 6.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -51.86 -29.82 21.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.77 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -71.66 -38.98 70.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.588 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -64.46 -49.56 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.529 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.652 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.2 mm -59.27 -52.47 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -34.84 62.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.363 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 -31.92 60.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.293 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.0 t80 -63.15 -40.83 98.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.455 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.943 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -80.58 -34.0 35.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.912 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.297 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.777 0.322 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.49 -47.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.98 127.51 47.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.926 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 147' ' ' ARG . 23.5 t -64.0 159.4 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.76 HG22 ' HG2' ' A' ' 157' ' ' ARG . 14.8 mt -113.43 119.64 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.317 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.04 164.55 9.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.769 ' HB2' HG23 ' A' ' 135' ' ' VAL . 29.1 mmm -76.49 141.64 69.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.431 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.605 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 72.2 Cg_exo -48.62 -45.53 27.21 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.302 2.001 . . . . 0.0 112.403 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.473 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 3.2 p -63.56 -32.67 74.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.822 HG11 ' O ' ' A' ' 158' ' ' VAL . 65.6 t -66.0 -40.49 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.085 0.469 . . . . 0.0 109.791 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 2.5 mmm180 -63.45 -44.01 95.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.904 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -65.87 -41.1 92.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.669 ' CD1' HG21 ' A' ' 163' ' ' ILE . 54.9 t-105 -58.07 -50.17 74.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.086 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.658 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.78 -52.56 64.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.033 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -54.93 -30.45 58.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.44 -35.23 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.415 ' HE3' ' CZ3' ' A' ' 138' ' ' TRP . 0.8 OUTLIER -91.75 -3.99 55.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.745 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.93 63.07 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.575 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.938 HG21 HD21 ' A' ' 167' ' ' LEU . 19.0 t -101.0 145.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.265 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 24.2 t0 -111.24 133.89 53.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.348 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.587 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -58.1 -33.45 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.43 . . . . 0.0 110.797 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.789 ' HA ' HG21 ' A' ' 129' ' ' VAL . 7.1 mtp180 -54.85 -22.64 15.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.889 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.98 25.6 11.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.721 0.296 . . . . 0.0 111.405 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.458 HG11 ' CG1' ' A' ' 158' ' ' VAL . 29.1 t -129.04 112.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 111.247 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -80.56 73.03 7.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.611 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -54.75 150.47 17.67 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.651 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.09 12.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.267 . . . . 0.0 111.202 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -70.09 95.1 0.48 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.711 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.14 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.689 0.28 . . . . 0.0 111.259 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.6 p30 -97.11 5.7 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.099 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.13 26.04 4.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.621 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.76 ' HG2' HG22 ' A' ' 130' ' ' ILE . 12.4 mtt180 -77.35 122.43 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.822 ' O ' HG11 ' A' ' 135' ' ' VAL . 36.5 t -71.11 102.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.843 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.8 mt -94.14 173.08 7.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -51.34 -30.11 17.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.654 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -69.02 -41.11 78.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.404 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -63.39 -49.39 74.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.392 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.9 mm -59.81 -52.28 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.275 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -31.71 61.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.332 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -33.2 49.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.183 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 18.4 t80 -60.88 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.441 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.938 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.93 -40.2 40.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.4 30.82 3.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -139.78 27.87 2.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.494 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.1 p30 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.752 0.31 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.31 77.72 0.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -94.84 -179.94 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.831 HG11 HG23 ' A' ' 146' ' ' ILE . 20.2 t -91.2 141.03 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 157' ' ' ARG . 1.9 mt -126.15 120.8 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.3 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.15 166.05 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.075 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.7 mtp -91.89 149.88 39.72 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.77 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.4 -30.98 28.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.487 2.124 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -66.04 -40.69 91.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.622 HG21 ' O ' ' A' ' 158' ' ' VAL . 39.3 t -72.3 -44.44 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.457 ' HD3' HG21 ' A' ' 146' ' ' ILE . 2.6 mmm180 -58.32 -46.64 85.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 109.775 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -63.09 -39.95 96.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.941 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 163' ' ' ILE . 56.1 t-105 -63.11 -46.27 88.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.221 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.632 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -64.37 -47.28 79.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.235 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.2 -29.53 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.864 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -80.81 -31.23 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.997 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -5.36 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.576 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.42 -10.11 64.98 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.669 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.959 HG21 HD21 ' A' ' 167' ' ' LEU . 40.0 t -82.74 145.02 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 53.6 t0 -110.65 113.36 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.222 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.831 HG23 HG11 ' A' ' 129' ' ' VAL . 0.6 OUTLIER -44.47 -25.61 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.495 ' HA ' HG21 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -58.63 -18.03 27.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 149' ' ' VAL . 0.5 OUTLIER -115.44 29.16 8.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.621 0.248 . . . . 0.0 111.545 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 148' ' ' LEU . 43.1 t -129.04 109.54 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.393 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 82.29 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -53.6 142.57 29.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.787 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -118.25 -21.14 8.28 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.859 ' H ' HD21 ' A' ' 159' ' ' LEU . . . -60.51 153.3 36.64 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.493 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 48.02 -104.8 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -105.46 30.04 6.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.734 0.302 . . . . 0.0 111.435 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.27 20.48 13.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.761 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.578 ' HB3' HG22 ' A' ' 130' ' ' ILE . 22.4 ptt180 -85.47 154.15 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.649 0.262 . . . . 0.0 110.399 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.742 ' C ' HD13 ' A' ' 159' ' ' LEU . 22.2 t -80.74 133.93 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.488 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.859 HD21 ' H ' ' A' ' 153' ' ' GLY . 0.0 OUTLIER -119.34 169.82 9.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -52.17 -30.7 28.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.02 -39.99 78.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.412 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.705 ' OD2' HD22 ' A' ' 159' ' ' LEU . 87.6 m-20 -64.1 -51.05 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.652 HG21 ' CD1' ' A' ' 138' ' ' TRP . 42.2 mm -59.48 -52.06 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -54.38 -33.85 60.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.384 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.73 -31.19 52.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.209 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 24.2 t80 -64.24 -37.66 88.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.628 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.959 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -89.06 -26.64 21.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.73 31.06 1.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.361 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -137.49 27.0 2.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.523 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.525 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.846 0.355 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -83.61 -24.18 31.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -56.08 172.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.743 HG21 ' HA ' ' A' ' 147' ' ' ARG . 26.1 t -103.86 158.13 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.782 HG22 ' CG ' ' A' ' 157' ' ' ARG . 23.8 mm -127.05 121.98 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.245 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.11 160.98 8.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.3 mtp -81.92 145.88 54.51 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.68 -32.55 45.6 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.489 2.126 . . . . 0.0 112.283 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -40.41 95.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.697 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.772 HG21 ' HA ' ' A' ' 159' ' ' LEU . 46.3 t -70.25 -46.26 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.2 OUTLIER -56.31 -45.7 80.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.798 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -61.92 -41.1 97.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.615 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.633 ' CD1' HG21 ' A' ' 163' ' ' ILE . 54.0 t-105 -61.24 -50.48 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.247 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -58.6 -44.09 89.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.76 -32.76 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -77.88 -27.47 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -96.69 -6.07 37.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.606 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.74 -9.01 71.13 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.63 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.743 HG21 HD21 ' A' ' 167' ' ' LEU . 18.1 t -82.06 145.21 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.888 0.375 . . . . 0.0 111.49 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 62.5 t0 -110.24 122.67 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.1 tp -50.7 -27.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.294 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.743 ' HA ' HG21 ' A' ' 129' ' ' VAL . 1.3 mtp180 -61.36 -23.22 65.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.933 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.679 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -109.44 23.52 14.35 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.409 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.443 HG23 HD12 ' A' ' 148' ' ' LEU . 44.2 t -123.91 114.74 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.9 78.98 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.66 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.65 142.16 34.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.718 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p -118.05 23.93 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -75.08 90.09 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.537 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.64 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.618 0.247 . . . . 0.0 111.145 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . 87.4 m-20 -85.69 -0.74 56.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.145 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.03 26.07 4.82 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.587 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.782 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -80.92 122.87 27.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.735 0.302 . . . . 0.0 110.816 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.674 ' HB ' HD11 ' A' ' 146' ' ' ILE . 35.4 t -67.9 111.27 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.939 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.772 ' HA ' HG21 ' A' ' 135' ' ' VAL . 3.1 mt -102.44 175.28 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.744 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -32.49 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.33 -35.43 75.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.415 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.424 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.633 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.8 mm -60.95 -45.78 97.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HA ' HD12 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -58.27 -41.12 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.311 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.62 -34.59 74.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.348 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.679 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 19.2 t80 -59.98 -45.46 92.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.372 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.743 HD21 HG21 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -76.6 -27.73 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.099 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.59 30.97 1.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.394 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -102.6 -27.25 6.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.41 -1.217 . . . . 0.0 112.509 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 t30 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.839 0.352 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -124.55 68.91 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.688 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.03 139.81 43.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.673 HG11 HG23 ' A' ' 146' ' ' ILE . 16.2 t -90.29 126.32 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.011 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.559 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mt -117.85 128.3 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.037 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.18 150.89 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.0 mtm -74.99 161.67 76.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.55 -29.28 84.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.524 2.149 . . . . 0.0 112.125 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 p -67.02 -37.32 83.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.598 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 158' ' ' VAL . 45.0 t -74.77 -47.52 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 109.746 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -61.68 -41.78 98.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.752 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.69 ' CD1' HG21 ' A' ' 163' ' ' ILE . 49.6 t-105 -60.22 -47.24 86.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.43 -50.34 73.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.069 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -54.21 -33.5 58.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.095 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -78.42 -29.73 47.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.817 0.341 . . . . 0.0 110.943 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.408 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 2.1 mmtt -92.98 -3.64 54.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.9 12.68 68.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.569 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.805 ' CG2' HD21 ' A' ' 167' ' ' LEU . 20.4 t -104.04 145.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.367 . . . . 0.0 111.214 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 22.6 t0 -107.82 121.06 43.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.344 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.762 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.1 tp -50.74 -26.41 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.449 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.576 ' HA ' HG21 ' A' ' 129' ' ' VAL . 0.1 OUTLIER -60.43 -23.37 64.34 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.707 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -110.15 25.77 11.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.0 111.503 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.455 HG23 HD12 ' A' ' 148' ' ' LEU . 39.7 t -127.09 108.01 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -76.15 79.02 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.645 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -53.26 159.34 3.87 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.765 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 p -118.27 8.48 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -63.85 87.07 0.06 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.65 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.623 0.249 . . . . 0.0 111.257 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.8 m-80 -87.7 3.21 48.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.119 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.16 4.78 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.559 ' HG3' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -73.02 113.3 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 0.0 110.918 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.762 ' HB ' HD11 ' A' ' 146' ' ' ILE . 40.1 t -67.84 111.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.518 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -100.65 176.16 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -30.97 60.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.676 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.73 -33.83 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.73 -47.61 62.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.69 HG21 ' CD1' ' A' ' 138' ' ' TRP . 36.5 mm -60.99 -47.74 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.31 -40.06 85.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.299 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.41 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.132 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.686 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.0 t80 -60.01 -46.03 90.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.201 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.805 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -76.28 -27.12 56.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.132 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.22 31.14 1.75 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.282 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -112.23 -27.38 3.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.487 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.534 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.778 0.323 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 85.96 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.44 162.94 12.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 147' ' ' ARG . 20.2 t -60.01 159.24 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.7 HG22 ' HG3' ' A' ' 157' ' ' ARG . 2.8 mp -92.61 114.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.77 152.41 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.39 153.94 71.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.52 -33.26 67.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.191 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.2 m -64.01 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 159' ' ' LEU . 61.4 t -74.17 -48.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -47.0 82.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.829 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -61.56 -42.1 98.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.729 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 163' ' ' ILE . 51.5 t-105 -59.32 -48.93 79.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.136 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.698 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.05 -49.59 76.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.016 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 tpt85 -54.47 -30.7 53.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.84 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -79.71 -32.21 41.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.412 ' HD3' ' CH2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -92.18 -2.67 56.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.713 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.77 16.06 64.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.491 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 1.083 HG21 HD11 ' A' ' 167' ' ' LEU . 34.4 t -105.86 145.11 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.368 . . . . 0.0 111.261 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.1 t0 -108.77 122.11 46.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.74 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.9 tp -50.06 -27.15 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 111.292 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.734 ' HA ' HG21 ' A' ' 129' ' ' VAL . 12.5 mmt-85 -60.04 -25.17 65.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.739 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -107.41 25.43 11.46 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.344 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.426 HG23 HD12 ' A' ' 148' ' ' LEU . 31.3 t -126.51 111.3 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.975 0.417 . . . . 0.0 111.459 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -79.91 74.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.536 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -53.31 145.59 22.08 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.773 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.7 p -118.05 24.21 11.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.991 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -73.68 101.72 1.22 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.7 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.62 -83.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.651 0.262 . . . . 0.0 111.197 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -97.09 6.28 48.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.463 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.99 26.07 4.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.715 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.7 ' HG3' HG22 ' A' ' 130' ' ' ILE . 26.6 ttm180 -83.45 125.26 31.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.74 ' HB ' HD11 ' A' ' 146' ' ' ILE . 21.5 t -67.95 119.44 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.603 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.7 mt -113.34 171.99 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.815 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -50.6 -28.8 9.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.975 0.417 . . . . 0.0 110.729 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -72.47 -41.0 66.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.507 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.3 -45.74 91.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.6 mm -62.75 -49.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -31.8 63.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.202 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.46 -41.21 40.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.892 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.739 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 16.3 t80 -61.38 -24.85 66.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.202 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.083 HD11 HG21 ' A' ' 144' ' ' VAL . 4.5 mp -87.95 -39.96 14.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.82 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.89 31.02 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.409 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -120.57 27.39 6.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.029 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.468 -179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.799 0.333 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -61.29 -174.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -73.05 157.11 37.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 130' ' ' ILE . 24.9 t -132.14 158.56 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.484 ' N ' HG12 ' A' ' 129' ' ' VAL . 35.0 mm -95.58 123.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.21 157.96 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.094 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.95 161.89 54.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.75 -28.96 87.35 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.536 2.157 . . . . 0.0 112.119 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.8 p -67.5 -37.1 82.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' A' ' 159' ' ' LEU . 60.2 t -74.6 -47.71 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -43.63 93.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 109.789 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -64.07 -41.17 97.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.533 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.659 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.5 t-105 -61.01 -50.32 73.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.099 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.35 -47.19 87.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.156 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -57.71 -30.22 65.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.791 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.09 -40.17 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.29 -9.38 67.31 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.676 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.771 ' CG2' HD21 ' A' ' 167' ' ' LEU . 19.4 t -80.17 145.25 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.8 t0 -111.27 130.75 55.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.425 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.686 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.8 OUTLIER -56.7 -28.65 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.127 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.4 mtt85 -59.46 -19.0 44.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.961 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.651 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -114.71 27.23 9.59 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.621 0.248 . . . . 0.0 111.391 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.5 t -128.87 115.98 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.35 73.97 7.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.531 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -52.05 142.74 21.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.715 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.2 p -118.03 26.11 9.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -78.16 100.71 1.66 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.665 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.41 -85.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.58 0.228 . . . . 0.0 111.095 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 10.6 p30 -83.94 -4.76 58.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.05 26.02 4.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.476 ' NE ' HD21 ' A' ' 159' ' ' LEU . 23.8 ptt-85 -82.21 134.86 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.969 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HD11 ' A' ' 146' ' ' ILE . 18.7 t -69.34 119.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.306 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.1 mt -111.73 176.99 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.619 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.43 -35.16 62.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -69.15 -32.58 72.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.59 -50.0 55.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.623 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.659 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.6 mm -60.1 -46.2 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -39.7 84.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.224 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -33.96 70.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.316 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.651 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.5 t80 -58.7 -49.24 78.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -73.56 -31.55 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.38 31.04 2.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -139.87 27.83 2.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.512 -179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.757 0.313 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.4 132.41 35.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -116.89 119.65 36.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.94 141.77 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 157' ' ' ARG . 5.4 mt -98.74 136.16 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.241 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.444 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.07 177.35 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.602 ' HE1' HD23 ' A' ' 159' ' ' LEU . 2.7 mtm -108.79 155.45 40.67 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.94 -30.75 31.6 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.48 2.12 . . . . 0.0 112.284 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.2 m -63.86 -45.95 87.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 159' ' ' LEU . 60.3 t -70.31 -44.4 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.835 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 12.8 mmm-85 -58.63 -42.88 89.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 109.869 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.4 -41.65 98.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.643 ' CD1' HG21 ' A' ' 163' ' ' ILE . 58.1 t-105 -61.87 -51.0 69.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.207 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.84 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 13.6 ttm105 -60.35 -31.38 70.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -77.52 -34.85 53.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.428 ' HE2' ' CZ3' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -89.98 -5.87 56.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.574 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.6 72.75 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.717 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.751 ' CG2' HD21 ' A' ' 167' ' ' LEU . 19.2 t -80.93 145.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.875 0.369 . . . . 0.0 111.355 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.4 t0 -109.52 134.28 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 131' ' ' ALA . 2.0 tp -60.37 -28.82 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -61.51 -17.09 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.84 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -115.4 25.02 11.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.539 0.209 . . . . 0.0 111.402 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.59 111.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.93 75.34 5.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.661 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.58 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -51.04 159.5 1.88 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.729 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.0 p -118.11 12.14 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.642 0.258 . . . . 0.0 111.356 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.67 92.17 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.697 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt 56.6 -86.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -88.07 5.95 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.294 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.07 4.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.572 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.65 ' HG3' HG22 ' A' ' 130' ' ' ILE . 25.2 ttm180 -73.35 115.9 13.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 151' ' ' GLY . 41.8 t -67.92 119.65 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.03 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.642 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.3 mt -110.78 177.41 4.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -33.34 61.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.98 0.419 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -70.46 -33.2 71.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.453 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.79 -48.87 65.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.545 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.643 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.8 mm -61.49 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.492 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.09 -39.08 81.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.27 64.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.658 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.6 t80 -59.47 -52.36 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.751 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -70.09 -38.42 75.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.88 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.9 64.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.271 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -84.76 -29.64 28.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.573 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.518 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.838 0.352 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -116.05 117.89 31.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.963 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.39 120.79 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.771 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.407 ' CG1' HG23 ' A' ' 146' ' ' ILE . 33.6 t -116.46 118.33 58.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.225 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.76 HG22 ' CG ' ' A' ' 157' ' ' ARG . 1.7 mp -127.07 130.45 71.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.94 160.24 8.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.218 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.798 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.9 mtp -74.56 148.95 85.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.568 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.588 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.4 Cg_endo -53.52 -46.29 34.88 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.492 2.128 . . . . 0.0 112.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.535 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 65.3 p -63.57 -32.03 73.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 132' ' ' MET . 48.1 t -66.69 -41.06 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 110.04 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.906 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -66.96 -40.53 87.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.381 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.67 ' CD1' HG21 ' A' ' 163' ' ' ILE . 56.5 t-105 -59.89 -47.3 86.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.137 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.07 -52.09 66.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.076 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -51.99 -37.01 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.904 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.66 -40.74 80.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -85.03 -4.77 59.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.66 10.06 65.69 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.646 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.739 HG21 HD21 ' A' ' 167' ' ' LEU . 20.4 t -99.19 145.04 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.362 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 52.5 t0 -112.06 114.11 26.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.928 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.591 ' CD1' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -45.76 -26.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -57.46 -20.11 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -113.79 24.15 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.609 0.242 . . . . 0.0 111.327 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.556 HG23 HD12 ' A' ' 148' ' ' LEU . 40.0 t -123.06 111.75 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.96 78.79 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.717 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.669 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.57 152.24 12.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.4 p -117.95 19.21 13.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.557 0.218 . . . . 0.0 111.25 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -72.59 88.17 0.53 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.483 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.74 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.647 0.26 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.0 p30 -84.02 -0.34 51.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.211 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.07 26.04 4.82 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.609 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.76 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.29 119.75 21.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.32 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.669 HG22 ' N ' ' A' ' 151' ' ' GLY . 41.6 t -68.02 111.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.97 176.4 5.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.755 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.22 -31.96 54.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.55 -35.5 75.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.578 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -68.22 -47.62 67.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.67 HG21 ' CD1' ' A' ' 138' ' ' TRP . 44.8 mm -60.04 -48.42 88.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -58.87 -39.68 82.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.178 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.28 72.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.422 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.539 ' CE2' HD13 ' A' ' 148' ' ' LEU . 18.5 t80 -59.18 -50.26 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -69.73 -35.35 74.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.09 67.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.232 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.73 28.84 14.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.324 -1.265 . . . . 0.0 112.479 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -137.3 156.89 47.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.93 160.72 20.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 147' ' ' ARG . 21.8 t -116.58 159.18 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.735 HG22 ' CG ' ' A' ' 157' ' ' ARG . 3.2 mp -103.23 118.94 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.228 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.08 153.09 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.6 mtp -81.33 150.43 67.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.81 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.56 -31.24 39.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.1 m -63.91 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.744 HG21 ' O ' ' A' ' 158' ' ' VAL . 43.6 t -75.34 -49.66 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.56 -47.07 80.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -45.97 90.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.596 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.636 ' CD1' HG21 ' A' ' 163' ' ' ILE . 52.4 t-105 -57.04 -49.17 76.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.402 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.69 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.11 -38.85 92.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.456 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.39 -30.9 71.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -82.8 -30.51 28.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.497 ' HG2' HD21 ' A' ' 167' ' ' LEU . 2.3 tptt -88.76 -15.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.506 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.77 45.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.667 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 1.074 HG21 HD11 ' A' ' 167' ' ' LEU . 38.8 t -85.5 145.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 111.264 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 43.1 t0 -108.98 119.86 40.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.384 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.671 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.0 OUTLIER -49.17 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.888 0.375 . . . . 0.0 111.498 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.799 ' HA ' HG21 ' A' ' 129' ' ' VAL . 10.7 mtm180 -59.47 -27.41 66.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.76 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.762 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -104.64 26.49 9.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.227 . . . . 0.0 111.33 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.445 HG23 HD12 ' A' ' 148' ' ' LEU . 24.8 t -128.79 109.7 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 111.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -79.11 75.78 5.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.621 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -55.38 145.86 30.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.736 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.9 p -118.1 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.844 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -74.88 100.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.639 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? 59.26 -82.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.535 0.207 . . . . 0.0 111.055 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.1 p30 -97.5 7.16 47.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.655 0.264 . . . . 0.0 111.297 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.94 26.13 4.82 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.526 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.735 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -81.83 123.83 29.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 111.116 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.744 ' O ' HG21 ' A' ' 135' ' ' VAL . 24.3 t -67.95 111.1 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.481 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -102.11 175.1 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -53.83 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.39 -36.76 68.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.432 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -66.0 -46.7 77.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.419 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.636 HG21 ' CD1' ' A' ' 138' ' ' TRP . 34.9 mm -63.01 -50.79 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.332 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -57.45 -31.91 66.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 110.392 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.983 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.762 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.3 t80 -61.83 -28.66 69.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.117 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.074 HD11 HG21 ' A' ' 144' ' ' VAL . 3.7 mp -81.17 -47.99 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.784 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.03 67.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -84.37 -28.93 31.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.557 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.562 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.808 0.337 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -97.11 25.93 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.15 149.36 52.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 146' ' ' ILE . 18.4 t -107.13 156.74 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.039 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.483 HG21 ' OD1' ' A' ' 155' ' ' ASN . 29.4 mt -127.06 124.84 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.176 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.444 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.22 174.77 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 135' ' ' VAL . 33.1 mmm -91.07 147.13 35.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.394 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.576 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 72.0 Cg_exo -48.5 -50.56 12.03 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.444 2.096 . . . . 0.0 112.81 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.517 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -63.44 -26.6 68.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.837 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 159' ' ' LEU . 80.5 t -71.59 -38.78 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.907 0.384 . . . . 0.0 110.223 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.6 OUTLIER -67.51 -41.55 84.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.714 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.37 -39.46 81.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.654 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.3 t-105 -59.93 -50.25 74.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.201 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.1 -49.61 73.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.87 -35.73 57.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.84 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -4.24 56.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.541 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.18 -10.56 65.59 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.628 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.967 HG21 HD21 ' A' ' 167' ' ' LEU . 18.8 t -80.97 145.27 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.007 0.432 . . . . 0.0 111.417 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 35.0 t0 -108.24 133.57 52.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.841 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.4 tp -59.39 -35.28 57.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.116 0.484 . . . . 0.0 110.928 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.566 ' HA ' HG21 ' A' ' 129' ' ' VAL . 4.5 mtp180 -55.1 -21.2 12.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.226 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.08 25.35 11.89 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.428 HG11 HD13 ' A' ' 163' ' ' ILE . 21.9 t -129.13 111.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 111.245 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.15 77.67 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.407 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -56.14 144.81 35.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.646 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.2 p -118.02 26.1 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.739 0.304 . . . . 0.0 111.068 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.5 102.37 1.97 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.718 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? 57.84 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.625 0.25 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.483 ' OD1' HG21 ' A' ' 130' ' ' ILE . 8.4 p30 -90.7 -0.54 57.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.252 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.02 26.07 4.82 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.679 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.471 ' CB ' HG22 ' A' ' 130' ' ' ILE . 8.6 ptp180 -82.33 133.35 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.748 0.309 . . . . 0.0 110.979 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.841 ' HB ' HD11 ' A' ' 146' ' ' ILE . 5.0 t -68.0 123.89 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.527 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.6 mt -114.71 170.17 8.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -32.0 11.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.57 -40.95 73.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.633 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -61.91 -50.91 70.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.572 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.654 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -58.34 -52.24 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.413 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.65 -34.07 57.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.401 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.45 -32.39 60.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.66 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 19.4 t80 -64.14 -37.68 88.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.496 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.967 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -86.16 -27.56 24.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.043 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.32 31.07 1.55 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.417 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 96.7 56.03 1.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.467 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.419 -1.212 . . . . 0.0 112.503 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.96 142.77 58.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -115.3 157.66 23.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.702 HG11 HG23 ' A' ' 146' ' ' ILE . 13.4 t -111.95 159.76 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.465 ' N ' HG12 ' A' ' 129' ' ' VAL . 1.8 mp -122.83 118.45 55.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -169.97 162.56 9.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.799 ' HB2' HG23 ' A' ' 135' ' ' VAL . 15.3 mtp -75.12 144.31 78.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.554 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 73.5 Cg_exo -49.06 -47.56 21.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.386 2.057 . . . . 0.0 112.397 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 1.3 m -63.46 -30.47 71.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.677 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.799 HG23 ' HB2' ' A' ' 132' ' ' MET . 63.6 t -66.93 -40.69 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 109.93 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -64.41 -43.84 93.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.778 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -65.2 -41.36 94.59 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.6 t-105 -58.18 -50.83 72.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.236 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -62.96 -49.22 75.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.853 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -56.4 -29.94 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.781 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.7 -43.53 59.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -84.5 -4.63 59.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.496 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.4 66.28 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.617 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.938 HG21 HD21 ' A' ' 167' ' ' LEU . 18.6 t -78.96 145.09 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 111.311 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 7.6 t0 -108.29 134.6 50.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.418 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.702 HG23 HG11 ' A' ' 129' ' ' VAL . 3.4 tp -59.7 -35.17 58.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.021 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.423 ' HA ' HG21 ' A' ' 129' ' ' VAL . 44.8 mtp180 -55.59 -21.05 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.14 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.644 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.42 26.8 10.29 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.634 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 163' ' ' ILE . 21.8 t -128.95 113.76 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -77.76 76.96 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.721 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.623 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.95 142.68 34.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.604 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.7 p -117.46 25.37 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.7 0.286 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -77.51 98.48 1.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.12 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.634 0.254 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 11.7 p-10 -79.32 -6.48 56.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.182 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.09 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -83.83 133.81 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.342 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.695 ' HB ' HD11 ' A' ' 146' ' ' ILE . 31.4 t -70.44 118.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.568 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.3 mt -108.16 171.81 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.684 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -32.24 18.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -70.72 -39.26 73.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.621 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.01 -47.28 83.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.0 mm -60.8 -51.44 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.291 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -33.87 61.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.201 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.29 -34.11 61.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.123 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.8 t80 -60.91 -39.66 90.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.157 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.938 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -82.16 -31.46 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.956 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.65 31.03 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.55 66.43 0.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.367 -1.241 . . . . 0.0 112.524 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.845 0.355 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.93 -46.57 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.964 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -77.21 -177.59 4.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.806 HG21 ' HA ' ' A' ' 147' ' ' ARG . 21.7 t -130.3 143.46 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.086 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 130' ' ' ILE . 4.0 mp -84.92 118.39 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 156.54 6.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -82.91 152.13 65.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.41 -36.26 68.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.505 2.137 . . . . 0.0 112.232 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.4 p -63.92 -34.04 77.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.831 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.496 HG12 ' CD1' ' A' ' 146' ' ' ILE . 48.1 t -75.18 -47.97 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -47.75 84.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.115 0.483 . . . . 0.0 109.802 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -62.48 -39.54 93.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.767 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.647 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.2 t-105 -61.39 -49.16 78.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.5 -49.05 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.167 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -56.75 -30.24 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.824 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.96 -40.95 62.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.9 -4.24 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.616 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.19 66.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 167' ' ' LEU . 22.0 t -79.59 145.21 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.365 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 18.3 t0 -111.47 122.98 49.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.507 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.686 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.7 tp -50.84 -25.8 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.806 ' HA ' HG21 ' A' ' 129' ' ' VAL . 3.5 mtm180 -60.42 -22.88 63.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.834 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.697 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -110.3 25.65 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.614 0.245 . . . . 0.0 111.394 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.429 HG23 HD12 ' A' ' 148' ' ' LEU . 28.5 t -127.65 106.48 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.88 0.371 . . . . 0.0 111.213 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -75.84 78.91 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -52.26 140.15 28.62 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.784 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.1 p -118.17 26.06 9.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 157' ' ' ARG . . . -89.79 128.89 9.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.809 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -87.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.555 0.217 . . . . 0.0 111.524 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 25.0 m-80 -108.99 17.82 21.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.633 0.254 . . . . 0.0 111.376 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 22.55 7.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.009 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.461 ' HG3' HD21 ' A' ' 159' ' ' LEU . 7.3 ptp180 -84.45 133.93 34.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.62 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HD11 ' A' ' 146' ' ' ILE . 33.5 t -69.66 127.21 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.271 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.461 HD21 ' HG3' ' A' ' 157' ' ' ARG . 2.8 mt -116.22 172.54 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -53.46 -30.79 42.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.682 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.12 -35.95 69.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.0 -47.76 73.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.647 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.5 mm -61.57 -51.92 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.224 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -55.74 -33.18 64.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.415 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.44 -32.77 54.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.235 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.697 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 22.2 t80 -61.29 -43.08 99.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.4 -42.33 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.832 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.76 -24.98 64.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.21 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -122.39 28.23 5.83 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.487 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.467 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.0 m120 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.868 0.366 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -107.99 -38.1 5.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 173.01 6.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 147' ' ' ARG . 25.4 t -127.47 145.64 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.097 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.4 mp -107.69 114.27 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.05 146.34 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.8 mmm -74.12 151.01 88.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.05 -28.1 39.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.613 2.208 . . . . 0.0 112.073 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 p -63.87 -44.86 91.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 159' ' ' LEU . 48.4 t -70.05 -46.63 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.404 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 3.4 mmm180 -56.17 -47.55 78.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 109.808 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -60.67 -39.91 90.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.889 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 163' ' ' ILE . 60.9 t-105 -62.5 -50.21 72.32 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.199 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.74 -38.35 90.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.469 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -30.19 70.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.029 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -82.1 -31.26 30.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.351 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.43 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.6 mmtm -88.39 -24.03 23.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.397 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.83 -5.96 24.07 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.628 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 167' ' ' LEU . 43.5 t -85.32 145.18 8.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 58.0 t0 -111.52 114.88 28.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -47.01 -24.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.851 ' HA ' HG21 ' A' ' 129' ' ' VAL . 22.4 mtp85 -58.25 -19.86 37.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -111.28 -5.76 14.63 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.518 HG23 HD12 ' A' ' 148' ' ' LEU . 41.4 t -91.04 113.8 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 0.0 111.332 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -79.08 75.92 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.631 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -55.79 142.08 38.45 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.815 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.08 25.87 10.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.0 111.016 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.62 112.32 3.43 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.886 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.53 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.67 0.271 . . . . 0.0 111.399 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 18.4 m-80 -106.07 16.34 25.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.32 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.84 26.04 6.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.686 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.65 ' HG3' HG22 ' A' ' 130' ' ' ILE . 54.0 ttm-85 -84.29 126.05 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 146' ' ' ILE . 20.7 t -68.0 124.08 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.588 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.8 mt -113.88 169.07 9.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.738 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -50.91 -31.31 17.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.67 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -70.19 -40.16 74.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.456 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.54 -45.7 91.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.0 mm -60.85 -53.12 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.266 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -53.28 -34.45 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.349 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.93 -31.47 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 148' ' ' LEU . 19.7 t80 -63.48 -44.53 94.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 144' ' ' VAL . 3.1 mm? -79.34 -30.05 42.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.75 30.98 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.318 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -158.82 -50.03 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.527 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.775 0.321 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -87.54 150.35 23.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.03 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 128.41 33.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.808 HG11 HG23 ' A' ' 146' ' ' ILE . 15.9 t -86.89 146.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.036 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.05 116.97 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.364 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.14 158.1 6.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 55.8 mtp -77.86 157.34 79.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.626 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.86 -35.54 77.74 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.464 2.109 . . . . 0.0 112.183 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -66.51 -29.6 69.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 158' ' ' VAL . 48.7 t -77.08 -49.16 23.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.962 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -46.35 88.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.36 94.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.633 ' CD1' HG21 ' A' ' 163' ' ' ILE . 59.7 t-105 -56.78 -51.55 68.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.057 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -56.51 -48.22 77.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.211 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -37.53 56.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.17 -49.65 59.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.257 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -72.26 -19.61 61.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.09 13.68 28.42 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.266 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 1.066 HG21 HD11 ' A' ' 167' ' ' LEU . 41.5 t -100.74 145.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.896 0.379 . . . . 0.0 111.233 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.2 t0 -107.46 115.38 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.808 HG23 HG11 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -46.71 -26.23 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -56.86 -22.37 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.008 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -111.94 28.67 8.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.57 0.224 . . . . 0.0 111.319 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 148' ' ' LEU . 21.9 t -129.04 108.53 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.938 0.399 . . . . 0.0 111.302 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.19 77.58 3.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.435 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -55.23 143.69 33.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.689 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 p -118.1 26.16 9.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.801 0.334 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.42 102.4 1.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.1 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.602 0.239 . . . . 0.0 111.272 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.92 -5.07 58.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 0.0 111.317 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.04 26.05 4.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.603 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -85.99 137.74 32.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.79 ' HB ' HD11 ' A' ' 146' ' ' ILE . 5.2 t -67.95 126.49 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.507 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.2 mt -116.2 169.29 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.568 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -50.33 -30.41 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 110.7 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.88 -40.98 71.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.483 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -62.7 -46.91 85.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.566 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.633 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.7 mm -62.67 -48.64 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.453 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -57.68 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.355 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.78 -40.87 31.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.2 t80 -61.66 -25.9 67.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.256 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.066 HD11 HG21 ' A' ' 144' ' ' VAL . 3.3 mp -86.04 -45.5 11.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.77 31.11 2.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.29 28.04 1.37 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.395 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.449 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 mmt-85 -81.21 74.44 8.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 165.15 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.68 HG11 HG23 ' A' ' 146' ' ' ILE . 17.2 t -76.95 159.39 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.976 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 157' ' ' ARG . 1.9 mt -116.15 113.07 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.208 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.409 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.12 162.23 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 31.2 mtp -79.53 155.38 76.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.659 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.82 -32.99 93.39 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.525 2.15 . . . . 0.0 112.072 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -33.62 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.464 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 159' ' ' LEU . 41.2 t -74.93 -47.32 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.881 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -58.13 -49.62 76.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.54 -41.31 94.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.762 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.653 ' CD1' HG21 ' A' ' 163' ' ' ILE . 48.5 t-105 -59.89 -48.28 82.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.123 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.19 -50.47 73.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.91 -28.84 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -81.03 -28.59 35.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.033 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -96.53 -4.03 42.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.62 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.19 8.95 64.05 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.784 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 167' ' ' LEU . 22.3 t -100.92 145.19 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.852 0.358 . . . . 0.0 111.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 23.5 t0 -108.4 121.13 44.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.504 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.788 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.2 tp -50.02 -27.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.943 0.401 . . . . 0.0 111.38 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -59.56 -21.83 60.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.063 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.714 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -111.39 26.78 10.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.559 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.438 HG23 HD12 ' A' ' 148' ' ' LEU . 22.4 t -129.04 107.15 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.463 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.84 81.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -56.04 139.38 43.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.689 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.19 26.07 9.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.55 128.91 9.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.873 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.62 -88.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 80.5 m-20 -105.55 26.27 9.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.4 24.08 27.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.801 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.469 ' HB3' HG22 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -83.97 136.73 33.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.788 ' HB ' HD11 ' A' ' 146' ' ' ILE . 24.0 t -69.23 130.52 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.301 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.612 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.6 mt -117.51 169.47 9.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -33.3 23.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 110.673 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.76 -38.68 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.53 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.91 -49.37 75.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.653 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -59.2 -52.19 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.414 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -54.97 -33.56 62.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.335 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.224 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.714 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 38.6 t80 -60.27 -43.25 96.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.434 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.91 -39.13 43.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.08 65.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.22 -30.11 76.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.599 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.57 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.857 0.36 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.24 99.39 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -60.0 147.94 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.843 HG21 ' HA ' ' A' ' 147' ' ' ARG . 29.0 t -72.91 153.83 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.071 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.404 ' N ' HG12 ' A' ' 129' ' ' VAL . 31.8 mm -113.87 122.7 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.222 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.01 165.28 9.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.779 ' HB2' HG23 ' A' ' 135' ' ' VAL . 30.9 mtp -80.34 149.93 69.84 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.612 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.9 Cg_endo -53.15 -47.68 26.21 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.588 2.192 . . . . 0.0 112.201 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.539 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 28.7 t -63.58 -30.6 71.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.605 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.779 HG23 ' HB2' ' A' ' 132' ' ' MET . 58.0 t -67.24 -40.86 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 109.986 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 146' ' ' ILE . 4.1 mmm180 -65.35 -41.4 93.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.935 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 1.5 mttt -68.43 -38.19 80.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.693 ' CD1' HG21 ' A' ' 163' ' ' ILE . 64.0 t-105 -61.39 -50.01 74.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -62.72 -45.27 93.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.933 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -60.18 -31.38 70.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.918 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.25 -31.38 54.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.464 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -92.37 -6.79 49.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.422 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.28 -10.42 67.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.348 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.961 HG21 HD21 ' A' ' 167' ' ' LEU . 18.0 t -80.58 145.17 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.528 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 32.0 t0 -107.36 132.84 52.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.219 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.685 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.7 tp -59.34 -35.2 57.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 110.996 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.843 ' HA ' HG21 ' A' ' 129' ' ' VAL . 58.6 mtp180 -55.59 -21.23 16.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.084 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.644 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -109.6 26.25 10.87 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.56 0.219 . . . . 0.0 111.548 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.433 HG11 ' CG1' ' A' ' 158' ' ' VAL . 30.4 t -127.28 112.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.261 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.33 73.09 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.495 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -57.74 153.42 24.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.62 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.2 p -118.18 25.63 10.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.677 0.275 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -76.99 105.17 2.0 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.941 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.612 0.244 . . . . 0.0 111.399 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -108.56 13.42 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.721 0.296 . . . . 0.0 111.068 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 110.58 26.08 4.94 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.436 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -78.28 122.83 26.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.11 -179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.685 ' HB ' HD11 ' A' ' 146' ' ' ILE . 11.5 t -67.97 113.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.062 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.9 mt -105.52 170.48 7.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.614 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -30.65 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.924 0.392 . . . . 0.0 110.723 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -71.26 -40.74 70.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.602 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -61.98 -46.62 88.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.43 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.693 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -61.11 -52.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.278 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -32.93 56.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.16 -33.1 61.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.238 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 18.3 t80 -63.97 -39.2 93.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.961 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -85.89 -24.97 26.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.7 31.06 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.424 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -110.63 27.61 11.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.479 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.445 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.751 0.31 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -147.41 123.32 10.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.96 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -76.29 158.36 31.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.846 HG11 HG23 ' A' ' 146' ' ' ILE . 23.0 t -108.26 147.03 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.208 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.55 HG22 ' HG3' ' A' ' 157' ' ' ARG . 18.6 mm -127.01 122.71 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.278 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.503 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -167.57 162.49 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.243 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.798 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -76.42 149.12 81.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.465 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.543 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.2 Cg_endo -53.6 -45.99 37.0 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.527 2.152 . . . . 0.0 112.147 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.544 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 12.2 p -63.58 -31.71 72.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 132' ' ' MET . 49.1 t -66.92 -41.93 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.169 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.29 -44.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.834 179.118 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.544 ' HG3' ' HA ' ' A' ' 134' ' ' SER . 1.2 mtmt -65.08 -40.79 95.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.655 ' CD1' HG21 ' A' ' 163' ' ' ILE . 50.9 t-105 -58.46 -51.97 67.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.157 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.14 -45.53 94.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.027 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -29.99 69.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.984 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.72 -30.63 51.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -95.21 -5.57 43.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.575 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.79 -9.52 68.47 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.492 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.978 HG21 HD21 ' A' ' 167' ' ' LEU . 17.5 t -80.56 145.18 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.902 0.382 . . . . 0.0 111.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.3 t0 -106.65 133.17 51.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.846 HG23 HG11 ' A' ' 129' ' ' VAL . 5.8 tp -58.45 -38.27 68.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -54.3 -20.72 7.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.379 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.608 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.21 27.79 9.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.607 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 163' ' ' ILE . 22.4 t -128.54 117.18 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -79.23 75.57 5.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.588 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.623 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -52.2 154.4 5.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.861 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.5 p -118.19 21.7 12.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.649 0.261 . . . . 0.0 111.124 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.83 94.86 1.34 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.696 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.02 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.586 0.232 . . . . 0.0 111.203 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -88.27 5.07 43.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.26 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.88 26.05 4.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.612 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.55 ' HG3' HG22 ' A' ' 130' ' ' ILE . 6.5 ttt180 -74.18 120.6 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.309 . . . . 0.0 110.963 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.785 ' HB ' HD11 ' A' ' 146' ' ' ILE . 34.7 t -67.93 115.13 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.579 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.3 mt -105.03 170.35 7.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.504 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -31.36 13.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.86 -40.32 72.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.608 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.12 -46.08 90.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.482 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.655 HG21 ' CD1' ' A' ' 138' ' ' TRP . 36.9 mm -61.27 -51.72 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -53.98 -33.88 58.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.69 -33.65 62.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.608 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 17.5 t80 -60.43 -44.79 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.361 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.978 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -76.76 -34.07 58.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.853 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.97 -24.85 67.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -56.54 -26.78 53.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.596 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.591 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.914 0.388 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -31.46 14.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.5 140.94 44.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.522 HG21 ' HD3' ' A' ' 147' ' ' ARG . 22.9 t -97.05 123.95 49.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.029 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 157' ' ' ARG . 4.0 mp -126.99 123.78 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.332 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 152.51 4.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 44.3 mtp -80.33 151.46 72.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.48 -35.98 57.46 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.573 2.182 . . . . 0.0 112.218 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -64.01 -33.22 75.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 158' ' ' VAL . 45.2 t -75.44 -48.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -47.7 84.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.09 0.472 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.26 -40.5 96.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.599 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.648 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.5 t-105 -60.27 -49.43 77.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.82 -50.32 73.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -54.35 -30.51 51.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.82 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.54 -34.94 53.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.5 mmpt? -90.42 -2.94 57.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.7 65.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.949 HG21 HD21 ' A' ' 167' ' ' LEU . 23.1 t -103.72 145.18 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.794 0.331 . . . . 0.0 111.269 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.3 t70 -104.89 132.23 51.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.662 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.0 tp -61.23 -28.85 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.401 . . . . 0.0 111.148 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.522 ' HD3' HG21 ' A' ' 129' ' ' VAL . 9.3 mmt180 -61.09 -17.92 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.983 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.647 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -112.47 25.86 11.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 163' ' ' ILE . 23.8 t -128.2 110.76 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.97 0.414 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -69.63 82.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.609 ' CA ' HG22 ' A' ' 158' ' ' VAL . . . -57.57 129.65 49.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.565 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.14 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.719 0.295 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -81.76 102.72 2.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.722 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 56.51 -84.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.617 0.246 . . . . 0.0 111.405 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -86.98 -0.17 56.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.82 26.03 5.71 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.661 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.595 ' HD2' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -90.05 133.2 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.903 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.713 ' O ' HG21 ' A' ' 135' ' ' VAL . 44.2 t -67.92 119.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.149 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.595 HD21 ' HD2' ' A' ' 157' ' ' ARG . 2.6 mt -108.41 171.92 7.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.796 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -51.65 -30.1 20.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.742 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.48 -39.34 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -63.3 -50.39 70.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.1 mm -59.91 -51.72 69.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.209 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.56 -31.94 57.55 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.67 -32.82 47.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.647 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.8 t80 -60.74 -40.33 91.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.949 HD21 HG21 ' A' ' 144' ' ' VAL . 3.3 mm? -82.64 -37.28 25.14 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.75 30.98 2.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.55 -35.38 6.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.513 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.493 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.838 0.352 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.4 ptt85 -86.02 -175.45 5.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -114.32 144.82 42.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.77 HG11 HG23 ' A' ' 146' ' ' ILE . 16.4 t -101.1 152.64 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.6 mt -126.85 115.43 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.235 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -169.98 141.61 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.1 mmm -67.65 158.29 83.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.84 -28.64 87.68 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.537 2.158 . . . . 0.0 112.062 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -64.96 -42.57 94.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.625 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' A' ' 159' ' ' LEU . 47.6 t -71.42 -46.95 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 1.1 mmm180 -56.1 -51.0 69.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.689 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -59.15 -39.37 82.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.785 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.638 ' CD1' HG21 ' A' ' 163' ' ' ILE . 48.9 t-105 -60.54 -50.65 72.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -59.49 -48.54 81.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.195 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -54.97 -33.94 62.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -79.92 -27.34 39.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -4.01 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.31 13.45 65.77 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.532 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.89 HG21 HD21 ' A' ' 167' ' ' LEU . 21.4 t -106.58 145.26 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 12.9 t0 -107.56 128.81 54.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.77 HG23 HG11 ' A' ' 129' ' ' VAL . 2.4 tp -57.09 -28.61 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.91 0.386 . . . . 0.0 111.046 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -61.18 -19.24 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.889 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.665 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -112.53 25.72 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.386 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 163' ' ' ILE . 22.0 t -127.48 112.28 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.68 77.13 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -53.64 145.47 23.87 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.76 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.5 p -117.94 18.8 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.622 0.248 . . . . 0.0 111.315 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -69.81 97.21 0.55 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.478 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.58 -87.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.499 0.19 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 153' ' ' GLY . 82.3 m-20 -78.03 -6.79 55.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.666 0.269 . . . . 0.0 111.256 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.11 4.81 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.603 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -84.37 131.41 34.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.698 ' HB ' HD11 ' A' ' 146' ' ' ILE . 32.2 t -67.9 123.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.257 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.728 ' HA ' HG21 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -114.95 172.72 6.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.472 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -32.72 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.933 0.397 . . . . 0.0 110.762 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.12 -39.36 75.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.12 -47.76 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.598 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.638 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -60.07 -51.66 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.4 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.52 -34.91 62.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.295 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.79 -33.52 62.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.277 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.665 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 22.5 t80 -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.89 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -80.55 -32.75 36.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.06 27.61 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.63 29.3 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.518 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.493 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.847 0.356 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -91.24 124.53 35.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.99 149.28 24.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.759 HG11 HG23 ' A' ' 146' ' ' ILE . 22.9 t -73.47 138.75 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.046 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.61 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.3 mp -121.75 123.51 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.09 148.82 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.75 154.79 73.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.81 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.17 -30.17 31.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.508 2.139 . . . . 0.0 112.362 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -64.18 -41.31 97.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.7 HG21 ' O ' ' A' ' 158' ' ' VAL . 40.9 t -73.03 -47.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -48.97 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.252 0.548 . . . . 0.0 109.686 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -59.82 -41.96 92.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.832 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 163' ' ' ILE . 55.6 t-105 -60.33 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.296 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.52 -48.0 83.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.21 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -56.2 -31.62 63.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -81.49 -28.08 34.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.73 -3.52 49.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.723 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.17 14.67 66.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.611 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.943 HG21 HD21 ' A' ' 167' ' ' LEU . 26.0 t -105.54 145.13 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.201 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.483 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 9.7 t0 -106.71 120.77 42.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.759 HG23 HG11 ' A' ' 129' ' ' VAL . 1.4 tp -50.34 -28.27 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.965 0.412 . . . . 0.0 111.378 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.676 ' HA ' HG21 ' A' ' 129' ' ' VAL . 4.2 mtm180 -60.73 -21.53 63.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.076 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.671 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -109.75 25.86 11.31 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.292 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.515 HG11 HD13 ' A' ' 163' ' ' ILE . 29.0 t -129.01 108.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -75.99 79.0 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.831 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.641 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -56.28 149.93 26.19 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.78 12.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.68 0.276 . . . . 0.0 111.3 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.57 105.43 2.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.663 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.084 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -93.38 13.0 22.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.09 26.08 7.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.389 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.61 ' HG3' HG22 ' A' ' 130' ' ' ILE . 16.0 ttm105 -77.54 125.28 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.319 . . . . 0.0 110.999 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.7 ' O ' HG21 ' A' ' 135' ' ' VAL . 40.0 t -68.02 121.08 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.48 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -110.22 172.22 6.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -51.86 -29.82 21.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.77 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -71.66 -38.98 70.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.588 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -64.46 -49.56 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.529 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.652 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.2 mm -59.27 -52.47 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -34.84 62.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.363 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 -31.92 60.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.293 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.0 t80 -63.15 -40.83 98.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.455 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.943 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -80.58 -34.0 35.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.912 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.73 30.95 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.297 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -112.99 -28.54 3.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.594 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.402 -1.221 . . . . 0.0 112.553 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.76 HG22 ' HG2' ' A' ' 157' ' ' ARG . 14.8 mt . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.842 0.353 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.04 164.55 9.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.769 ' HB2' HG23 ' A' ' 135' ' ' VAL . 29.1 mmm -76.49 141.64 69.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.431 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.605 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 72.2 Cg_exo -48.62 -45.53 27.21 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.302 2.001 . . . . 0.0 112.403 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.473 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 3.2 p -63.56 -32.67 74.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.822 HG11 ' O ' ' A' ' 158' ' ' VAL . 65.6 t -66.0 -40.49 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.085 0.469 . . . . 0.0 109.791 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 2.5 mmm180 -63.45 -44.01 95.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.904 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -65.87 -41.1 92.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.669 ' CD1' HG21 ' A' ' 163' ' ' ILE . 54.9 t-105 -58.07 -50.17 74.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.086 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.658 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.78 -52.56 64.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.033 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -54.93 -30.45 58.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.44 -35.23 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.415 ' HE3' ' CZ3' ' A' ' 138' ' ' TRP . 0.8 OUTLIER -91.75 -3.99 55.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.745 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.93 63.07 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.575 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.938 HG21 HD21 ' A' ' 167' ' ' LEU . 19.0 t -101.0 145.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.265 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 24.2 t0 -111.24 133.89 53.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.348 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.587 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -58.1 -33.45 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.43 . . . . 0.0 110.797 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.85 -22.64 15.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.889 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.98 25.6 11.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.721 0.296 . . . . 0.0 111.405 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.458 HG11 ' CG1' ' A' ' 158' ' ' VAL . 29.1 t -129.04 112.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 111.247 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -80.56 73.03 7.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.611 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -54.75 150.47 17.67 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.651 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.09 12.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.267 . . . . 0.0 111.202 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -70.09 95.1 0.48 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.711 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.14 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.689 0.28 . . . . 0.0 111.259 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.6 p30 -97.11 5.7 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.099 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.13 26.04 4.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.621 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.76 ' HG2' HG22 ' A' ' 130' ' ' ILE . 12.4 mtt180 -77.35 122.43 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.822 ' O ' HG11 ' A' ' 135' ' ' VAL . 36.5 t -71.11 102.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.843 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.8 mt -94.14 173.08 7.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -51.34 -30.11 17.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.654 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -69.02 -41.11 78.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.404 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -63.39 -49.39 74.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.392 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.9 mm -59.81 -52.28 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.275 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -31.71 61.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.332 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -33.2 49.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.183 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 18.4 t80 -60.88 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.441 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.938 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.93 -40.2 40.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.076 -179.913 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 157' ' ' ARG . 1.9 mt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.871 0.367 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.15 166.05 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.075 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.7 mtp -91.89 149.88 39.72 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.77 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.4 -30.98 28.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.487 2.124 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -66.04 -40.69 91.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.622 HG21 ' O ' ' A' ' 158' ' ' VAL . 39.3 t -72.3 -44.44 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.457 ' HD3' HG21 ' A' ' 146' ' ' ILE . 2.6 mmm180 -58.32 -46.64 85.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 109.775 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -63.09 -39.95 96.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.941 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 163' ' ' ILE . 56.1 t-105 -63.11 -46.27 88.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.221 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.632 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -64.37 -47.28 79.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.235 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.2 -29.53 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.864 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -80.81 -31.23 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.997 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -5.36 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.576 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.42 -10.11 64.98 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.669 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.959 HG21 HD21 ' A' ' 167' ' ' LEU . 40.0 t -82.74 145.02 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 53.6 t0 -110.65 113.36 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.222 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.6 OUTLIER -44.47 -25.61 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -18.03 27.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 149' ' ' VAL . 0.5 OUTLIER -115.44 29.16 8.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.621 0.248 . . . . 0.0 111.545 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 148' ' ' LEU . 43.1 t -129.04 109.54 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.393 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 82.29 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -53.6 142.57 29.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.787 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -118.25 -21.14 8.28 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.859 ' H ' HD21 ' A' ' 159' ' ' LEU . . . -60.51 153.3 36.64 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.493 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 48.02 -104.8 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -105.46 30.04 6.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.734 0.302 . . . . 0.0 111.435 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.27 20.48 13.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.761 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.578 ' HB3' HG22 ' A' ' 130' ' ' ILE . 22.4 ptt180 -85.47 154.15 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.649 0.262 . . . . 0.0 110.399 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.742 ' C ' HD13 ' A' ' 159' ' ' LEU . 22.2 t -80.74 133.93 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.488 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.859 HD21 ' H ' ' A' ' 153' ' ' GLY . 0.0 OUTLIER -119.34 169.82 9.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -52.17 -30.7 28.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.02 -39.99 78.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.412 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.705 ' OD2' HD22 ' A' ' 159' ' ' LEU . 87.6 m-20 -64.1 -51.05 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.652 HG21 ' CD1' ' A' ' 138' ' ' TRP . 42.2 mm -59.48 -52.06 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -54.38 -33.85 60.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.384 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.73 -31.19 52.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.209 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 24.2 t80 -64.24 -37.66 88.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.628 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.959 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -89.06 -26.64 21.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.361 -179.831 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.782 HG22 ' CG ' ' A' ' 157' ' ' ARG . 23.8 mm . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.795 0.331 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.11 160.98 8.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.3 mtp -81.92 145.88 54.51 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.68 -32.55 45.6 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.489 2.126 . . . . 0.0 112.283 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -40.41 95.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.697 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.772 HG21 ' HA ' ' A' ' 159' ' ' LEU . 46.3 t -70.25 -46.26 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.2 OUTLIER -56.31 -45.7 80.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.798 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -61.92 -41.1 97.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.615 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.633 ' CD1' HG21 ' A' ' 163' ' ' ILE . 54.0 t-105 -61.24 -50.48 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.247 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -58.6 -44.09 89.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.76 -32.76 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -77.88 -27.47 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -96.69 -6.07 37.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.606 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.74 -9.01 71.13 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.63 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.743 HG21 HD21 ' A' ' 167' ' ' LEU . 18.1 t -82.06 145.21 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.888 0.375 . . . . 0.0 111.49 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 62.5 t0 -110.24 122.67 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.1 tp -50.7 -27.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.294 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -61.36 -23.22 65.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.933 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.679 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -109.44 23.52 14.35 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.409 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.443 HG23 HD12 ' A' ' 148' ' ' LEU . 44.2 t -123.91 114.74 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.9 78.98 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.66 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.65 142.16 34.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.718 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p -118.05 23.93 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -75.08 90.09 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.537 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.64 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.618 0.247 . . . . 0.0 111.145 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . 87.4 m-20 -85.69 -0.74 56.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.145 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.03 26.07 4.82 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.587 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.782 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -80.92 122.87 27.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.735 0.302 . . . . 0.0 110.816 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.674 ' HB ' HD11 ' A' ' 146' ' ' ILE . 35.4 t -67.9 111.27 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.939 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.772 ' HA ' HG21 ' A' ' 135' ' ' VAL . 3.1 mt -102.44 175.28 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.744 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -32.49 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.33 -35.43 75.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.415 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.424 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.633 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.8 mm -60.95 -45.78 97.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HA ' HD12 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -58.27 -41.12 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.311 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.62 -34.59 74.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.348 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.679 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 19.2 t80 -59.98 -45.46 92.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.372 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.743 HD21 HG21 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -76.6 -27.73 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.099 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.394 -179.859 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.559 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.18 150.89 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.0 mtm -74.99 161.67 76.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.55 -29.28 84.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.524 2.149 . . . . 0.0 112.125 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 p -67.02 -37.32 83.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.598 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 158' ' ' VAL . 45.0 t -74.77 -47.52 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 109.746 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -61.68 -41.78 98.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.752 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.69 ' CD1' HG21 ' A' ' 163' ' ' ILE . 49.6 t-105 -60.22 -47.24 86.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.43 -50.34 73.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.069 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -54.21 -33.5 58.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.095 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -78.42 -29.73 47.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.817 0.341 . . . . 0.0 110.943 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.408 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 2.1 mmtt -92.98 -3.64 54.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.9 12.68 68.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.569 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.805 ' CG2' HD21 ' A' ' 167' ' ' LEU . 20.4 t -104.04 145.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.367 . . . . 0.0 111.214 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 22.6 t0 -107.82 121.06 43.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.344 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.762 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.1 tp -50.74 -26.41 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.449 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -23.37 64.34 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.707 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -110.15 25.77 11.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.0 111.503 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.455 HG23 HD12 ' A' ' 148' ' ' LEU . 39.7 t -127.09 108.01 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -76.15 79.02 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.645 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -53.26 159.34 3.87 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.765 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 p -118.27 8.48 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -63.85 87.07 0.06 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.65 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.623 0.249 . . . . 0.0 111.257 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.8 m-80 -87.7 3.21 48.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.119 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.16 4.78 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.559 ' HG3' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -73.02 113.3 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 0.0 110.918 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.762 ' HB ' HD11 ' A' ' 146' ' ' ILE . 40.1 t -67.84 111.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.518 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -100.65 176.16 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -30.97 60.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.676 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.73 -33.83 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.73 -47.61 62.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.69 HG21 ' CD1' ' A' ' 138' ' ' TRP . 36.5 mm -60.99 -47.74 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.31 -40.06 85.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.299 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.41 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.132 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.686 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.0 t80 -60.01 -46.03 90.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.201 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.805 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -76.28 -27.12 56.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.132 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.282 -179.802 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.7 HG22 ' HG3' ' A' ' 157' ' ' ARG . 2.8 mp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.77 152.41 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.39 153.94 71.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.52 -33.26 67.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.191 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.2 m -64.01 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 159' ' ' LEU . 61.4 t -74.17 -48.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -47.0 82.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.829 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -61.56 -42.1 98.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.729 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 163' ' ' ILE . 51.5 t-105 -59.32 -48.93 79.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.136 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.698 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.05 -49.59 76.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.016 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 tpt85 -54.47 -30.7 53.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.84 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -79.71 -32.21 41.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.412 ' HD3' ' CH2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -92.18 -2.67 56.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.713 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.77 16.06 64.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.491 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 1.083 HG21 HD11 ' A' ' 167' ' ' LEU . 34.4 t -105.86 145.11 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.368 . . . . 0.0 111.261 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.1 t0 -108.77 122.11 46.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.74 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.9 tp -50.06 -27.15 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 111.292 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 mmt-85 -60.04 -25.17 65.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.739 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -107.41 25.43 11.46 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.344 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.426 HG23 HD12 ' A' ' 148' ' ' LEU . 31.3 t -126.51 111.3 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.975 0.417 . . . . 0.0 111.459 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -79.91 74.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.536 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -53.31 145.59 22.08 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.773 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.7 p -118.05 24.21 11.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.991 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -73.68 101.72 1.22 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.7 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.62 -83.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.651 0.262 . . . . 0.0 111.197 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -97.09 6.28 48.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.463 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.99 26.07 4.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.715 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.7 ' HG3' HG22 ' A' ' 130' ' ' ILE . 26.6 ttm180 -83.45 125.26 31.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.74 ' HB ' HD11 ' A' ' 146' ' ' ILE . 21.5 t -67.95 119.44 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.603 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.7 mt -113.34 171.99 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.815 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -50.6 -28.8 9.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.975 0.417 . . . . 0.0 110.729 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -72.47 -41.0 66.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.507 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.3 -45.74 91.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.6 mm -62.75 -49.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -31.8 63.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.202 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.46 -41.21 40.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.892 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.739 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 16.3 t80 -61.38 -24.85 66.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.202 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.083 HD11 HG21 ' A' ' 144' ' ' VAL . 4.5 mp -87.95 -39.96 14.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.82 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.409 -179.843 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 157' ' ' ARG . 35.0 mm . . . . . 0 C--O 1.23 0.029 0 CA-C-O 120.853 0.359 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.21 157.96 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.094 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.95 161.89 54.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.75 -28.96 87.35 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.536 2.157 . . . . 0.0 112.119 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.8 p -67.5 -37.1 82.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' A' ' 159' ' ' LEU . 60.2 t -74.6 -47.71 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -43.63 93.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 109.789 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -64.07 -41.17 97.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.533 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.659 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.5 t-105 -61.01 -50.32 73.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.099 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.35 -47.19 87.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.156 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -57.71 -30.22 65.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.791 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.09 -40.17 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.29 -9.38 67.31 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.676 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.771 ' CG2' HD21 ' A' ' 167' ' ' LEU . 19.4 t -80.17 145.25 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.8 t0 -111.27 130.75 55.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.425 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.686 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.8 OUTLIER -56.7 -28.65 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.127 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.4 mtt85 -59.46 -19.0 44.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.961 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.651 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -114.71 27.23 9.59 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.621 0.248 . . . . 0.0 111.391 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.5 t -128.87 115.98 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.35 73.97 7.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.531 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -52.05 142.74 21.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.715 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.2 p -118.03 26.11 9.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -78.16 100.71 1.66 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.665 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.41 -85.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.58 0.228 . . . . 0.0 111.095 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 10.6 p30 -83.94 -4.76 58.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.05 26.02 4.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.476 ' NE ' HD21 ' A' ' 159' ' ' LEU . 23.8 ptt-85 -82.21 134.86 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.969 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HD11 ' A' ' 146' ' ' ILE . 18.7 t -69.34 119.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.306 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.1 mt -111.73 176.99 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.619 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.43 -35.16 62.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -69.15 -32.58 72.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.59 -50.0 55.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.623 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.659 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.6 mm -60.1 -46.2 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -39.7 84.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.224 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -33.96 70.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.316 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.651 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.5 t80 -58.7 -49.24 78.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -73.56 -31.55 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 157' ' ' ARG . 5.4 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.79 0.329 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.444 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.07 177.35 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.602 ' HE1' HD23 ' A' ' 159' ' ' LEU . 2.7 mtm -108.79 155.45 40.67 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.94 -30.75 31.6 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.48 2.12 . . . . 0.0 112.284 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.2 m -63.86 -45.95 87.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 159' ' ' LEU . 60.3 t -70.31 -44.4 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.835 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 12.8 mmm-85 -58.63 -42.88 89.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 109.869 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.4 -41.65 98.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.643 ' CD1' HG21 ' A' ' 163' ' ' ILE . 58.1 t-105 -61.87 -51.0 69.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.207 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.84 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 13.6 ttm105 -60.35 -31.38 70.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -77.52 -34.85 53.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.428 ' HE2' ' CZ3' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -89.98 -5.87 56.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.574 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.6 72.75 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.717 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.751 ' CG2' HD21 ' A' ' 167' ' ' LEU . 19.2 t -80.93 145.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.875 0.369 . . . . 0.0 111.355 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.4 t0 -109.52 134.28 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 131' ' ' ALA . 2.0 tp -60.37 -28.82 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -61.51 -17.09 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.84 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -115.4 25.02 11.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.539 0.209 . . . . 0.0 111.402 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.59 111.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.93 75.34 5.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.661 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.58 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -51.04 159.5 1.88 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.729 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.0 p -118.11 12.14 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.642 0.258 . . . . 0.0 111.356 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.67 92.17 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.697 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt 56.6 -86.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -88.07 5.95 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.294 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.07 4.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.572 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.65 ' HG3' HG22 ' A' ' 130' ' ' ILE . 25.2 ttm180 -73.35 115.9 13.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 151' ' ' GLY . 41.8 t -67.92 119.65 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.03 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.642 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.3 mt -110.78 177.41 4.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -33.34 61.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.98 0.419 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -70.46 -33.2 71.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.453 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.79 -48.87 65.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.545 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.643 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.8 mm -61.49 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.492 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.09 -39.08 81.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.27 64.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.658 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.6 t80 -59.47 -52.36 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.751 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -70.09 -38.42 75.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.88 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.271 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.76 HG22 ' CG ' ' A' ' 157' ' ' ARG . 1.7 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.711 0.291 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.94 160.24 8.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.218 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.798 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.9 mtp -74.56 148.95 85.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.568 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.588 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.4 Cg_endo -53.52 -46.29 34.88 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.492 2.128 . . . . 0.0 112.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.535 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 65.3 p -63.57 -32.03 73.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 132' ' ' MET . 48.1 t -66.69 -41.06 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 110.04 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.906 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -66.96 -40.53 87.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.381 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.67 ' CD1' HG21 ' A' ' 163' ' ' ILE . 56.5 t-105 -59.89 -47.3 86.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.137 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.07 -52.09 66.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.076 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -51.99 -37.01 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.904 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.66 -40.74 80.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -85.03 -4.77 59.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.66 10.06 65.69 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.646 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.739 HG21 HD21 ' A' ' 167' ' ' LEU . 20.4 t -99.19 145.04 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.362 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 52.5 t0 -112.06 114.11 26.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.928 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.591 ' CD1' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -45.76 -26.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -57.46 -20.11 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -113.79 24.15 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.609 0.242 . . . . 0.0 111.327 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.556 HG23 HD12 ' A' ' 148' ' ' LEU . 40.0 t -123.06 111.75 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.96 78.79 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.717 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.669 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.57 152.24 12.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.4 p -117.95 19.21 13.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.557 0.218 . . . . 0.0 111.25 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -72.59 88.17 0.53 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.483 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.74 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.647 0.26 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.7 OUTLIER -84.02 -0.34 51.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.211 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.07 26.04 4.82 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.609 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.76 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.29 119.75 21.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.32 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.669 HG22 ' N ' ' A' ' 151' ' ' GLY . 41.6 t -68.02 111.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.97 176.4 5.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.755 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.22 -31.96 54.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.55 -35.5 75.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.578 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -68.22 -47.62 67.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.67 HG21 ' CD1' ' A' ' 138' ' ' TRP . 44.8 mm -60.04 -48.42 88.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -58.87 -39.68 82.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.178 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.28 72.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.422 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.539 ' CE2' HD13 ' A' ' 148' ' ' LEU . 18.5 t80 -59.18 -50.26 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -69.73 -35.35 74.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.232 -179.938 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.735 HG22 ' CG ' ' A' ' 157' ' ' ARG . 3.2 mp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.881 0.372 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.08 153.09 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.6 mtp -81.33 150.43 67.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.81 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.56 -31.24 39.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.1 m -63.91 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.744 HG21 ' O ' ' A' ' 158' ' ' VAL . 43.6 t -75.34 -49.66 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.56 -47.07 80.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -45.97 90.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.596 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.636 ' CD1' HG21 ' A' ' 163' ' ' ILE . 52.4 t-105 -57.04 -49.17 76.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.402 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.69 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.11 -38.85 92.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.456 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.39 -30.9 71.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -82.8 -30.51 28.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.497 ' HG2' HD21 ' A' ' 167' ' ' LEU . 2.3 tptt -88.76 -15.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.506 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.77 45.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.667 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 1.074 HG21 HD11 ' A' ' 167' ' ' LEU . 38.8 t -85.5 145.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 111.264 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 43.1 t0 -108.98 119.86 40.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.384 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.671 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.0 OUTLIER -49.17 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.888 0.375 . . . . 0.0 111.498 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -59.47 -27.41 66.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.76 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.762 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -104.64 26.49 9.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.227 . . . . 0.0 111.33 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.445 HG23 HD12 ' A' ' 148' ' ' LEU . 24.8 t -128.79 109.7 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 111.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -79.11 75.78 5.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.621 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -55.38 145.86 30.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.736 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.9 p -118.1 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.844 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -74.88 100.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.639 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? 59.26 -82.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.535 0.207 . . . . 0.0 111.055 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.1 p30 -97.5 7.16 47.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.655 0.264 . . . . 0.0 111.297 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.94 26.13 4.82 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.526 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.735 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -81.83 123.83 29.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 111.116 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.744 ' O ' HG21 ' A' ' 135' ' ' VAL . 24.3 t -67.95 111.1 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.481 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -102.11 175.1 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -53.83 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.39 -36.76 68.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.432 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -66.0 -46.7 77.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.419 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.636 HG21 ' CD1' ' A' ' 138' ' ' TRP . 34.9 mm -63.01 -50.79 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.332 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -57.45 -31.91 66.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 110.392 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.983 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.762 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.3 t80 -61.83 -28.66 69.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.117 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.074 HD11 HG21 ' A' ' 144' ' ' VAL . 3.7 mp -81.17 -47.99 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.784 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.483 HG21 ' OD1' ' A' ' 155' ' ' ASN . 29.4 mt . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.8 0.333 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.444 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.22 174.77 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 135' ' ' VAL . 33.1 mmm -91.07 147.13 35.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.394 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.576 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 72.0 Cg_exo -48.5 -50.56 12.03 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.444 2.096 . . . . 0.0 112.81 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.517 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -63.44 -26.6 68.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.837 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 159' ' ' LEU . 80.5 t -71.59 -38.78 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.907 0.384 . . . . 0.0 110.223 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.6 OUTLIER -67.51 -41.55 84.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.714 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.37 -39.46 81.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.654 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.3 t-105 -59.93 -50.25 74.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.201 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.1 -49.61 73.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.87 -35.73 57.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.84 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -4.24 56.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.541 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.18 -10.56 65.59 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.628 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.967 HG21 HD21 ' A' ' 167' ' ' LEU . 18.8 t -80.97 145.27 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.007 0.432 . . . . 0.0 111.417 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 35.0 t0 -108.24 133.57 52.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.841 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.4 tp -59.39 -35.28 57.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.116 0.484 . . . . 0.0 110.928 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -55.1 -21.2 12.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.226 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.08 25.35 11.89 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.428 HG11 HD13 ' A' ' 163' ' ' ILE . 21.9 t -129.13 111.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 111.245 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.15 77.67 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.407 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -56.14 144.81 35.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.646 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.2 p -118.02 26.1 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.739 0.304 . . . . 0.0 111.068 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.5 102.37 1.97 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.718 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? 57.84 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.625 0.25 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.483 ' OD1' HG21 ' A' ' 130' ' ' ILE . 8.4 p30 -90.7 -0.54 57.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.252 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.02 26.07 4.82 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.679 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.471 ' CB ' HG22 ' A' ' 130' ' ' ILE . 8.6 ptp180 -82.33 133.35 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.748 0.309 . . . . 0.0 110.979 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.841 ' HB ' HD11 ' A' ' 146' ' ' ILE . 5.0 t -68.0 123.89 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.527 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.6 mt -114.71 170.17 8.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -32.0 11.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.57 -40.95 73.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.633 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -61.91 -50.91 70.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.572 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.654 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -58.34 -52.24 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.413 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.65 -34.07 57.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.401 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.45 -32.39 60.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.66 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 19.4 t80 -64.14 -37.68 88.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.496 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.967 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -86.16 -27.56 24.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.043 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.417 -179.861 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.837 0.351 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -169.97 162.56 9.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.799 ' HB2' HG23 ' A' ' 135' ' ' VAL . 15.3 mtp -75.12 144.31 78.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.554 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 73.5 Cg_exo -49.06 -47.56 21.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.386 2.057 . . . . 0.0 112.397 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 1.3 m -63.46 -30.47 71.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.677 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.799 HG23 ' HB2' ' A' ' 132' ' ' MET . 63.6 t -66.93 -40.69 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 109.93 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -64.41 -43.84 93.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.778 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -65.2 -41.36 94.59 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.6 t-105 -58.18 -50.83 72.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.236 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -62.96 -49.22 75.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.853 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -56.4 -29.94 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.781 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.7 -43.53 59.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -84.5 -4.63 59.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.496 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.4 66.28 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.617 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.938 HG21 HD21 ' A' ' 167' ' ' LEU . 18.6 t -78.96 145.09 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 111.311 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 7.6 t0 -108.29 134.6 50.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.418 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.695 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.4 tp -59.7 -35.17 58.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.021 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -55.59 -21.05 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.14 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.644 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.42 26.8 10.29 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.634 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 163' ' ' ILE . 21.8 t -128.95 113.76 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -77.76 76.96 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.721 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.623 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.95 142.68 34.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.604 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.7 p -117.46 25.37 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.7 0.286 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -77.51 98.48 1.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.12 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.634 0.254 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 11.7 p-10 -79.32 -6.48 56.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.182 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.09 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -83.83 133.81 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.342 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.695 ' HB ' HD11 ' A' ' 146' ' ' ILE . 31.4 t -70.44 118.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.568 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.3 mt -108.16 171.81 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.684 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -32.24 18.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -70.72 -39.26 73.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.621 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.01 -47.28 83.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.0 mm -60.8 -51.44 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.291 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -33.87 61.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.201 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.29 -34.11 61.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.123 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.8 t80 -60.91 -39.66 90.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.157 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.938 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -82.16 -31.46 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.956 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.87 0.367 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 156.54 6.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -82.91 152.13 65.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.41 -36.26 68.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.505 2.137 . . . . 0.0 112.232 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.4 p -63.92 -34.04 77.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.831 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.496 HG12 ' CD1' ' A' ' 146' ' ' ILE . 48.1 t -75.18 -47.97 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -47.75 84.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.115 0.483 . . . . 0.0 109.802 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -62.48 -39.54 93.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.767 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.647 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.2 t-105 -61.39 -49.16 78.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.5 -49.05 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.167 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -56.75 -30.24 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.824 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.96 -40.95 62.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.9 -4.24 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.616 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.19 66.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 167' ' ' LEU . 22.0 t -79.59 145.21 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.365 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 18.3 t0 -111.47 122.98 49.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.507 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.686 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.7 tp -50.84 -25.8 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.42 -22.88 63.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.834 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.697 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -110.3 25.65 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.614 0.245 . . . . 0.0 111.394 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.429 HG23 HD12 ' A' ' 148' ' ' LEU . 28.5 t -127.65 106.48 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.88 0.371 . . . . 0.0 111.213 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -75.84 78.91 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -52.26 140.15 28.62 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.784 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.1 p -118.17 26.06 9.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 157' ' ' ARG . . . -89.79 128.89 9.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.809 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -87.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.555 0.217 . . . . 0.0 111.524 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 25.0 m-80 -108.99 17.82 21.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.633 0.254 . . . . 0.0 111.376 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 22.55 7.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.009 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.461 ' HG3' HD21 ' A' ' 159' ' ' LEU . 7.3 ptp180 -84.45 133.93 34.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.62 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HD11 ' A' ' 146' ' ' ILE . 33.5 t -69.66 127.21 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.271 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.461 HD21 ' HG3' ' A' ' 157' ' ' ARG . 2.8 mt -116.22 172.54 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -53.46 -30.79 42.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.682 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.12 -35.95 69.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.0 -47.76 73.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.647 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.5 mm -61.57 -51.92 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.224 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -55.74 -33.18 64.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.415 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.44 -32.77 54.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.235 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.697 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 22.2 t80 -61.29 -43.08 99.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.4 -42.33 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.832 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.21 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.4 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.814 0.34 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.05 146.34 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.8 mmm -74.12 151.01 88.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.05 -28.1 39.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.613 2.208 . . . . 0.0 112.073 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 p -63.87 -44.86 91.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 159' ' ' LEU . 48.4 t -70.05 -46.63 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.404 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 3.4 mmm180 -56.17 -47.55 78.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 109.808 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -60.67 -39.91 90.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.889 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 163' ' ' ILE . 60.9 t-105 -62.5 -50.21 72.32 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.199 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.74 -38.35 90.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.469 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -30.19 70.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.029 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -82.1 -31.26 30.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.351 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.43 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.6 mmtm -88.39 -24.03 23.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.397 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.83 -5.96 24.07 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.628 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 167' ' ' LEU . 43.5 t -85.32 145.18 8.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 58.0 t0 -111.52 114.88 28.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -47.01 -24.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.4 mtp85 -58.25 -19.86 37.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -111.28 -5.76 14.63 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.518 HG23 HD12 ' A' ' 148' ' ' LEU . 41.4 t -91.04 113.8 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 0.0 111.332 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -79.08 75.92 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.631 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -55.79 142.08 38.45 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.815 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.08 25.87 10.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.0 111.016 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.62 112.32 3.43 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.886 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.53 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.67 0.271 . . . . 0.0 111.399 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 18.4 m-80 -106.07 16.34 25.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.32 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.84 26.04 6.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.686 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.65 ' HG3' HG22 ' A' ' 130' ' ' ILE . 54.0 ttm-85 -84.29 126.05 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 146' ' ' ILE . 20.7 t -68.0 124.08 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.588 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.8 mt -113.88 169.07 9.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.738 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -50.91 -31.31 17.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.67 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -70.19 -40.16 74.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.456 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.54 -45.7 91.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.0 mm -60.85 -53.12 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.266 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -53.28 -34.45 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.349 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.93 -31.47 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 148' ' ' LEU . 19.7 t80 -63.48 -44.53 94.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 144' ' ' VAL . 3.1 mm? -79.34 -30.05 42.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.318 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.836 0.35 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.14 158.1 6.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 55.8 mtp -77.86 157.34 79.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.626 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.86 -35.54 77.74 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.464 2.109 . . . . 0.0 112.183 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -66.51 -29.6 69.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 158' ' ' VAL . 48.7 t -77.08 -49.16 23.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.962 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -46.35 88.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.36 94.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.633 ' CD1' HG21 ' A' ' 163' ' ' ILE . 59.7 t-105 -56.78 -51.55 68.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.057 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -56.51 -48.22 77.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.211 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -37.53 56.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.17 -49.65 59.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.257 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -72.26 -19.61 61.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.09 13.68 28.42 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.266 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 1.066 HG21 HD11 ' A' ' 167' ' ' LEU . 41.5 t -100.74 145.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.896 0.379 . . . . 0.0 111.233 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.2 t0 -107.46 115.38 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.79 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.7 OUTLIER -46.71 -26.23 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -56.86 -22.37 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.008 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -111.94 28.67 8.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.57 0.224 . . . . 0.0 111.319 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 148' ' ' LEU . 21.9 t -129.04 108.53 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.938 0.399 . . . . 0.0 111.302 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.19 77.58 3.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.435 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -55.23 143.69 33.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.689 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 p -118.1 26.16 9.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.801 0.334 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.42 102.4 1.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.1 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.602 0.239 . . . . 0.0 111.272 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.92 -5.07 58.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 0.0 111.317 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.04 26.05 4.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.603 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -85.99 137.74 32.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.79 ' HB ' HD11 ' A' ' 146' ' ' ILE . 5.2 t -67.95 126.49 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.507 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.2 mt -116.2 169.29 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.568 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -50.33 -30.41 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 110.7 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.88 -40.98 71.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.483 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -62.7 -46.91 85.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.566 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.633 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.7 mm -62.67 -48.64 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.453 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -57.68 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.355 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.78 -40.87 31.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.2 t80 -61.66 -25.9 67.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.256 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.066 HD11 HG21 ' A' ' 144' ' ' VAL . 3.3 mp -86.04 -45.5 11.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.148 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 157' ' ' ARG . 1.9 mt . . . . . 0 N--CA 1.458 -0.032 0 CA-C-O 120.848 0.356 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.409 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.12 162.23 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 31.2 mtp -79.53 155.38 76.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.659 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.82 -32.99 93.39 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.525 2.15 . . . . 0.0 112.072 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -33.62 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.464 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 159' ' ' LEU . 41.2 t -74.93 -47.32 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.881 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -58.13 -49.62 76.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.54 -41.31 94.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.762 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.653 ' CD1' HG21 ' A' ' 163' ' ' ILE . 48.5 t-105 -59.89 -48.28 82.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.123 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.19 -50.47 73.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.91 -28.84 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -81.03 -28.59 35.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.033 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -96.53 -4.03 42.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.62 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.19 8.95 64.05 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.784 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 167' ' ' LEU . 22.3 t -100.92 145.19 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.852 0.358 . . . . 0.0 111.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 23.5 t0 -108.4 121.13 44.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.504 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.788 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.2 tp -50.02 -27.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.943 0.401 . . . . 0.0 111.38 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -59.56 -21.83 60.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.063 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.714 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -111.39 26.78 10.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.559 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.438 HG23 HD12 ' A' ' 148' ' ' LEU . 22.4 t -129.04 107.15 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.463 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.84 81.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -56.04 139.38 43.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.689 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.19 26.07 9.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.55 128.91 9.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.873 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.62 -88.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 80.5 m-20 -105.55 26.27 9.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.4 24.08 27.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.801 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.469 ' HB3' HG22 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -83.97 136.73 33.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.788 ' HB ' HD11 ' A' ' 146' ' ' ILE . 24.0 t -69.23 130.52 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.301 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.612 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.6 mt -117.51 169.47 9.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -33.3 23.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 110.673 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.76 -38.68 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.53 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.91 -49.37 75.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.653 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -59.2 -52.19 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.414 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -54.97 -33.56 62.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.335 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.224 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.714 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 38.6 t80 -60.27 -43.25 96.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.434 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.91 -39.13 43.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 -179.838 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.831 0.348 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.01 165.28 9.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.779 ' HB2' HG23 ' A' ' 135' ' ' VAL . 30.9 mtp -80.34 149.93 69.84 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.612 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.9 Cg_endo -53.15 -47.68 26.21 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.588 2.192 . . . . 0.0 112.201 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.539 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 28.7 t -63.58 -30.6 71.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.605 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.779 HG23 ' HB2' ' A' ' 132' ' ' MET . 58.0 t -67.24 -40.86 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 109.986 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 146' ' ' ILE . 4.1 mmm180 -65.35 -41.4 93.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.935 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 1.5 mttt -68.43 -38.19 80.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.693 ' CD1' HG21 ' A' ' 163' ' ' ILE . 64.0 t-105 -61.39 -50.01 74.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -62.72 -45.27 93.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.933 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -60.18 -31.38 70.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.918 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.25 -31.38 54.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.464 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -92.37 -6.79 49.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.422 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.28 -10.42 67.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.348 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.961 HG21 HD21 ' A' ' 167' ' ' LEU . 18.0 t -80.58 145.17 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.528 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 32.0 t0 -107.36 132.84 52.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.219 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.685 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.7 tp -59.34 -35.2 57.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 110.996 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -55.59 -21.23 16.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.084 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.644 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -109.6 26.25 10.87 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.56 0.219 . . . . 0.0 111.548 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.433 HG11 ' CG1' ' A' ' 158' ' ' VAL . 30.4 t -127.28 112.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.261 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.33 73.09 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.495 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -57.74 153.42 24.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.62 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.2 p -118.18 25.63 10.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.677 0.275 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -76.99 105.17 2.0 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.941 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.612 0.244 . . . . 0.0 111.399 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -108.56 13.42 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.721 0.296 . . . . 0.0 111.068 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 110.58 26.08 4.94 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.436 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -78.28 122.83 26.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.11 -179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.685 ' HB ' HD11 ' A' ' 146' ' ' ILE . 11.5 t -67.97 113.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.062 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.9 mt -105.52 170.48 7.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.614 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -30.65 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.924 0.392 . . . . 0.0 110.723 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -71.26 -40.74 70.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.602 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -61.98 -46.62 88.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.43 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.693 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -61.11 -52.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.278 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -32.93 56.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.16 -33.1 61.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.238 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 18.3 t80 -63.97 -39.2 93.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.961 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -85.89 -24.97 26.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.424 -179.746 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.55 HG22 ' HG3' ' A' ' 157' ' ' ARG . 18.6 mm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.772 0.32 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.503 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -167.57 162.49 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.243 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.798 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -76.42 149.12 81.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.465 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.543 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.2 Cg_endo -53.6 -45.99 37.0 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.527 2.152 . . . . 0.0 112.147 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.544 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 12.2 p -63.58 -31.71 72.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 132' ' ' MET . 49.1 t -66.92 -41.93 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.169 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.29 -44.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.834 179.118 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.544 ' HG3' ' HA ' ' A' ' 134' ' ' SER . 1.2 mtmt -65.08 -40.79 95.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.655 ' CD1' HG21 ' A' ' 163' ' ' ILE . 50.9 t-105 -58.46 -51.97 67.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.157 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.14 -45.53 94.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.027 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -29.99 69.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.984 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.72 -30.63 51.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -95.21 -5.57 43.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.575 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.79 -9.52 68.47 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.492 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.978 HG21 HD21 ' A' ' 167' ' ' LEU . 17.5 t -80.56 145.18 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.902 0.382 . . . . 0.0 111.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.3 t0 -106.65 133.17 51.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.785 HD11 ' HB ' ' A' ' 158' ' ' VAL . 5.8 tp -58.45 -38.27 68.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -54.3 -20.72 7.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.379 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.608 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.21 27.79 9.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.607 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 163' ' ' ILE . 22.4 t -128.54 117.18 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -79.23 75.57 5.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.588 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.623 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -52.2 154.4 5.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.861 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.5 p -118.19 21.7 12.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.649 0.261 . . . . 0.0 111.124 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.83 94.86 1.34 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.696 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.02 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.586 0.232 . . . . 0.0 111.203 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -88.27 5.07 43.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.26 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.88 26.05 4.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.612 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.55 ' HG3' HG22 ' A' ' 130' ' ' ILE . 6.5 ttt180 -74.18 120.6 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.309 . . . . 0.0 110.963 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.785 ' HB ' HD11 ' A' ' 146' ' ' ILE . 34.7 t -67.93 115.13 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.579 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.3 mt -105.03 170.35 7.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.504 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -31.36 13.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.86 -40.32 72.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.608 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.12 -46.08 90.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.482 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.655 HG21 ' CD1' ' A' ' 138' ' ' TRP . 36.9 mm -61.27 -51.72 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -53.98 -33.88 58.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.69 -33.65 62.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.608 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 17.5 t80 -60.43 -44.79 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.361 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.978 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -76.76 -34.07 58.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.853 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 -179.95 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 157' ' ' ARG . 4.0 mp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.888 0.375 . . . . 0.0 111.332 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 152.51 4.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 44.3 mtp -80.33 151.46 72.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.48 -35.98 57.46 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.573 2.182 . . . . 0.0 112.218 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -64.01 -33.22 75.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 158' ' ' VAL . 45.2 t -75.44 -48.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -47.7 84.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.09 0.472 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.26 -40.5 96.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.599 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.648 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.5 t-105 -60.27 -49.43 77.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.82 -50.32 73.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -54.35 -30.51 51.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.82 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.54 -34.94 53.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.5 mmpt? -90.42 -2.94 57.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.7 65.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.949 HG21 HD21 ' A' ' 167' ' ' LEU . 23.1 t -103.72 145.18 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.794 0.331 . . . . 0.0 111.269 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.3 t70 -104.89 132.23 51.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.662 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.0 tp -61.23 -28.85 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.401 . . . . 0.0 111.148 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.09 -17.92 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.983 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.647 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -112.47 25.86 11.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 163' ' ' ILE . 23.8 t -128.2 110.76 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.97 0.414 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -69.63 82.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.609 ' CA ' HG22 ' A' ' 158' ' ' VAL . . . -57.57 129.65 49.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.565 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.14 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.719 0.295 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -81.76 102.72 2.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.722 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 56.51 -84.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.617 0.246 . . . . 0.0 111.405 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -86.98 -0.17 56.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.82 26.03 5.71 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.661 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.595 ' HD2' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -90.05 133.2 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.903 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.713 ' O ' HG21 ' A' ' 135' ' ' VAL . 44.2 t -67.92 119.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.149 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.595 HD21 ' HD2' ' A' ' 157' ' ' ARG . 2.6 mt -108.41 171.92 7.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.796 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -51.65 -30.1 20.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.742 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.48 -39.34 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -63.3 -50.39 70.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.1 mm -59.91 -51.72 69.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.209 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.56 -31.94 57.55 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.67 -32.82 47.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.647 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.8 t80 -60.74 -40.33 91.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.949 HD21 HG21 ' A' ' 144' ' ' VAL . 3.3 mm? -82.64 -37.28 25.14 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.6 mt . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.906 0.384 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -169.98 141.61 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.1 mmm -67.65 158.29 83.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.84 -28.64 87.68 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.537 2.158 . . . . 0.0 112.062 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -64.96 -42.57 94.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.625 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' A' ' 159' ' ' LEU . 47.6 t -71.42 -46.95 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 1.1 mmm180 -56.1 -51.0 69.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.689 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -59.15 -39.37 82.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.785 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.638 ' CD1' HG21 ' A' ' 163' ' ' ILE . 48.9 t-105 -60.54 -50.65 72.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -59.49 -48.54 81.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.195 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -54.97 -33.94 62.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -79.92 -27.34 39.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -4.01 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.31 13.45 65.77 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.532 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.89 HG21 HD21 ' A' ' 167' ' ' LEU . 21.4 t -106.58 145.26 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 12.9 t0 -107.56 128.81 54.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.698 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.4 tp -57.09 -28.61 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.91 0.386 . . . . 0.0 111.046 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -61.18 -19.24 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.889 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.665 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -112.53 25.72 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.386 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 163' ' ' ILE . 22.0 t -127.48 112.28 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.68 77.13 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -53.64 145.47 23.87 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.76 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.5 p -117.94 18.8 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.622 0.248 . . . . 0.0 111.315 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -69.81 97.21 0.55 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.478 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.58 -87.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.499 0.19 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 153' ' ' GLY . 82.3 m-20 -78.03 -6.79 55.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.666 0.269 . . . . 0.0 111.256 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.11 4.81 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.603 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -84.37 131.41 34.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.698 ' HB ' HD11 ' A' ' 146' ' ' ILE . 32.2 t -67.9 123.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.257 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.728 ' HA ' HG21 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -114.95 172.72 6.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.472 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -32.72 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.933 0.397 . . . . 0.0 110.762 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.12 -39.36 75.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.12 -47.76 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.598 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.638 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -60.07 -51.66 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.4 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.52 -34.91 62.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.295 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.79 -33.52 62.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.277 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.665 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 22.5 t80 -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.89 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -80.55 -32.75 36.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.61 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.3 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.861 0.362 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.09 148.82 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.75 154.79 73.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.81 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.17 -30.17 31.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.508 2.139 . . . . 0.0 112.362 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -64.18 -41.31 97.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.7 HG21 ' O ' ' A' ' 158' ' ' VAL . 40.9 t -73.03 -47.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -48.97 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.252 0.548 . . . . 0.0 109.686 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -59.82 -41.96 92.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.832 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 163' ' ' ILE . 55.6 t-105 -60.33 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.296 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.52 -48.0 83.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.21 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -56.2 -31.62 63.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -81.49 -28.08 34.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.73 -3.52 49.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.723 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.17 14.67 66.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.611 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.943 HG21 HD21 ' A' ' 167' ' ' LEU . 26.0 t -105.54 145.13 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.201 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.483 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 9.7 t0 -106.71 120.77 42.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.4 tp -50.34 -28.27 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.965 0.412 . . . . 0.0 111.378 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -60.73 -21.53 63.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.076 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.671 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -109.75 25.86 11.31 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.292 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.515 HG11 HD13 ' A' ' 163' ' ' ILE . 29.0 t -129.01 108.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -75.99 79.0 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.831 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.641 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -56.28 149.93 26.19 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.78 12.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.68 0.276 . . . . 0.0 111.3 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.57 105.43 2.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.663 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.084 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -93.38 13.0 22.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.09 26.08 7.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.389 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.61 ' HG3' HG22 ' A' ' 130' ' ' ILE . 16.0 ttm105 -77.54 125.28 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.319 . . . . 0.0 110.999 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.7 ' O ' HG21 ' A' ' 135' ' ' VAL . 40.0 t -68.02 121.08 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.48 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -110.22 172.22 6.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -51.86 -29.82 21.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.77 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -71.66 -38.98 70.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.588 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -64.46 -49.56 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.529 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.652 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.2 mm -59.27 -52.47 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -34.84 62.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.363 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 -31.92 60.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.293 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.0 t80 -63.15 -40.83 98.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.455 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.943 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -80.58 -34.0 35.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.912 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.297 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.777 0.322 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.49 -47.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.98 127.51 47.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.926 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 147' ' ' ARG . 23.5 t -64.0 159.4 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.76 HG22 ' HG2' ' A' ' 157' ' ' ARG . 14.8 mt -113.43 119.64 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.317 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.04 164.55 9.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.769 ' HB2' HG23 ' A' ' 135' ' ' VAL . 29.1 mmm -76.49 141.64 69.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.431 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.605 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 72.2 Cg_exo -48.62 -45.53 27.21 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.302 2.001 . . . . 0.0 112.403 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.473 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 3.2 p -63.56 -32.67 74.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.822 HG11 ' O ' ' A' ' 158' ' ' VAL . 65.6 t -66.0 -40.49 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.085 0.469 . . . . 0.0 109.791 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 2.5 mmm180 -63.45 -44.01 95.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.904 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -65.87 -41.1 92.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.669 ' CD1' HG21 ' A' ' 163' ' ' ILE . 54.9 t-105 -58.07 -50.17 74.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.086 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.658 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.78 -52.56 64.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.033 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -54.93 -30.45 58.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.44 -35.23 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.415 ' HE3' ' CZ3' ' A' ' 138' ' ' TRP . 0.8 OUTLIER -91.75 -3.99 55.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.745 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.93 63.07 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.575 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.938 HG21 HD21 ' A' ' 167' ' ' LEU . 19.0 t -101.0 145.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.265 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 24.2 t0 -111.24 133.89 53.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.348 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.587 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -58.1 -33.45 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.43 . . . . 0.0 110.797 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.789 ' HA ' HG21 ' A' ' 129' ' ' VAL . 7.1 mtp180 -54.85 -22.64 15.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.889 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.98 25.6 11.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.721 0.296 . . . . 0.0 111.405 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.458 HG11 ' CG1' ' A' ' 158' ' ' VAL . 29.1 t -129.04 112.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 111.247 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -80.56 73.03 7.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.611 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -54.75 150.47 17.67 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.651 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.09 12.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.267 . . . . 0.0 111.202 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -70.09 95.1 0.48 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.711 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.14 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.689 0.28 . . . . 0.0 111.259 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.6 p30 -97.11 5.7 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.099 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.13 26.04 4.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.621 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.76 ' HG2' HG22 ' A' ' 130' ' ' ILE . 12.4 mtt180 -77.35 122.43 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.822 ' O ' HG11 ' A' ' 135' ' ' VAL . 36.5 t -71.11 102.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.843 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.8 mt -94.14 173.08 7.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -51.34 -30.11 17.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.654 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -69.02 -41.11 78.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.404 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -63.39 -49.39 74.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.392 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.9 mm -59.81 -52.28 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.275 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -31.71 61.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.332 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -33.2 49.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.183 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 18.4 t80 -60.88 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.441 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.938 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.93 -40.2 40.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.4 30.82 3.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -139.78 27.87 2.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.494 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.1 p30 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.752 0.31 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.31 77.72 0.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -94.84 -179.94 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.831 HG11 HG23 ' A' ' 146' ' ' ILE . 20.2 t -91.2 141.03 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 157' ' ' ARG . 1.9 mt -126.15 120.8 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.3 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.15 166.05 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.075 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.7 mtp -91.89 149.88 39.72 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.77 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.4 -30.98 28.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.487 2.124 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -66.04 -40.69 91.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.622 HG21 ' O ' ' A' ' 158' ' ' VAL . 39.3 t -72.3 -44.44 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.457 ' HD3' HG21 ' A' ' 146' ' ' ILE . 2.6 mmm180 -58.32 -46.64 85.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 109.775 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -63.09 -39.95 96.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.941 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 163' ' ' ILE . 56.1 t-105 -63.11 -46.27 88.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.221 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.632 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -64.37 -47.28 79.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.235 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.2 -29.53 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.864 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -80.81 -31.23 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.997 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -5.36 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.576 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.42 -10.11 64.98 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.669 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.959 HG21 HD21 ' A' ' 167' ' ' LEU . 40.0 t -82.74 145.02 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 53.6 t0 -110.65 113.36 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.222 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.831 HG23 HG11 ' A' ' 129' ' ' VAL . 0.6 OUTLIER -44.47 -25.61 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.495 ' HA ' HG21 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -58.63 -18.03 27.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 149' ' ' VAL . 0.5 OUTLIER -115.44 29.16 8.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.621 0.248 . . . . 0.0 111.545 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 148' ' ' LEU . 43.1 t -129.04 109.54 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.393 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 82.29 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -53.6 142.57 29.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.787 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -118.25 -21.14 8.28 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.859 ' H ' HD21 ' A' ' 159' ' ' LEU . . . -60.51 153.3 36.64 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.493 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 48.02 -104.8 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -105.46 30.04 6.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.734 0.302 . . . . 0.0 111.435 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.27 20.48 13.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.761 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.578 ' HB3' HG22 ' A' ' 130' ' ' ILE . 22.4 ptt180 -85.47 154.15 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.649 0.262 . . . . 0.0 110.399 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.742 ' C ' HD13 ' A' ' 159' ' ' LEU . 22.2 t -80.74 133.93 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.488 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.859 HD21 ' H ' ' A' ' 153' ' ' GLY . 0.0 OUTLIER -119.34 169.82 9.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -52.17 -30.7 28.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.02 -39.99 78.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.412 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.705 ' OD2' HD22 ' A' ' 159' ' ' LEU . 87.6 m-20 -64.1 -51.05 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.652 HG21 ' CD1' ' A' ' 138' ' ' TRP . 42.2 mm -59.48 -52.06 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -54.38 -33.85 60.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.384 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.73 -31.19 52.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.209 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 24.2 t80 -64.24 -37.66 88.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.628 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.959 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -89.06 -26.64 21.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.73 31.06 1.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.361 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -137.49 27.0 2.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.523 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.525 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.846 0.355 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -83.61 -24.18 31.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -56.08 172.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.743 HG21 ' HA ' ' A' ' 147' ' ' ARG . 26.1 t -103.86 158.13 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.782 HG22 ' CG ' ' A' ' 157' ' ' ARG . 23.8 mm -127.05 121.98 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.245 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.11 160.98 8.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.3 mtp -81.92 145.88 54.51 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.68 -32.55 45.6 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.489 2.126 . . . . 0.0 112.283 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -40.41 95.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.697 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.772 HG21 ' HA ' ' A' ' 159' ' ' LEU . 46.3 t -70.25 -46.26 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.2 OUTLIER -56.31 -45.7 80.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.798 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -61.92 -41.1 97.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.615 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.633 ' CD1' HG21 ' A' ' 163' ' ' ILE . 54.0 t-105 -61.24 -50.48 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.247 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -58.6 -44.09 89.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.76 -32.76 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -77.88 -27.47 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -96.69 -6.07 37.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.606 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.74 -9.01 71.13 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.63 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.743 HG21 HD21 ' A' ' 167' ' ' LEU . 18.1 t -82.06 145.21 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.888 0.375 . . . . 0.0 111.49 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 62.5 t0 -110.24 122.67 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.1 tp -50.7 -27.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.294 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.743 ' HA ' HG21 ' A' ' 129' ' ' VAL . 1.3 mtp180 -61.36 -23.22 65.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.933 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.679 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -109.44 23.52 14.35 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.409 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.443 HG23 HD12 ' A' ' 148' ' ' LEU . 44.2 t -123.91 114.74 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.9 78.98 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.66 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.65 142.16 34.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.718 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p -118.05 23.93 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -75.08 90.09 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.537 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.64 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.618 0.247 . . . . 0.0 111.145 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . 87.4 m-20 -85.69 -0.74 56.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.145 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.03 26.07 4.82 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.587 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.782 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -80.92 122.87 27.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.735 0.302 . . . . 0.0 110.816 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.674 ' HB ' HD11 ' A' ' 146' ' ' ILE . 35.4 t -67.9 111.27 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.939 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.772 ' HA ' HG21 ' A' ' 135' ' ' VAL . 3.1 mt -102.44 175.28 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.744 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -32.49 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.33 -35.43 75.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.415 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.424 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.633 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.8 mm -60.95 -45.78 97.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HA ' HD12 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -58.27 -41.12 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.311 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.62 -34.59 74.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.348 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.679 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 19.2 t80 -59.98 -45.46 92.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.372 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.743 HD21 HG21 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -76.6 -27.73 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.099 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.59 30.97 1.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.394 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -102.6 -27.25 6.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.41 -1.217 . . . . 0.0 112.509 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 t30 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.839 0.352 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -124.55 68.91 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.688 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.03 139.81 43.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.673 HG11 HG23 ' A' ' 146' ' ' ILE . 16.2 t -90.29 126.32 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.011 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.559 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mt -117.85 128.3 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.037 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.18 150.89 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.0 mtm -74.99 161.67 76.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.55 -29.28 84.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.524 2.149 . . . . 0.0 112.125 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 p -67.02 -37.32 83.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.598 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 158' ' ' VAL . 45.0 t -74.77 -47.52 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 109.746 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -61.68 -41.78 98.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.752 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.69 ' CD1' HG21 ' A' ' 163' ' ' ILE . 49.6 t-105 -60.22 -47.24 86.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.43 -50.34 73.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.069 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -54.21 -33.5 58.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.095 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -78.42 -29.73 47.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.817 0.341 . . . . 0.0 110.943 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.408 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 2.1 mmtt -92.98 -3.64 54.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.9 12.68 68.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.569 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.805 ' CG2' HD21 ' A' ' 167' ' ' LEU . 20.4 t -104.04 145.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.367 . . . . 0.0 111.214 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 22.6 t0 -107.82 121.06 43.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.344 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.762 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.1 tp -50.74 -26.41 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.449 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.576 ' HA ' HG21 ' A' ' 129' ' ' VAL . 0.1 OUTLIER -60.43 -23.37 64.34 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.707 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -110.15 25.77 11.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.0 111.503 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.455 HG23 HD12 ' A' ' 148' ' ' LEU . 39.7 t -127.09 108.01 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -76.15 79.02 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.645 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -53.26 159.34 3.87 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.765 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 p -118.27 8.48 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -63.85 87.07 0.06 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.65 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.623 0.249 . . . . 0.0 111.257 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.8 m-80 -87.7 3.21 48.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.119 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.16 4.78 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.559 ' HG3' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -73.02 113.3 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 0.0 110.918 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.762 ' HB ' HD11 ' A' ' 146' ' ' ILE . 40.1 t -67.84 111.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.518 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -100.65 176.16 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -30.97 60.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.676 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.73 -33.83 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.73 -47.61 62.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.69 HG21 ' CD1' ' A' ' 138' ' ' TRP . 36.5 mm -60.99 -47.74 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.31 -40.06 85.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.299 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.41 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.132 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.686 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.0 t80 -60.01 -46.03 90.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.201 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.805 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -76.28 -27.12 56.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.132 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.22 31.14 1.75 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.282 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -112.23 -27.38 3.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.487 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.534 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.778 0.323 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 85.96 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.44 162.94 12.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 147' ' ' ARG . 20.2 t -60.01 159.24 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.7 HG22 ' HG3' ' A' ' 157' ' ' ARG . 2.8 mp -92.61 114.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.77 152.41 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.39 153.94 71.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.52 -33.26 67.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.191 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.2 m -64.01 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 159' ' ' LEU . 61.4 t -74.17 -48.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -47.0 82.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.829 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -61.56 -42.1 98.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.729 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 163' ' ' ILE . 51.5 t-105 -59.32 -48.93 79.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.136 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.698 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.05 -49.59 76.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.016 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 tpt85 -54.47 -30.7 53.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.84 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -79.71 -32.21 41.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.412 ' HD3' ' CH2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -92.18 -2.67 56.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.713 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.77 16.06 64.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.491 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 1.083 HG21 HD11 ' A' ' 167' ' ' LEU . 34.4 t -105.86 145.11 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.368 . . . . 0.0 111.261 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.1 t0 -108.77 122.11 46.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.74 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.9 tp -50.06 -27.15 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 111.292 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.734 ' HA ' HG21 ' A' ' 129' ' ' VAL . 12.5 mmt-85 -60.04 -25.17 65.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.739 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -107.41 25.43 11.46 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.344 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.426 HG23 HD12 ' A' ' 148' ' ' LEU . 31.3 t -126.51 111.3 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.975 0.417 . . . . 0.0 111.459 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -79.91 74.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.536 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -53.31 145.59 22.08 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.773 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.7 p -118.05 24.21 11.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.991 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -73.68 101.72 1.22 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.7 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.62 -83.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.651 0.262 . . . . 0.0 111.197 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -97.09 6.28 48.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.463 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.99 26.07 4.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.715 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.7 ' HG3' HG22 ' A' ' 130' ' ' ILE . 26.6 ttm180 -83.45 125.26 31.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.74 ' HB ' HD11 ' A' ' 146' ' ' ILE . 21.5 t -67.95 119.44 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.603 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.7 mt -113.34 171.99 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.815 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -50.6 -28.8 9.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.975 0.417 . . . . 0.0 110.729 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -72.47 -41.0 66.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.507 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.3 -45.74 91.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.6 mm -62.75 -49.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -31.8 63.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.202 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.46 -41.21 40.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.892 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.739 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 16.3 t80 -61.38 -24.85 66.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.202 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.083 HD11 HG21 ' A' ' 144' ' ' VAL . 4.5 mp -87.95 -39.96 14.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.82 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.89 31.02 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.409 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -120.57 27.39 6.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.029 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.468 -179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.799 0.333 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -61.29 -174.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -73.05 157.11 37.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 130' ' ' ILE . 24.9 t -132.14 158.56 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.484 ' N ' HG12 ' A' ' 129' ' ' VAL . 35.0 mm -95.58 123.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.21 157.96 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.094 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.95 161.89 54.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.75 -28.96 87.35 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.536 2.157 . . . . 0.0 112.119 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.8 p -67.5 -37.1 82.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' A' ' 159' ' ' LEU . 60.2 t -74.6 -47.71 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -43.63 93.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 109.789 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -64.07 -41.17 97.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.533 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.659 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.5 t-105 -61.01 -50.32 73.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.099 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.35 -47.19 87.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.156 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -57.71 -30.22 65.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.791 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.09 -40.17 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.29 -9.38 67.31 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.676 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.771 ' CG2' HD21 ' A' ' 167' ' ' LEU . 19.4 t -80.17 145.25 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.8 t0 -111.27 130.75 55.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.425 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.686 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.8 OUTLIER -56.7 -28.65 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.127 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.4 mtt85 -59.46 -19.0 44.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.961 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.651 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -114.71 27.23 9.59 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.621 0.248 . . . . 0.0 111.391 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.5 t -128.87 115.98 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.35 73.97 7.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.531 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -52.05 142.74 21.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.715 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.2 p -118.03 26.11 9.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -78.16 100.71 1.66 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.665 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.41 -85.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.58 0.228 . . . . 0.0 111.095 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 10.6 p30 -83.94 -4.76 58.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.05 26.02 4.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.476 ' NE ' HD21 ' A' ' 159' ' ' LEU . 23.8 ptt-85 -82.21 134.86 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.969 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HD11 ' A' ' 146' ' ' ILE . 18.7 t -69.34 119.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.306 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.1 mt -111.73 176.99 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.619 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.43 -35.16 62.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -69.15 -32.58 72.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.59 -50.0 55.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.623 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.659 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.6 mm -60.1 -46.2 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -39.7 84.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.224 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -33.96 70.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.316 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.651 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.5 t80 -58.7 -49.24 78.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -73.56 -31.55 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.38 31.04 2.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -139.87 27.83 2.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.512 -179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.757 0.313 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.4 132.41 35.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -116.89 119.65 36.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.94 141.77 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 157' ' ' ARG . 5.4 mt -98.74 136.16 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.241 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.444 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.07 177.35 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.602 ' HE1' HD23 ' A' ' 159' ' ' LEU . 2.7 mtm -108.79 155.45 40.67 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.94 -30.75 31.6 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.48 2.12 . . . . 0.0 112.284 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.2 m -63.86 -45.95 87.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 159' ' ' LEU . 60.3 t -70.31 -44.4 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.835 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 12.8 mmm-85 -58.63 -42.88 89.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 109.869 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.4 -41.65 98.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.643 ' CD1' HG21 ' A' ' 163' ' ' ILE . 58.1 t-105 -61.87 -51.0 69.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.207 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.84 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 13.6 ttm105 -60.35 -31.38 70.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -77.52 -34.85 53.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.428 ' HE2' ' CZ3' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -89.98 -5.87 56.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.574 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.6 72.75 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.717 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.751 ' CG2' HD21 ' A' ' 167' ' ' LEU . 19.2 t -80.93 145.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.875 0.369 . . . . 0.0 111.355 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 49.4 t0 -109.52 134.28 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 131' ' ' ALA . 2.0 tp -60.37 -28.82 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -61.51 -17.09 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.84 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -115.4 25.02 11.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.539 0.209 . . . . 0.0 111.402 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.59 111.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.93 75.34 5.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.661 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.58 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -51.04 159.5 1.88 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.729 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.0 p -118.11 12.14 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.642 0.258 . . . . 0.0 111.356 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.67 92.17 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.697 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt 56.6 -86.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -88.07 5.95 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.294 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.07 4.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.572 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.65 ' HG3' HG22 ' A' ' 130' ' ' ILE . 25.2 ttm180 -73.35 115.9 13.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 151' ' ' GLY . 41.8 t -67.92 119.65 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.03 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.642 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.3 mt -110.78 177.41 4.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -33.34 61.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.98 0.419 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -70.46 -33.2 71.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.453 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.79 -48.87 65.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.545 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.643 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.8 mm -61.49 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.492 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.09 -39.08 81.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.27 64.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.658 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.6 t80 -59.47 -52.36 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.751 HD21 ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -70.09 -38.42 75.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.88 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.9 64.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.271 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -84.76 -29.64 28.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.573 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.518 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.838 0.352 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -116.05 117.89 31.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.963 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.39 120.79 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.771 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.407 ' CG1' HG23 ' A' ' 146' ' ' ILE . 33.6 t -116.46 118.33 58.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.225 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.76 HG22 ' CG ' ' A' ' 157' ' ' ARG . 1.7 mp -127.07 130.45 71.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.94 160.24 8.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.218 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.798 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.9 mtp -74.56 148.95 85.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.568 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.588 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.4 Cg_endo -53.52 -46.29 34.88 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.492 2.128 . . . . 0.0 112.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.535 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 65.3 p -63.57 -32.03 73.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 132' ' ' MET . 48.1 t -66.69 -41.06 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 110.04 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.906 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -66.96 -40.53 87.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.381 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.67 ' CD1' HG21 ' A' ' 163' ' ' ILE . 56.5 t-105 -59.89 -47.3 86.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.137 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.07 -52.09 66.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.076 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -51.99 -37.01 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.904 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.66 -40.74 80.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -85.03 -4.77 59.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.66 10.06 65.69 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.646 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.739 HG21 HD21 ' A' ' 167' ' ' LEU . 20.4 t -99.19 145.04 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.362 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 52.5 t0 -112.06 114.11 26.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.928 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.591 ' CD1' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -45.76 -26.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -57.46 -20.11 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -113.79 24.15 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.609 0.242 . . . . 0.0 111.327 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.556 HG23 HD12 ' A' ' 148' ' ' LEU . 40.0 t -123.06 111.75 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.96 78.79 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.717 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.669 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.57 152.24 12.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.4 p -117.95 19.21 13.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.557 0.218 . . . . 0.0 111.25 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -72.59 88.17 0.53 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.483 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.74 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.647 0.26 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.7 OUTLIER -84.02 -0.34 51.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.211 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.07 26.04 4.82 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.609 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.76 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.29 119.75 21.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.32 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.669 HG22 ' N ' ' A' ' 151' ' ' GLY . 41.6 t -68.02 111.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.97 176.4 5.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.755 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.22 -31.96 54.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.55 -35.5 75.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.578 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -68.22 -47.62 67.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.67 HG21 ' CD1' ' A' ' 138' ' ' TRP . 44.8 mm -60.04 -48.42 88.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -58.87 -39.68 82.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.178 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.28 72.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.422 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.539 ' CE2' HD13 ' A' ' 148' ' ' LEU . 18.5 t80 -59.18 -50.26 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -69.73 -35.35 74.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.09 67.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.232 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.73 28.84 14.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.324 -1.265 . . . . 0.0 112.479 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -137.3 156.89 47.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.93 160.72 20.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 147' ' ' ARG . 21.8 t -116.58 159.18 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.735 HG22 ' CG ' ' A' ' 157' ' ' ARG . 3.2 mp -103.23 118.94 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.228 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.08 153.09 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.6 mtp -81.33 150.43 67.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.81 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.56 -31.24 39.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.1 m -63.91 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.744 HG21 ' O ' ' A' ' 158' ' ' VAL . 43.6 t -75.34 -49.66 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.56 -47.07 80.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -45.97 90.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.596 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.636 ' CD1' HG21 ' A' ' 163' ' ' ILE . 52.4 t-105 -57.04 -49.17 76.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.402 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.69 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.11 -38.85 92.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.456 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.39 -30.9 71.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -82.8 -30.51 28.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.497 ' HG2' HD21 ' A' ' 167' ' ' LEU . 2.3 tptt -88.76 -15.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.506 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.77 45.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.667 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 1.074 HG21 HD11 ' A' ' 167' ' ' LEU . 38.8 t -85.5 145.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 111.264 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 43.1 t0 -108.98 119.86 40.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.384 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.671 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.0 OUTLIER -49.17 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.888 0.375 . . . . 0.0 111.498 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.799 ' HA ' HG21 ' A' ' 129' ' ' VAL . 10.7 mtm180 -59.47 -27.41 66.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.76 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.762 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -104.64 26.49 9.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.227 . . . . 0.0 111.33 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.445 HG23 HD12 ' A' ' 148' ' ' LEU . 24.8 t -128.79 109.7 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 111.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -79.11 75.78 5.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.621 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -55.38 145.86 30.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.736 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.9 p -118.1 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.844 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -74.88 100.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.639 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? 59.26 -82.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.535 0.207 . . . . 0.0 111.055 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.1 p30 -97.5 7.16 47.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.655 0.264 . . . . 0.0 111.297 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.94 26.13 4.82 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.526 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.735 ' CG ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -81.83 123.83 29.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 111.116 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.744 ' O ' HG21 ' A' ' 135' ' ' VAL . 24.3 t -67.95 111.1 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.481 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -102.11 175.1 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -53.83 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.39 -36.76 68.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.432 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -66.0 -46.7 77.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.419 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.636 HG21 ' CD1' ' A' ' 138' ' ' TRP . 34.9 mm -63.01 -50.79 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.332 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -57.45 -31.91 66.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 110.392 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.983 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.762 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.3 t80 -61.83 -28.66 69.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.117 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.074 HD11 HG21 ' A' ' 144' ' ' VAL . 3.7 mp -81.17 -47.99 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.784 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.03 67.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -84.37 -28.93 31.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.557 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.562 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.808 0.337 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -97.11 25.93 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.15 149.36 52.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 146' ' ' ILE . 18.4 t -107.13 156.74 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.039 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.483 HG21 ' OD1' ' A' ' 155' ' ' ASN . 29.4 mt -127.06 124.84 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.176 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.444 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.22 174.77 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 135' ' ' VAL . 33.1 mmm -91.07 147.13 35.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.394 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.576 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 72.0 Cg_exo -48.5 -50.56 12.03 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.444 2.096 . . . . 0.0 112.81 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.517 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -63.44 -26.6 68.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.837 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 159' ' ' LEU . 80.5 t -71.59 -38.78 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.907 0.384 . . . . 0.0 110.223 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.6 OUTLIER -67.51 -41.55 84.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.714 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.37 -39.46 81.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.654 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.3 t-105 -59.93 -50.25 74.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.201 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.1 -49.61 73.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.87 -35.73 57.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.84 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -4.24 56.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.541 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.18 -10.56 65.59 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.628 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.967 HG21 HD21 ' A' ' 167' ' ' LEU . 18.8 t -80.97 145.27 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.007 0.432 . . . . 0.0 111.417 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 35.0 t0 -108.24 133.57 52.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.841 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.4 tp -59.39 -35.28 57.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.116 0.484 . . . . 0.0 110.928 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.566 ' HA ' HG21 ' A' ' 129' ' ' VAL . 4.5 mtp180 -55.1 -21.2 12.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.226 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.08 25.35 11.89 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.428 HG11 HD13 ' A' ' 163' ' ' ILE . 21.9 t -129.13 111.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 111.245 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.15 77.67 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.407 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -56.14 144.81 35.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.646 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.2 p -118.02 26.1 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.739 0.304 . . . . 0.0 111.068 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.5 102.37 1.97 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.718 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? 57.84 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.625 0.25 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.483 ' OD1' HG21 ' A' ' 130' ' ' ILE . 8.4 p30 -90.7 -0.54 57.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.252 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.02 26.07 4.82 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.679 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.471 ' CB ' HG22 ' A' ' 130' ' ' ILE . 8.6 ptp180 -82.33 133.35 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.748 0.309 . . . . 0.0 110.979 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.841 ' HB ' HD11 ' A' ' 146' ' ' ILE . 5.0 t -68.0 123.89 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.527 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.6 mt -114.71 170.17 8.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -32.0 11.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.57 -40.95 73.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.633 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -61.91 -50.91 70.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.572 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.654 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -58.34 -52.24 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.413 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.65 -34.07 57.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.401 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.45 -32.39 60.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.66 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 19.4 t80 -64.14 -37.68 88.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.496 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.967 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -86.16 -27.56 24.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.043 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.32 31.07 1.55 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.417 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 96.7 56.03 1.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.467 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.419 -1.212 . . . . 0.0 112.503 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.96 142.77 58.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -115.3 157.66 23.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.702 HG11 HG23 ' A' ' 146' ' ' ILE . 13.4 t -111.95 159.76 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.465 ' N ' HG12 ' A' ' 129' ' ' VAL . 1.8 mp -122.83 118.45 55.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -169.97 162.56 9.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.799 ' HB2' HG23 ' A' ' 135' ' ' VAL . 15.3 mtp -75.12 144.31 78.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.554 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 73.5 Cg_exo -49.06 -47.56 21.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.386 2.057 . . . . 0.0 112.397 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 137' ' ' LYS . 1.3 m -63.46 -30.47 71.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.677 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.799 HG23 ' HB2' ' A' ' 132' ' ' MET . 63.6 t -66.93 -40.69 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 109.93 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -64.41 -43.84 93.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.778 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -65.2 -41.36 94.59 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.6 t-105 -58.18 -50.83 72.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.236 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -62.96 -49.22 75.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.853 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -56.4 -29.94 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.781 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.7 -43.53 59.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -84.5 -4.63 59.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.496 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.4 66.28 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.617 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.938 HG21 HD21 ' A' ' 167' ' ' LEU . 18.6 t -78.96 145.09 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 111.311 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 7.6 t0 -108.29 134.6 50.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.418 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.702 HG23 HG11 ' A' ' 129' ' ' VAL . 3.4 tp -59.7 -35.17 58.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.021 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.423 ' HA ' HG21 ' A' ' 129' ' ' VAL . 44.8 mtp180 -55.59 -21.05 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.14 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.644 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -110.42 26.8 10.29 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.634 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 163' ' ' ILE . 21.8 t -128.95 113.76 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -77.76 76.96 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.721 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.623 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -54.95 142.68 34.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.604 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.7 p -117.46 25.37 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.7 0.286 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -77.51 98.48 1.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.12 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.634 0.254 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 11.7 p-10 -79.32 -6.48 56.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.182 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.06 26.09 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -83.83 133.81 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.342 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.695 ' HB ' HD11 ' A' ' 146' ' ' ILE . 31.4 t -70.44 118.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.568 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.3 mt -108.16 171.81 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.684 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -32.24 18.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -70.72 -39.26 73.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.621 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.01 -47.28 83.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.0 mm -60.8 -51.44 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.291 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -33.87 61.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.201 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.29 -34.11 61.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.123 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 20.8 t80 -60.91 -39.66 90.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.157 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.938 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -82.16 -31.46 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.956 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.65 31.03 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.55 66.43 0.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.367 -1.241 . . . . 0.0 112.524 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.845 0.355 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.93 -46.57 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.964 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -77.21 -177.59 4.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.806 HG21 ' HA ' ' A' ' 147' ' ' ARG . 21.7 t -130.3 143.46 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.086 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 130' ' ' ILE . 4.0 mp -84.92 118.39 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 156.54 6.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -82.91 152.13 65.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.41 -36.26 68.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.505 2.137 . . . . 0.0 112.232 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.4 p -63.92 -34.04 77.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.831 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.496 HG12 ' CD1' ' A' ' 146' ' ' ILE . 48.1 t -75.18 -47.97 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -47.75 84.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.115 0.483 . . . . 0.0 109.802 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -62.48 -39.54 93.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.767 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.647 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.2 t-105 -61.39 -49.16 78.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.5 -49.05 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.167 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -56.75 -30.24 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.824 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.96 -40.95 62.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.9 -4.24 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.616 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.19 66.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 167' ' ' LEU . 22.0 t -79.59 145.21 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.365 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 18.3 t0 -111.47 122.98 49.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.507 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.686 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.7 tp -50.84 -25.8 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.806 ' HA ' HG21 ' A' ' 129' ' ' VAL . 3.5 mtm180 -60.42 -22.88 63.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.834 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.697 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -110.3 25.65 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.614 0.245 . . . . 0.0 111.394 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.429 HG23 HD12 ' A' ' 148' ' ' LEU . 28.5 t -127.65 106.48 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.88 0.371 . . . . 0.0 111.213 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -75.84 78.91 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -52.26 140.15 28.62 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.784 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.1 p -118.17 26.06 9.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.743 0.306 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 157' ' ' ARG . . . -89.79 128.89 9.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.809 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -87.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.555 0.217 . . . . 0.0 111.524 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 25.0 m-80 -108.99 17.82 21.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.633 0.254 . . . . 0.0 111.376 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 22.55 7.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.009 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.461 ' HG3' HD21 ' A' ' 159' ' ' LEU . 7.3 ptp180 -84.45 133.93 34.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.62 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HD11 ' A' ' 146' ' ' ILE . 33.5 t -69.66 127.21 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.271 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.461 HD21 ' HG3' ' A' ' 157' ' ' ARG . 2.8 mt -116.22 172.54 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -53.46 -30.79 42.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.682 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.12 -35.95 69.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.0 -47.76 73.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.647 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.5 mm -61.57 -51.92 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.224 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -55.74 -33.18 64.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.415 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.44 -32.77 54.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.235 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.697 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 22.2 t80 -61.29 -43.08 99.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.4 -42.33 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.832 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.76 -24.98 64.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.21 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -122.39 28.23 5.83 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.487 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.467 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.0 m120 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.868 0.366 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -107.99 -38.1 5.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 173.01 6.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 147' ' ' ARG . 25.4 t -127.47 145.64 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.097 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.4 mp -107.69 114.27 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.05 146.34 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.8 mmm -74.12 151.01 88.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.05 -28.1 39.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.613 2.208 . . . . 0.0 112.073 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 p -63.87 -44.86 91.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 159' ' ' LEU . 48.4 t -70.05 -46.63 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.404 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 3.4 mmm180 -56.17 -47.55 78.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 109.808 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -60.67 -39.91 90.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.889 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 163' ' ' ILE . 60.9 t-105 -62.5 -50.21 72.32 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.199 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -63.74 -38.35 90.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.469 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -30.19 70.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.029 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -82.1 -31.26 30.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.351 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.43 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.6 mmtm -88.39 -24.03 23.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.397 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.83 -5.96 24.07 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.628 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 167' ' ' LEU . 43.5 t -85.32 145.18 8.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 148' ' ' LEU . 58.0 t0 -111.52 114.88 28.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -47.01 -24.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.851 ' HA ' HG21 ' A' ' 129' ' ' VAL . 22.4 mtp85 -58.25 -19.86 37.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -111.28 -5.76 14.63 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.518 HG23 HD12 ' A' ' 148' ' ' LEU . 41.4 t -91.04 113.8 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 0.0 111.332 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -79.08 75.92 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.631 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -55.79 142.08 38.45 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.815 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.08 25.87 10.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.0 111.016 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -79.62 112.32 3.43 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.886 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.53 -82.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.67 0.271 . . . . 0.0 111.399 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 153' ' ' GLY . 18.4 m-80 -106.07 16.34 25.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.32 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.84 26.04 6.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.686 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.65 ' HG3' HG22 ' A' ' 130' ' ' ILE . 54.0 ttm-85 -84.29 126.05 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 146' ' ' ILE . 20.7 t -68.0 124.08 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.588 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.8 mt -113.88 169.07 9.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.738 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -50.91 -31.31 17.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.67 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -70.19 -40.16 74.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.456 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.54 -45.7 91.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.0 mm -60.85 -53.12 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.266 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -53.28 -34.45 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.349 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.93 -31.47 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 148' ' ' LEU . 19.7 t80 -63.48 -44.53 94.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 144' ' ' VAL . 3.1 mm? -79.34 -30.05 42.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.75 30.98 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.318 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -158.82 -50.03 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.527 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.775 0.321 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -87.54 150.35 23.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.03 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 128.41 33.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.808 HG11 HG23 ' A' ' 146' ' ' ILE . 15.9 t -86.89 146.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.036 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.05 116.97 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.364 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.14 158.1 6.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 55.8 mtp -77.86 157.34 79.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.626 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.86 -35.54 77.74 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.464 2.109 . . . . 0.0 112.183 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -66.51 -29.6 69.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 158' ' ' VAL . 48.7 t -77.08 -49.16 23.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.962 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -46.35 88.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.36 94.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.633 ' CD1' HG21 ' A' ' 163' ' ' ILE . 59.7 t-105 -56.78 -51.55 68.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.057 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -56.51 -48.22 77.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.211 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -37.53 56.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.17 -49.65 59.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.257 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -72.26 -19.61 61.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.09 13.68 28.42 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.266 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 1.066 HG21 HD11 ' A' ' 167' ' ' LEU . 41.5 t -100.74 145.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.896 0.379 . . . . 0.0 111.233 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.2 t0 -107.46 115.38 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.808 HG23 HG11 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -46.71 -26.23 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -56.86 -22.37 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.008 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -111.94 28.67 8.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.57 0.224 . . . . 0.0 111.319 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 148' ' ' LEU . 21.9 t -129.04 108.53 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.938 0.399 . . . . 0.0 111.302 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.19 77.58 3.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.435 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -55.23 143.69 33.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.689 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 p -118.1 26.16 9.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.801 0.334 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.42 102.4 1.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.1 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.602 0.239 . . . . 0.0 111.272 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.92 -5.07 58.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 0.0 111.317 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.04 26.05 4.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.603 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -85.99 137.74 32.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.79 ' HB ' HD11 ' A' ' 146' ' ' ILE . 5.2 t -67.95 126.49 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.507 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.2 mt -116.2 169.29 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.568 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -50.33 -30.41 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 110.7 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.88 -40.98 71.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.483 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -62.7 -46.91 85.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.566 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.633 HG21 ' CD1' ' A' ' 138' ' ' TRP . 40.7 mm -62.67 -48.64 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.453 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -57.68 -31.54 66.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.355 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.78 -40.87 31.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.2 t80 -61.66 -25.9 67.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.256 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.066 HD11 HG21 ' A' ' 144' ' ' VAL . 3.3 mp -86.04 -45.5 11.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.77 31.11 2.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.29 28.04 1.37 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.395 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.449 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 mmt-85 -81.21 74.44 8.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 165.15 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.68 HG11 HG23 ' A' ' 146' ' ' ILE . 17.2 t -76.95 159.39 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.976 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 157' ' ' ARG . 1.9 mt -116.15 113.07 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.208 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.409 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.12 162.23 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 31.2 mtp -79.53 155.38 76.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.659 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.82 -32.99 93.39 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.525 2.15 . . . . 0.0 112.072 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -33.62 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.464 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 159' ' ' LEU . 41.2 t -74.93 -47.32 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.881 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -58.13 -49.62 76.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.54 -41.31 94.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.762 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.653 ' CD1' HG21 ' A' ' 163' ' ' ILE . 48.5 t-105 -59.89 -48.28 82.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.123 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.19 -50.47 73.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.91 -28.84 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -81.03 -28.59 35.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.033 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.0 OUTLIER -96.53 -4.03 42.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.62 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.19 8.95 64.05 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.784 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 167' ' ' LEU . 22.3 t -100.92 145.19 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.852 0.358 . . . . 0.0 111.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 23.5 t0 -108.4 121.13 44.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.504 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.788 HD11 ' HB ' ' A' ' 158' ' ' VAL . 1.2 tp -50.02 -27.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.943 0.401 . . . . 0.0 111.38 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -59.56 -21.83 60.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.063 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.714 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -111.39 26.78 10.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.559 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.438 HG23 HD12 ' A' ' 148' ' ' LEU . 22.4 t -129.04 107.15 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.463 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.84 81.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -56.04 139.38 43.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.689 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.19 26.07 9.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.55 128.91 9.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.873 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.62 -88.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 80.5 m-20 -105.55 26.27 9.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.4 24.08 27.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.801 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.469 ' HB3' HG22 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -83.97 136.73 33.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.788 ' HB ' HD11 ' A' ' 146' ' ' ILE . 24.0 t -69.23 130.52 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.301 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.612 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.6 mt -117.51 169.47 9.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -33.3 23.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 110.673 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.76 -38.68 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.53 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.91 -49.37 75.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.653 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -59.2 -52.19 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.414 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -54.97 -33.56 62.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.335 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.224 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.714 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 38.6 t80 -60.27 -43.25 96.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.434 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -77.91 -39.13 43.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.08 65.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.22 -30.11 76.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.599 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.57 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.857 0.36 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.24 99.39 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -60.0 147.94 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.843 HG21 ' HA ' ' A' ' 147' ' ' ARG . 29.0 t -72.91 153.83 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.071 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.404 ' N ' HG12 ' A' ' 129' ' ' VAL . 31.8 mm -113.87 122.7 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.222 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -170.01 165.28 9.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.779 ' HB2' HG23 ' A' ' 135' ' ' VAL . 30.9 mtp -80.34 149.93 69.84 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.612 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.9 Cg_endo -53.15 -47.68 26.21 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.588 2.192 . . . . 0.0 112.201 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.539 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 28.7 t -63.58 -30.6 71.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.605 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.779 HG23 ' HB2' ' A' ' 132' ' ' MET . 58.0 t -67.24 -40.86 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 109.986 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 146' ' ' ILE . 4.1 mmm180 -65.35 -41.4 93.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.935 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 1.5 mttt -68.43 -38.19 80.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.693 ' CD1' HG21 ' A' ' 163' ' ' ILE . 64.0 t-105 -61.39 -50.01 74.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -62.72 -45.27 93.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.933 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -60.18 -31.38 70.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.918 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.25 -31.38 54.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.464 ' HD3' ' CZ2' ' A' ' 138' ' ' TRP . 0.1 OUTLIER -92.37 -6.79 49.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.422 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.28 -10.42 67.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.348 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.961 HG21 HD21 ' A' ' 167' ' ' LEU . 18.0 t -80.58 145.17 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.528 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 32.0 t0 -107.36 132.84 52.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.219 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.685 HD11 ' HB ' ' A' ' 158' ' ' VAL . 3.7 tp -59.34 -35.2 57.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 110.996 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.843 ' HA ' HG21 ' A' ' 129' ' ' VAL . 58.6 mtp180 -55.59 -21.23 16.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.084 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.644 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.2 pp -109.6 26.25 10.87 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.56 0.219 . . . . 0.0 111.548 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.433 HG11 ' CG1' ' A' ' 158' ' ' VAL . 30.4 t -127.28 112.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.261 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.33 73.09 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.748 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.495 ' H ' HG22 ' A' ' 158' ' ' VAL . . . -57.74 153.42 24.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.62 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.2 p -118.18 25.63 10.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.677 0.275 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -76.99 105.17 2.0 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.941 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.612 0.244 . . . . 0.0 111.399 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -108.56 13.42 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.721 0.296 . . . . 0.0 111.068 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 110.58 26.08 4.94 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.436 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -78.28 122.83 26.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.11 -179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.685 ' HB ' HD11 ' A' ' 146' ' ' ILE . 11.5 t -67.97 113.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.062 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 135' ' ' VAL . 1.9 mt -105.52 170.48 7.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.614 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -30.65 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.924 0.392 . . . . 0.0 110.723 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -71.26 -40.74 70.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.602 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -61.98 -46.62 88.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.43 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.693 HG21 ' CD1' ' A' ' 138' ' ' TRP . 39.7 mm -61.11 -52.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.278 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -32.93 56.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.16 -33.1 61.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.238 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 18.3 t80 -63.97 -39.2 93.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.961 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -85.89 -24.97 26.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.7 31.06 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.424 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -110.63 27.61 11.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.479 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.445 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.751 0.31 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -147.41 123.32 10.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.96 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -76.29 158.36 31.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.846 HG11 HG23 ' A' ' 146' ' ' ILE . 23.0 t -108.26 147.03 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.208 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.55 HG22 ' HG3' ' A' ' 157' ' ' ARG . 18.6 mm -127.01 122.71 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.278 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.503 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -167.57 162.49 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.243 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.798 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -76.42 149.12 81.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.465 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.543 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 10.2 Cg_endo -53.6 -45.99 37.0 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.527 2.152 . . . . 0.0 112.147 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.544 ' HA ' ' HG3' ' A' ' 137' ' ' LYS . 12.2 p -63.58 -31.71 72.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 132' ' ' MET . 49.1 t -66.92 -41.93 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.169 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -63.29 -44.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.834 179.118 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.544 ' HG3' ' HA ' ' A' ' 134' ' ' SER . 1.2 mtmt -65.08 -40.79 95.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.655 ' CD1' HG21 ' A' ' 163' ' ' ILE . 50.9 t-105 -58.46 -51.97 67.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.157 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.14 -45.53 94.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.027 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -29.99 69.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.984 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -77.72 -30.63 51.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -95.21 -5.57 43.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.575 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.79 -9.52 68.47 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.492 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.978 HG21 HD21 ' A' ' 167' ' ' LEU . 17.5 t -80.56 145.18 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.902 0.382 . . . . 0.0 111.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 58.3 t0 -106.65 133.17 51.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.846 HG23 HG11 ' A' ' 129' ' ' VAL . 5.8 tp -58.45 -38.27 68.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -54.3 -20.72 7.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.379 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.608 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.3 pp -110.21 27.79 9.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.607 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 163' ' ' ILE . 22.4 t -128.54 117.18 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -79.23 75.57 5.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.588 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.623 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -52.2 154.4 5.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.861 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.5 p -118.19 21.7 12.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.649 0.261 . . . . 0.0 111.124 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.83 94.86 1.34 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.696 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.02 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.586 0.232 . . . . 0.0 111.203 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -88.27 5.07 43.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.26 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.88 26.05 4.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.612 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.55 ' HG3' HG22 ' A' ' 130' ' ' ILE . 6.5 ttt180 -74.18 120.6 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.309 . . . . 0.0 110.963 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.785 ' HB ' HD11 ' A' ' 146' ' ' ILE . 34.7 t -67.93 115.13 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.579 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.3 mt -105.03 170.35 7.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.504 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -31.36 13.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.86 -40.32 72.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.608 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -62.12 -46.08 90.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.482 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.655 HG21 ' CD1' ' A' ' 138' ' ' TRP . 36.9 mm -61.27 -51.72 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -53.98 -33.88 58.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.69 -33.65 62.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.608 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 17.5 t80 -60.43 -44.79 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.361 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.978 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -76.76 -34.07 58.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.853 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.97 -24.85 67.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -56.54 -26.78 53.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.596 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.591 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.914 0.388 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -31.46 14.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.5 140.94 44.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.522 HG21 ' HD3' ' A' ' 147' ' ' ARG . 22.9 t -97.05 123.95 49.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.029 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 157' ' ' ARG . 4.0 mp -126.99 123.78 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.332 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 152.51 4.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 44.3 mtp -80.33 151.46 72.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.48 -35.98 57.46 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.573 2.182 . . . . 0.0 112.218 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -64.01 -33.22 75.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 158' ' ' VAL . 45.2 t -75.44 -48.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -47.7 84.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.09 0.472 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.26 -40.5 96.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.599 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.648 ' CD1' HG21 ' A' ' 163' ' ' ILE . 53.5 t-105 -60.27 -49.43 77.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -60.82 -50.32 73.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -54.35 -30.51 51.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.82 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.54 -34.94 53.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HE3' ' CH2' ' A' ' 138' ' ' TRP . 1.5 mmpt? -90.42 -2.94 57.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.7 65.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.949 HG21 HD21 ' A' ' 167' ' ' LEU . 23.1 t -103.72 145.18 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.794 0.331 . . . . 0.0 111.269 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 8.3 t70 -104.89 132.23 51.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.662 HD11 ' HB ' ' A' ' 158' ' ' VAL . 2.0 tp -61.23 -28.85 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.401 . . . . 0.0 111.148 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.522 ' HD3' HG21 ' A' ' 129' ' ' VAL . 9.3 mmt180 -61.09 -17.92 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.983 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.647 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -112.47 25.86 11.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 163' ' ' ILE . 23.8 t -128.2 110.76 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.97 0.414 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -69.63 82.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.609 ' CA ' HG22 ' A' ' 158' ' ' VAL . . . -57.57 129.65 49.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.565 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.14 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.719 0.295 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -81.76 102.72 2.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.722 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 56.51 -84.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.617 0.246 . . . . 0.0 111.405 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -86.98 -0.17 56.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.82 26.03 5.71 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.661 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.595 ' HD2' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -90.05 133.2 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.903 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.713 ' O ' HG21 ' A' ' 135' ' ' VAL . 44.2 t -67.92 119.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.149 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.595 HD21 ' HD2' ' A' ' 157' ' ' ARG . 2.6 mt -108.41 171.92 7.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.796 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -51.65 -30.1 20.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.742 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.48 -39.34 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -63.3 -50.39 70.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.1 mm -59.91 -51.72 69.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.209 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.56 -31.94 57.55 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.67 -32.82 47.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.647 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.8 t80 -60.74 -40.33 91.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.949 HD21 HG21 ' A' ' 144' ' ' VAL . 3.3 mm? -82.64 -37.28 25.14 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.75 30.98 2.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.55 -35.38 6.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.513 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.493 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.838 0.352 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.4 ptt85 -86.02 -175.45 5.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -114.32 144.82 42.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.77 HG11 HG23 ' A' ' 146' ' ' ILE . 16.4 t -101.1 152.64 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.6 mt -126.85 115.43 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.235 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 146' ' ' ILE . . . -169.98 141.61 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.1 mmm -67.65 158.29 83.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.84 -28.64 87.68 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.537 2.158 . . . . 0.0 112.062 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -64.96 -42.57 94.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.625 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' A' ' 159' ' ' LEU . 47.6 t -71.42 -46.95 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HD3' ' CG2' ' A' ' 146' ' ' ILE . 1.1 mmm180 -56.1 -51.0 69.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.689 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -59.15 -39.37 82.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.785 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.638 ' CD1' HG21 ' A' ' 163' ' ' ILE . 48.9 t-105 -60.54 -50.65 72.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -59.49 -48.54 81.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.195 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -54.97 -33.94 62.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -79.92 -27.34 39.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -4.01 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.31 13.45 65.77 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.532 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.89 HG21 HD21 ' A' ' 167' ' ' LEU . 21.4 t -106.58 145.26 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 12.9 t0 -107.56 128.81 54.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.77 HG23 HG11 ' A' ' 129' ' ' VAL . 2.4 tp -57.09 -28.61 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.91 0.386 . . . . 0.0 111.046 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -61.18 -19.24 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.889 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.665 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 1.1 pp -112.53 25.72 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.386 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 163' ' ' ILE . 22.0 t -127.48 112.28 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.68 77.13 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -53.64 145.47 23.87 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.76 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.5 p -117.94 18.8 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.622 0.248 . . . . 0.0 111.315 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -69.81 97.21 0.55 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.478 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.58 -87.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.499 0.19 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 153' ' ' GLY . 82.3 m-20 -78.03 -6.79 55.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.666 0.269 . . . . 0.0 111.256 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 111.0 26.11 4.81 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.603 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -84.37 131.41 34.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.698 ' HB ' HD11 ' A' ' 146' ' ' ILE . 32.2 t -67.9 123.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.257 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.728 ' HA ' HG21 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -114.95 172.72 6.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.472 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -32.72 18.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.933 0.397 . . . . 0.0 110.762 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.12 -39.36 75.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.12 -47.76 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.598 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.638 HG21 ' CD1' ' A' ' 138' ' ' TRP . 43.2 mm -60.07 -51.66 70.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.4 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.52 -34.91 62.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.295 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.79 -33.52 62.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.277 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.665 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 22.5 t80 -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.89 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -80.55 -32.75 36.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.06 27.61 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.63 29.3 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.518 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.493 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.847 0.356 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -91.24 124.53 35.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.99 149.28 24.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.759 HG11 HG23 ' A' ' 146' ' ' ILE . 22.9 t -73.47 138.75 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.046 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.61 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.3 mp -121.75 123.51 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 146' ' ' ILE . . . -170.09 148.82 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.75 154.79 73.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.81 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.17 -30.17 31.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.508 2.139 . . . . 0.0 112.362 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -64.18 -41.31 97.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.7 HG21 ' O ' ' A' ' 158' ' ' VAL . 40.9 t -73.03 -47.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -48.97 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.252 0.548 . . . . 0.0 109.686 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -59.82 -41.96 92.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.832 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 163' ' ' ILE . 55.6 t-105 -60.33 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.296 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 144' ' ' VAL . . . -61.52 -48.0 83.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.21 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -56.2 -31.62 63.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -81.49 -28.08 34.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.73 -3.52 49.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.723 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.17 14.67 66.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.611 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.943 HG21 HD21 ' A' ' 167' ' ' LEU . 26.0 t -105.54 145.13 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.201 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.483 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 9.7 t0 -106.71 120.77 42.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.759 HG23 HG11 ' A' ' 129' ' ' VAL . 1.4 tp -50.34 -28.27 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.965 0.412 . . . . 0.0 111.378 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.676 ' HA ' HG21 ' A' ' 129' ' ' VAL . 4.2 mtm180 -60.73 -21.53 63.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.076 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.671 HD13 ' CZ ' ' A' ' 166' ' ' PHE . 0.8 OUTLIER -109.75 25.86 11.31 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.292 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.515 HG11 HD13 ' A' ' 163' ' ' ILE . 29.0 t -129.01 108.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -75.99 79.0 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.831 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.641 ' N ' HG22 ' A' ' 158' ' ' VAL . . . -56.28 149.93 26.19 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 22.78 12.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.68 0.276 . . . . 0.0 111.3 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.57 105.43 2.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.663 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.084 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -93.38 13.0 22.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.09 26.08 7.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.389 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.61 ' HG3' HG22 ' A' ' 130' ' ' ILE . 16.0 ttm105 -77.54 125.28 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.319 . . . . 0.0 110.999 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.7 ' O ' HG21 ' A' ' 135' ' ' VAL . 40.0 t -68.02 121.08 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.48 ' HA ' HG21 ' A' ' 135' ' ' VAL . 2.6 mt -110.22 172.22 6.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -51.86 -29.82 21.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.77 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -71.66 -38.98 70.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.588 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -64.46 -49.56 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.529 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.652 HG21 ' CD1' ' A' ' 138' ' ' TRP . 38.2 mm -59.27 -52.47 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -34.84 62.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.363 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 -31.92 60.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.293 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 148' ' ' LEU . 21.0 t80 -63.15 -40.83 98.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.455 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.943 HD21 HG21 ' A' ' 144' ' ' VAL . 3.2 mm? -80.58 -34.0 35.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.912 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.73 30.95 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.297 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -112.99 -28.54 3.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.594 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.402 -1.221 . . . . 0.0 112.553 179.999 . . . . . . . . 0 0 . 1 stop_ save_